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Abstract 
Resolution of four-way junction (Holliday junction, HJ) structures is a key event 
during recombination. The enzymatic activities that promote Holliday junction 
formation and resolution have been extensively characterized in bacteria. However, 
much less is known in eukaryotic cells and to identify similar activities in eukaryotes 
have been difficult. In this thesis, we aimed to identify HJ resolvases through protein 
sequence alignment. We identified Saccharomyces cerevisiae Yo1093wp by the PSI-
BLAST search with the sequence of the yeast mitochondrial resolvase Ccelp or 
Ydc2p. Yo1093wp homologs are widely found in eukaryotes. Each sequence of the 
Yo1093wp family has diverged substantially from every other with relatively small 
sizes, and contains some conserved acidic residues, which might contribute to the 
binding site catalytic metal ion(s). These are similar to those observed among the 
families of known resolvases. In this work, a variety of general and specific 
approaches were used to characterize the functions of YOL093W. We have shown 
that His-tagged Yo1093wp expressed in E. coli and has been enriched, and the 
Yo1093wp extracts might have DNA binding properties. Interestingly, in vitro 
studies revealed the preferential binding of Yo1093wp extracts to a mobile four-way 
junction than to a 60 nt-ssDNA or a 60 bp-dsDNA. The basis of this binding activity 
is still unclear. Further analysis will be required to elucidate the specificity of this 
DNA binding. Cells lacking Yo1093wp have no obvious growth defects under 
standard growth conditions. Meiotic recombination assays showed that YOL093W 
deletion has no effect on meiotic recombination. A yeast two-hybrid screen and TAP 
tag purification were utilised to identify Yo1093wp-interacting proteins. In the two-
hybrid screen, Mtllp that is involved in cell wall biogenesis was retrieved with 
relatively low significance. The TAP purification of Yo1093wp complex showed 
that the Yo1093w protein was synthesized in the TAP-tagged strain, and could be 
purified followed the TAP purification precedure. However, the identities of the 
potential interacting proteins identified did not throw much light on the function of 
Yol093wp. Finally, the immunofluorescence micrographs of Yo1093wp-GFP and 
Yo1093wp-13myc in conjunction with DAPI straining suggested that the Yo1093w 
fusion proteins are located in the nucleus. All of these data may be indicative of the 
function of Yo1093wp. 
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Chapter One: Introduction 
CHAPTER ONE 
Introduction 
1.1 Homologous Recombination 
1.1.1 Introduction 
Homologous recombination (FIR) is a process for genetic exchange between DNA 
sequences that share homology. It is a fundamental biological process that promotes 
genetic diversity and the maintenance of genome integrity in prokaryotic and 
eukaryotic organisms. Several processes employ the mechanism of homologous 
recombination: the repair of broken replication forks or DNA lesions 
(Kowalczykowski, 2000), the reassortment of alleles, and the correct segregation of 
chromosomes during meiosis (Roeder, 1997). In meiosis, the primary function of 
recombination is to establish a physical connection between homologous 
chromosomes to ensure their correct disjunction at the first meiotic division. In 
1 
Chapter One: Introduction 
addition, meiotic recombination contributes to diversity by creating new linkage 
arrangements between genes, or parts of genes (Roeder, 1997). It is now widely 
recognized that the primary function of homologous recombination in mitotic cells is 
to repair DSBs that form as a result of replication fork collapse, from processing of 
spontaneous damage, and from exposure to DNA-damaging agents (Kogoma, 1997; 
Aguilera et al., 2000; Cox, 2001; Kuzminov, 2001). Recombination is also required 
to repair the DSBs that initiate programmed rearrangements, such as mating-type 
switching in Saccharomyces cerevisiae (Strathern et al., 2000). 
Recombination can be initiated by several types of DNA damage: single-strand DNA 
(ssDNA) lesions may result during DNA replication or during repair, after UV 
irradiation or the alkylation or cross-linking of DNA bases, or from intermediates of 
type I topoisomerases; double-strand breaks (DSBs) can appear as a consequence of 
ionizing radiation, by mechanical stress, by endonucleases, or by replication of a 
single-stranded nicked chromosome (Friedberge et al., 1995; Lindahl and West, 
1995; Smith and Jones, 2000). If unrepaired, DSBs will result in broken 
chromosomes and loss of genetic material, genomic alterations or cell death. If 
repaired incorrectly, they can cause genetic alterations that can lead to cancer (Haber, 
1999; Jackson, 1999; Thacker 1986; Jeggo, 1998a;  Kanaar and Hoeijmakers, 1998). 
For these reasons, DSBs must be efficiently repaired to restore the integrity and 
functionality of the genome. 
A single-strand DNA lesion can be repaired using the information present on the 
remaining intact strand, but a double-strand lesion cannot be repaired in this way. In 
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eukaryotic cells, repair can be carried out either by homologous recombination or by 
non-homologous end joining (NHEJ) (reviewed in Pastink and Lohman, 1999; 
Pastink et al., 2001; Bosch et al., 2002; Symington, 2002). These pathways differ in 
their requirement for a homologous DNA template and the fidelity of the repair 
reaction. Homologous recombination uses an intact sister duplex as the template for 
repair, so the reaction occurs with high fidelity. By contrast, NHEJ occurs without a 
template, and involves the simple religation of the broken termini. Any sequences 
that are lost at the break site will be fixed as a mutation or deletion in the rejoined 
product. These repair mechanisms have been conserved through evolution and 
operate in a wide range of organisms, including both prokaryotes and eukaryotes, 
however, significantly differs depending on the organism. While homologous 
recombination plays a major role in DSB repair in prokaryotes and lower eukaryotes, 
it operates rather rarely in somatic cells of higher eukaryotes. Instead, in somatic 
cells of higher eukaryotes including, DSB are repaired primarily through NHEJ 
(Jeggo, 1998b.  Critchlow and Jackson, 1998). The importance of each pathway also 
depends on the stage of the cell cycle, with NHEJ dominating in Gi, and 
homologous recombination making a greater contribution in the S and G2 phases 
(Liang et al., 1998; Takata et al., 1998; Essers et al., 2000). In addition, in 
muticellular organisms, it also depends on the cell type and the stage of development. 
Furthermore, the involvement of each pathway may be influenced by the complexity 
and/or the quality of the break (Pastink and Lohman, 1999; Pastink et al., 2001; van 
den Bosch et al., 2002). 
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The processes by which damaged DNA is repaired and the mechanisms of genetic 
recombination are intimately related. Much of what we know about these events has 
come from studies of the yeast Saccharomyces cerevisiae, for which the 
development of new molecular biological and genetic approaches has made it 
possible to appreciate the many different pathways used by eukaryotic cells. The 
study of these processes in a simple, unicellular eucaryote has the obvious 
advantages of the ease of manipulation of DNA sequences and the possibility of 
studying specific repair and recombination events induced synchronously in a large 
proportion of cells. Equally important is the growing conviction that the processes 
that one can study with relative ease in yeast are identical in most respects to the 
ways in which human cells repair DNA damage and generate genetic diversity. The 
expanding list of human genetic diseases associated with defects in DNA metabolism 
makes it especially important in understanding how these processes occur. Moreover, 
defining these mechanisms has taken on added importance in the quest to develop 
more efficient mechanisms of gene targeting and gene replacement in mammalian 
cells (Paques and Haber, 1999). 
1.1.2 Current Model of Homologous Recombination 
Although with different biological meaning and genetic control, both mitotic and 
meiotic recombination uses common factors and steps. For years, the model most 
commonly used to explain the molecular mechanism of recombination has been the 
double-strand break repair (DSBR) model (Figure 1.1) (Szostak et al., 1983). The 
repair processes commences as single-stranded (ss) degradation of the broken DNA 
molecule exposes protruding 3'-OH ends. In all organisms, the early steps of 
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recombination involving homologous pairing and strand exchange are promoted by 
proteins belonging to the RecAJRAD51 family of recombinases. The 5'-ends on 
either side of the break is resected to produce single-stranded (ss) 3'-tails. The D-loop 
created by single-end invasion (SET) may enter the double-strand-break repair 
(DSBR) pathway and form a double Holliday junction (dHJ) (Hunter and Kleckner, 
2001; Allers and Lichten, 2001b), which can be resolved to crossover (CO) and non-
crossover (NCO) products. Resolution to crossover requires a symmetric cleavage of 
both Holliday junctions in opposite orientations by a Holliday junction resolvase. 
Resolution to non-crossovers can also be achieved by the resolvase (cleavage of both 
junctions in the same orientation) or by collapsing the dHJ to a hemi-catenane 
followed by resolution involving a type I topoisomerase activity. Alternatively, the 
D-loop enters the synthesis-dependent strand annealing (SDSA) pathway. After 
extension by DNA polymerase, the invading strand retreats to reanneal with the 
single-stranded DNA tail that did not form a D-loop. In its simplest version, SDSA 
leads only to NCO products (as shown in Figure 1.1). More complex versions of 
SDSA involve dill formation, which can be resolved by a Holliday junction 
resolvase to CO and NCO products (Paques and Haber, 1999). 
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Figure 1.1 Double-strand-break Repair (DSBR) and Synthesis-
Dependent Strand Annealing (SDSA) Models for Meiotic Recombination 
(Heyer, 2004) 
Meiotic recombination is initiated by Spol 1-generated double-stranded DNA breaks (DSBs) 
(step 1). After DSB processing by the Mrel 1—Rad50—Xrs2 complex and other enzymes (step 
2), RPA, Rad52 and Rad55—Rad57 orchestrate formation of the Rad5l nucleoprotein 
filament capable of homology search and DNA strand invasion (step 3). Rad54 augments 
Rad51-mediated recombination in 0-loop formation and is also thought to allow access of 
DNA polymerases to the invading 3m-OH by displacing Rad5l from the product heteroduplex 
DNA (steps 3b, 4a). The D-Ioop created by single-end invasion (SEI) may enter the DSBR 
pathway (step 3a) and form a double Holliday junction (dHJ; steps 4a, 5), which can be 
resolved to crossover (CO; step 5a) and non-crossover (NCO; step 5b) products. Resolution 
to CO requires a symmetric cleavage of both Holliday junctions in opposite orientations by 
Holliday junction resolvase. Resolution to NCOs can also be achieved by the resolvase 
(cleavage of both junctions in the same orientation) and by collapsing the dHJ to a hemi-
catenane followed by resolution involving a type I topoisomerase activity. Alternatively, the 
0-loop enters the SDSA pathway (step 3b). After extension by DNA polymerase, the 
invading strand retreats to reanneal with the single-stranded DNA tail that did not form a D-
loop (step 4b). In its simplest version, SDSA leads only to NCO products (as shown). 
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1.1.2.1 Homologous Recombination in Escherichia co/i 
The molecular mechanism of Homologous recombination (HR) is best understood in 
Escherichia coli (Roca and Cox, 1997; Cox, 1999). The principal recombination 
protein in this organism is the RecA protein and almost all DSB repair by HR is 
through the RecBCD pathway (Kowalczykowski et al., 1994). In the initiating step, 
DSB are specifically recognized by the RecBCD heterotrimer (exonuclease V), 
which has both exonuclease and helicase activities. In the presence of Mg 2 and ATP, 
the RecBCD complex binds to the end of a double-stranded DNA (dsDNA) substrate, 
unwinds processively and degrades preferentially the 3'-ending strand until it 
encounters a Chi (X)-site sequences that create recombination hot spots. After 
interaction with the X-site, the nuclease activity of the enzyme is altered so that 
degradation of the 3'-temunal strand is downregulated and the nuclease activity at the 
5'-terminated strand is upregulated, whilst helicase activity remains unaltered. Finally, 
the X-modified RecBCD enzyme produces resected dsDNA with a 3'-ssDNA tail 
terminating at the X-sequence (Bianco and Kowalczykowski, 1997; Amundsen et al., 
2000). Another helicase, RecQ, has also been shown to be able to initiate 
recombination by providing the RecA protein with a suitable substrate (Harmon and 
Kowalczykowski, 1998). In the presence of ATP, RecA coats a 3'-ssDNA tail and 
polymerizes head-to-tail, forming a right-handed presynaptic helical nucleoprotein 
filament. Upon modification of nuclease activity, RecBCD enzyme coordinates the 
preferential loading of RecA onto the resultant 3'-ssDNA tail downstream of X 
(Arnold and Kowalczykowski, 2000). In this process, RecBCD promotes 
displacement of single-strand binding (SSB) protein from ssDNA by RecA. SSB 
plays a dual role in RecA-mediated strand exchange (Meyer and Lame, 1990). 
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Firstly, by binding to ssDNA, it removes any secondary structure and allows RecA to 
form a continuous filament. Secondly, as strand exchange proceeds, it binds to the 
released single-stranded DNA, and therefore stabilizes the joint molecule and 
prevents reinitiation (Roman et al., 1991). Additional proteins, RecF, RecO and 
RecR, help RecA to overcome inhibition of binding by the SSB protein (Umezu and 
Kolodner, 1994; Monmatsu and Kowalczykowski, 2003). The RecA nucleoprotein 
filament then recognizes and invades the homologous sequence in duplex DNA, 
thereby creating hDNA (West, 1996). Additional factors, including RuvA, RuvB and 
RecG proteins, bind to the Holliday junctions and promote branch migration (West, 
1996; Whitby and Lloyd, 1998). The RuvA protein specifically recognizes the 
Holliday junction, whereas RuvB is necessary for branch migration. RecG protein, 
like RuvA—RuvB, also promotes branch migration but the reaction is weaker. The 
Holliday junction can be resolved by the Holliday junction resolvase, RuvC (West, 
1996). In the absence of RuvC, another Holliday junction resolvase, RusA, can be 
activated and act on Holliday junction. Suppression function of RusA, however, 
critically depends on RecG protein (Mahdi et al., 1996). RuvC endonuclease binds to 
the RuvA—RuvB complex and then cuts the DNA intermediate at two sites. 
Subsequent ligation generates recombinant (or non-recombinant) molecules 
containing a segment of hDNA. Alternatively, the double Holliday junction might be 
resolved by reverse branch migration (Bianco et al., 1998). 
As expected, cells lacking the RecA protein show nearly no recombination events 
(Cox, 1999; Kowalczykowski et al., 1994). Nevertheless, recA mutants have 50% 
viability when grown in liquid cultures (Capaldo et al., 1974). The recA mutants 
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exhibit various defects in recombination, repair and SOS response and are sensitive 
to a variety of DNA damaging agents (reviewed in Cox, 1999; Kowalczykowski et 
al., 1994). 
1.1.2.2 Homologous Recombination in Saccharomyces cerevisiae 
As shown by Siede et al. (Siede et al., 1996), HR is the favored DSB repair pathway 
in S. cerevisiae, whereas N}IEJ is only of minor importance. These authors found 
that in cells competent for HR, deletion of NHEJ component did not result in 
increased sensitivity to JR or to MMS and DSB repair was not impaired. However, if 
HR was disabled, inactivation of NHEJ led to an additional sensitization to IR and 
MIMS. Hence, in S. cerevisiae NHEJ activity can be demonstrated only in the 
absence of HR and it may thus serve only as a backup system. 
In the S. cerevisiae, the genes implicated in HR belong to the RAD52 epistasis group, 
which includes RAD50, RAD51, RAD52, RAD54, RAD55, RAD57, RAD59, 
RDH541TIDJ, MRE11 and XRS2 genes (Pastink and Lohman, 1999; Pastink et al., 
2001; van den Bosch et al., 2002; Symington, 2002; Paques and Haber, 1999; Sung 
et al., 2000). Cells mutated in these genes are in general sensitive to IR, but not to 
ultraviolet (UV) irradiation, unable to repair DSB, and defective in mitotic and/or 
meiotic recombination (Petes et al., 1989). However, there is a considerable 
variability among the RAD52 epistasis group members with respect to the repair 
defect conferred by the particular mutation. Subdivision of the RAD52 epistasis 
group members into several families was therefore suggested (Paques and Haber, 
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1999). Since the RAD52 gene is required for virtually all HR events, it stands alone. 
The uniqueness of the RAD52 gene product is well established by the IR sensitivity 
of the rad52 mutant: the rad52 single mutant is as IR sensitive as a double mutant of 
rad52 combined with a mutation in one of the other RAD genes (Game and Mortimer, 
1974). The rad5l, rad54, rad55 and rad57 mutants have common phenotypes, and 
the corresponding gene products constitute a family that has been designated the 
RAD51 family. Contrary to RAD52, the RAD51 family is necessary for some HR 
events, but dispensable for others. Furthermore, the IR sensitive phenotype of the 
RAD51 family mutants is much less severe than that of the rad52 mutant. The rad5O, 
mrell and xrs2 mutants also display identical phenotypes and therefore the 
respective genes constitute another family. There are homologues of the RAD52 and 
RAD54 genes, designated RAD59 and RDH54ITID1, respectively, which may 
represent the separate subgroups because of their specific functions in HR. 
1.1.2.3 Homologous Recombination in Higher Eukaryotes 
For many years, HR had been considered to be a minor pathway that acts on DSB in 
higher eukaryotes. This opinion was based on the fact that none of the cell lines 
displaying an JR sensitive phenotype and/or DSB repair defects were found to be 
mutated in any of the genes encoding the HR proteins. Moreover, some of the HR 
mutants are lethal in vertebrate cell lines and therefore they could not be further 
tested for the particular mutation. It was therefore believed that DSB repair in higher 
eukaryotes is almost exclusively undertaken by the N}IEJ pathway. Recently, 
however, it has been established that HR also contributes considerably to DSB repair 
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in these cells (reviewed in van den Bosch et al., 2002; Morrison and Takeda, 2000; 
Johnson and Jasin, 2001; Thompson and Schild, 2001). This conclusion has come 
mainly from the identification of relevant mammalian HR genes either through 
cloning genes that complement cell lines that are sensitive to DNA damaging agents 
or through homology searches (Morita et al., 1993; Shinohara et al., 1993; Park, 
1995; Petrini et al., 1995; Tebbs et al., 1995; Albala et al., 1997; Tambini et al., 1997; 
Cartwright et al., 1998; Dosanjh et al., 1998; Liu et al., 1998; Pittman et al., 1998; 
Tanaka et al., 2000; Leasure et al., 2001), or from generating HR gene knockout 
mutants of the chicken B lymphocyte cell line, DT40. Furthermore, the generation of 
homozygous HR gene knockout mice (Lim and Hasty, 1996; Tsuzuki et al., 1996; 
Essers et al., 1997; Rijkers et al., 1998; Luo et al., 1999; Shu et al., 1999; Deans et al., 
2000; Pittman and Schimenti, 2000) and embryonic stem (ES) cells has also 
highlighted the importance of the HR pathway in DSB repair in higher eukaryotes 
(Lim and Hasty, 1996; Tsuzuki et al., 1996; Deans et al., 2000; Luo et al., 1999). 
In addition to the HR genes described for S. cerevisiae, mammalian cells contain 
some additional HR factors. Thus, there are five RAD51-like genes, namely 
RAD51BIRAD5JLJ/hREC2IR5JH2, RAD51 C/RAD51L2, RAD51D/RAD51L3, 
XRCC2 and XRCC3. In addition, the breast cancer susceptibility proteins, Brcal and 
Brca2, seem to be directly involved in the HR process in mammalian cells (reviewed 
in Thompson and Schild, 1999; van den Bosch et al., 2002; Morrison and Takeda, 
2000; Thompson and Schild, 2001). 
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1.1.3 Crossover verses Non-crossover Recombination 
Recent advances indicate, however, that the decision of whether a recombination 
event will result in a CO or NCO chromosome occurs much earlier, soon after DSB 
formation (Allers and Lichten, 2001b; Hunter and Kleckner, 2001; Clyne et al., 
2003). Several observations challenge the idea that the orientation of Holliday 
junction resolution accounts for the relative frequencies of COs and NCOs. First, 
several mutants have been identified that retain high levels of DSBs and NCOs, but 
reduced levels of COs (Engebrecht et al., 1990; and references for the genes/proteins 
discussed below in Borner et al., 2004; Fung et al., 2004). Proteins implicated 
specifically in promoting meiotic CO recombination include (1) a DNA helicase 
Mer3; (2) Msh4 and Msh5, relatives of E. coli MutS not involved in mismatch repair; 
(3) Zipi, a structural component of the central region of the synaptonemal complex; 
and (4) Zip2 and Zip3, two proteins required for initiating Zipl polymerization along 
homologs. Mutation of any member of this group reduces CO (but not NCO) 
frequency. These findings suggested that COs form via a more elaborate mechanism 
than NCOs. Second, the configuration of heteroduplex DNA on NCO recombinants 
did not conform to expectations of the DSBR model (Figure 1.1) (Gilbertson and 
Stahl, 1996 and Porter et al., 1993). Third, Allers and Lichten (Allers and Lichten, 
2001a) used physical detection methods to provide evidence that most or all of the 
dHJ intermediates are pre-CO intermediates rather than intermediates on the road to 
forming either COs or NCOs. Forth, two new studies in budding yeast show that the 
positions of COs are determined much earlier in prophase than the stage at which 
Holliday junction resolution occurs. These new studies support and extend an earlier 
proposition based on timing of dHJ resolution relative to that of recombination 
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nodule appearance (Storlazzi et al., 1996). These studies, particularly the work from 
the Kieckner and Lichten labs, support an "Early CO decision" (ECD) model of 
meiotic recombination (Figure 1.2). 
Allers and Lichten (Allers and Lichten, 2001a) suggested that NCO recombinants 
form by a pathway that does not involve a Holliday junction intermediate (see Figure 
1.2). They proposed that NCOs form by transient invasion of one or both of the two 
DNA ends formed by a DSB. Such transient invasion could allow an invading 3' end 
to be extended via limited DNA synthesis using the invaded duplex as template. 
Following ejection of the extended ends, annealing of partner ends could then lead to 
repair of the DSB. Evidence that such a recombination pathway can occur has been 
found in several mitotic systems and is referred to as "synthesis-dependent strand 
annealing" (SDSA) (reviewed in Nassif et al., 1994 and Paques and Haber, 1999). 
While it remains to be determined if meiotic NCOs form via SDSA, this hypothesis 
is attractive and accounts for available data. The mechanism through which 
recombination intermediates can be assigned a CO fate prior to Holliday junction 
resolution is, at present, mysterious. 
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Figure 1.2 The Early Crossover Decision (ECD) Models of Meiotic 
Recombination 
(a) DSB end forms an unstable ("nascent") interaction with a homologous chromatid. (b) En 
route to forming an NCO, the end involved in the nascent interaction is extended by DNA 
synthesis. This intermediate is either unstable or too transient to detect by current 20 gel 
methods. (C) The extended end is ejected from the nascent joint. (d) The extended end 
anneals with its partner. (e) DNA synthesis and ligation completes formation of the NCO. (f) 
En route to forming a CO, the nascent end is stabilized to form an SEI intermediate that can 
be detected by 2D gels. (9) The second end engages the SEI via strand invasion or 
annealing. (h) DNA synthesis from the invading ends fills in regions lost by end resection, 
ligation of extended strands forms two Holliday junctions. (i) Resolution of Holliday junctions 
occurs such that only a CO is formed. 
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In addition, studies of a newly discovered endonuc lease, Mus8 1, indicate that, in 
addition to dHJ resolution, COs may be formed by the processing of non-dI-LJ 
intermediates (Heyer et aL, 2003; Osman et al., 2003) (Figure 1.3). The decision of 
which crossover pathway to use appears to vary between organisms and may be 








Figure 1.3 A Model for Crossovers Formation without Resolution of 
Double Holliday Junctions (Osman et al., 2003) 
After single-end invasion, Mus8l—Emel cleaves the D-loop, which should topologically 
stabilize single-end invasion. Second-end capture and DNA synthesis produces a nicked 
Holliday junction subject to a second, possibly independent, cleavage by Mus8l—Emel. The 
potential Mus8l—EmelIMms4 cleavage sites are indicated by arrowheads. Processing of the 
cleavage products to accommodate possible flaps and ligation will always lead to crossovers. 
Osman et al. (Osman et al., 2003) propose this alternative crossover model based on the in 
vitro substrate specificity of Mus8l—Emel. This model was independently (Heyer et at, 2003) 
derived from the proposed function of XPF—ERCC1 in gene targeting (Niedemhofer et al., 
2001). XPF—ERCC1 is related to Mus8l—EmelIMms4, the enzymes having a similar subunit 
structure and sequence homology in their active sites (Heyer et al., 2003). 
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1.1.4 Non-homologous End Joining 
In eukaryotes, double-strand break repair mediated by homologous recombination 
occurs mainly during the late S and G2 phases of the cell cycle, when sister 
chromatids are present. Another repair pathway, N}IEJ, is operational throughout the 
cell cycle but may be more important during Gi, prior to DNA replication, or in cells 
that are no longer cycling (Hendrickson, 1997). The genetic requirements for this 
pathway were elucidated in mammalian cell lines, and two protein complexes were 
shown to be required. The first is the DNA-dependent protein kinase complex (DNA-
PK), the components of which are Ku70 and Ku80 (a heterodimer that binds DNA 
ends) and the DNA-PK catalytic subunit (DNA-PKcs). The second complex required 
is a heterodimer comprising DNA ligase IV and the product of the XRCC4 gene 
(Tsukamoto and Ikeda, 1998 and Cntchlow and Jackson, 1998). Mutations in genes 
encoding components of these complexes result in immune and DNA repair 
deficiencies (Hendrickson, 1997; Ochiai et al., 2001; Riballo et al., 2001). 
Ku70fKu8O are thought to stimulate end-joining by binding to DNA ends, recruiting 
DNA-PKcs to this site, and activating its DNA-dependent kinase activity. This 
complex in turn is believed to act by protecting the DNA from nonspecific nucleases 
and by recruiting DNA ligase IV/Xrcc4 to covalently join the broken DNA ends. 
The S. cerevisiae homologs of Ku70IKu8O (HdflIHdf2) and the DNA ligase 
IV/Xrcc4 complex (Dnl4/Lif 1) have been shown to belong to the same epistasis 
group as the MIRX complex (Chen et al., 2001) demonstrated that these proteins can 
stimulate the intermolecular end-joining of linear double-strand DNA molecules 
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containing cohesive ends. Their results suggest a model (that may be applicable to 
NHEJ) in which HdflIHdf2 binds DNA ends and facilitates end-bridging by the 
MRX complex; the MRX complex in turn specifically stimulates Dnl4ILif4-mediated 
end-joining. The observations of de Jager et al., 2001 make a model in which DNA 
end-joining is mediated by a protein complex containing Rad50/Mre1 1 even more 
attractive. Using scanning force microscopy, they showed directly that the human 
MR complex can tether the ends of two linear double-strand DNA molecules, and 
suggested that this observation might explain the importance of the Rad50IMre1 1 
complexes in a number of processes involving DNA ends. In the presence of DNA 
ligase IV and Xrcc4, purified hMrel 1 alone can stimulate the ligation of DNA 
molecules containing nonhomologous ends (Paull and Gellert, 2000). 
NHEJ is not considered a major pathway of DSB repair in prokaryotes. However, 
DNA sequences encoding homologs of Ku, the DNA binding component of 
eukaryotic DNA-PK, have been found to exist in various bacteria (Aravind and 
Koonin, 2001 and Doherty et al., 2001). Sequence similarity is greatest to eukaryotic 
Ku70 and Ku80 proteins in the central core domain that is responsible for 
heterodimerization and DNA binding. Very often these genes are found in 
association with an ATP-dependent DNA ligase, raising the possibility that bacteria 
possess a NHIEJ pathway. 
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1.1.5 DNA Damage Checkpoint Proteins 
When a chromosome is broken, cells must sense the presence of damage, activate the 
course of events that will eventually restore genomic integrity and then return to 
normal growth. Checkpoint proteins link repair and cell cycle by delaying cell cycle 
transitions, and also by causing changes in chromatin structure, transcriptional 
induction and post-traslational modifications of repair genes (Hartwell and Weinert, 
1989; Kiser and Weinert, 1996; Aboussekhra et al., 1996; Bashkirov et al., 2000; 
Scott and Plon, 2003). The DNA damage checkpoint is a signal transduction network 
consisting of sensors, transducers and effectors. 
The checkpoint sensor protein Rad24 forms an alternative RFC complex with 
Rfc2/3/415 and recruits a PCNA-like complex, Radl7IMec3fDdcl (Naiki et al., 2000; 
Venclovas et al., 2002; Green et al., 2000) to sites of damaged chromatin. This signal 
activates downstream-acting kinases. The Rad9 protein also acts as a DNA damage 
sensor and is hyperphosphorylated in response to damage (Schwartz et al., 2002; 
Gilbert et al., 2001). 
The ATM-like kinase Mecip together with Ddc2p form a complex on chromatin in 
response to DNA damage, thus playing an important role in damage sensing, as well 
as in signal transduction (Melo and Toczyski, 2002; Rouse and Jackson, 2002; 
Paciotti et al., 1998). Phosphorylation of some Mecip targets occurs independently 
of the RFC and PCNA-like complexes (Rouse and Jackson, 2002; Kondo et al., 
2001), however these complexes are necessary for the Mecip-dependent 
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phosphorylation of Rad53p to instigate a full cellular checkpoint response (Zou et al., 
2002). 
The sensor proteins activate signal transducers, such as the Rad53p, Chklp and 
Dunip protein kinases (Carr, 2002; Gardner et al., 1999). This signal transduction 
eventually leads to cell cycle arrest and transcriptional induction of repair genes 
(Aboussekhra et al., 1996). Recently, the DNA damage response has been shown to 
control additional processes including direct activation of DNA repair and processing 
of DNA damage (Aylon and Kupiec, 2003). These processes may play critical roles 
in the survival of cells in response to DNA damage (Aylon and Kupiec, 2003). 
1.2 Holliday Junctions (HJ) 
Holliday junction has been considered a central intermediate in homologous 
recombination ever since Robin Holliday proposed their existence and suggested that 
crossovers result from their resolution (Holliday, 1964). While recombination models 
have evolved since that time, the Holliday junction - more precisely the double 
Holliday junction (Szostak et al., 1983) - is still held as the critical intermediate in 
crossover formation (Paques and Haber, 1999) (Figure 1.1). Once Holliday junctions 
are formed, they must be removed from the genome to allow replication and 
transcription to continue unhindered, and enable chromosomes to segregate at cell 
division. The resolution of recombination intermediates by endonucleolytic cleavage 
is a central part of the recombination process in all organisms and it has been 
retained throughout evolution (Shinohara et al., 1993). Failure to repair damaged 
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DNA is associated at the cellular level with sensitivity to radiation, increased 
mutation rates, DNA and chromosomal aberrations, and reduced viability. 
Work to identify a Holliday junction resolvase with the correct junction-cleavage 
activity began in earnest two decades ago. Early research was accelerated by new 
methods to prepare plasmid substrates bearing authentic Holliday junctions and to 
synthesize structures from oligonucleotides that resemble these junctions. The 
molecular pathways of homologous recombination have been studied extensively in 
E. coli (Kowalczykowski et al., 1994; Lloyd, 1996; West, 1992). Heteroduplex 
intermediates are usually formed by the RecA filament, a structure that overcomes 
the natural tendency for Watson-Crick strands to remain paired and at the same time 
makes use of this property to exchange single strands between duplex molecules in a 
way that secures homologous alignment (West, 1992). Pioneering work in West's 
laboratory led to the discovery of a Holliday junction resolvase encoded by the ruvC 
gene in the bacterium Escherichia coli (West, 1996). The four-way junction 
processing is mediated by the RuvA, RuvB and RuvC proteins. A single tetramer of 
RuvA binds the junction and holds it in an open conformation that enables two 
hexamenc rings of RuvB helicase to assemble on diametrically opposed arms 
(Rafferty et al., 1996; West, 1997). RuvC binds the exposed face of the junction 
between the two RuvB rings, forming a "resolvasome" complex in which ATP-
dependent branch migration by RuvAB locates the junction at sequences that can be 
cleaved by RuvC (Davies and West, 1998; van Gool et al., 1998; Whitby et al., 1996; 
Zerbib et al., 1998). RuvC is a homodimenc endonuclease that converts junctions 
into duplex products by dual strand incision. In a RuvABC resolvasome, RuvB 
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directs RuvC to cleave target sequences that lie in the strands passing 5'-3' through 
the RuvB rings to the junction (van Gool et al., 1999) (Figure 1.4). 
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Figure 1.4 Model indicating the interactions between the RuvA, RuvB 
and RuvC proteins and the Holliday junction (van Gool et at., 1998) 
(A) Model of the RuvAB branch migration complex, in which RuvA binds the junction and 
holds it in an unfolded square planar configuration. RuvB hexameric rings, which are 
oppositely oriented and lie diametrically opposed on two DNA arms, drive branch migration 
using their DNA helicase activities. Although physical studies indicate that the junction is 
bound by two tetramers (Yu et al., 1997), one on either face of the junction, in this diagram 
only one RuvA tetramer is shown for purposes of clarity. Drawing adapted from Parsons et al. 
(Parsons et al., 1995) and Rafferty etal. (Rafferty et al., 1996). The arrows indicate the 
direction of DNA movement during branch migration. (B) Proposed structure of a RuvBC 
complex capable of limited branch migration and elevated junction-resolution efficiency. In 
this diagram, a RuvC dimer is shown binding the junction and interacting with two RuvB 
hexamers. (C) Two views of a hypothetical RuvABC complex in which RuvA and RuvC bind 
opposite faces of the Holliday junction and stabilise the binding of two RuvB rings. It is 
proposed that the RuvC dimer may displace a RuvA tetramer, as indicated. In this model, 
RuvAB promote branch migration, as shown in (A), driving DNA into and through the 
complex. The RuvC dimer 'scans' DNA sequences as they pass through the complex, 
resulting in efficient resolution at preferred sites. The complex is shown from above and in 
side view. 
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The RuvABC complex has proved a valuable system for understanding movement 
and resolution of Holliday junctions, but efforts to identify similar activities in 
eukaryotes have not been as fruitful. Early efforts to purify a cruciform cleaving 
activity from yeast resulted in the identification of Ccelp, an enzyme that works in 
mitochondna (Lockshon et al., 1995). Other studies reported Holliday junction 
cleavage in extracts of yeast and mammalian tissues that contain a protein known as 
Mus8lp (Elborough and West, 1988; Constantinou et al., 2001). Paul Russell's 
laboratory (Boddy et al., 2001) showing that S. pombe mus8l mutants were defective 
in a late stage of meiotic recombination, and that this defect could be partially 
overcome by expression of a bacterial Holliday junction resolvase (Boddy et al., 
2001). Moreover, complexes containing Mus8lp were shown to resolve Holliday 
junctions and fork structures in vitro (Boddy et al., 2001). Detailed biochemical 
studies with purified recombinant Mus81 and its partner protein (Mms4 in S. 
cerevisiae or Emel in S. pombe) showed that Mus81 shares sequence homology with 
the Radl/XPF subunits of structure-specific endonucleases that function in 
nucleotide excision repair (Interthal and Heyer, 2000; Boddy et al., 2000), therefore, 
the endonucleases actually show a much greater specific activity with 3'-flap or 
replication-fork structures than with Holliday junctions (Kaliraman et al., 2001; Doe 
et al., 2002). Similar results were obtained with purified fractions containing Mus8 1 
from human cells (Constantinou et al., 2002). However, it was shown that S. 
cerevisiae mus8l mutants, in contrast to those from S. pombe, did not have such a 
profound meiotic-recombination deficiency (de los Santos et al., 2001). Although 
mus8l mutants are sensitive to agents that block replication-fork progression, they do 
not show defects in DSB repair. Moreover, purified recombinant Mus8l complexes 
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show considerably greater activities with various substrates that mimic flap 
structures and replication forks than they do with Holliday junctions (Constantinou et 
al., 2002; Kaliraman et al., 2001; Doe et al., 2002). Whether or not Mus81 functions 
as a true resolvase is, at present, a topic of some debate (Haber and Heyer, 2001; 
Heyer et al., 2003). 
For years, efforts to determine the identity of any proteins required for resolvasome 
activity have been unsuccessful until 2004. In new work, Liu and colleagues (Liu et 
al., 2004) followed up on the observation that partially purified HeLa cell fractions 
catalyze ATP-dependent branch migration and resolution of Holliday junctions. 
Their most exciting finding was that this activity requires RAD51C, a key 
recombinationlrepair protein, but not other proteins known to be involved in 
resolution or branch migration (MIUS81, WRN, or BLM). Depletion of RAD51C 
with a highly specific monoclonal antibody reduced resolution and branch migration 
to almost background levels; resolvase activity could be reconstituted by adding back 
recombinant protein complexes containing RAD51C to the depleted fraction. 
Furthermore, they discovered that Chinese hamster ovary cell lines lacking RAD51C, 
or its binding partner XRCC3, had greatly reduced resolvase activity. Together, these 
in vitro results provide compelling evidence that, in eukaryotic cells, the Holliday 
junction resolvase is either RAD5 1C itself or another protein that is activated by 
RAD51C. 
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The resolvases studied to date share certain common features and biochemical 
characteristics (Lilley and White, 2000). Resolving enzymes function as dimers, 
resolving the four-way DNA junction by the introduction of paired nicks in opposing 
strands with a metal ion-dependent endonuclease activity. Despite these functional 
similarities, the junction resolvases are structurally diverse with no detectable 
sequence similarity between any of the known families. Structural studies have 
emphasized this diversity because the crystal structures of E. coli RuvC (Ariyoshi et 
al., 1994), bacteriophage T4 endonuclease VII (Raaijmakers et al., 1999), 
bacteriophage T7 endonuclease I (Hadden et al., 2001), archaeal Hjc form Sulfolobus 
solfataricus (Bond et al., 2001) and Pyrococcus feriosus (Nishino et al., 2001), 
Schizosaccharomyces pombe mitochondial YDC2 (Ceschini et al., 2001) and 
lambdoid prophage RusA (Rafferty et al., 2003) have radically different folds. These 
observations have led to the suggestion that Holliday junction resolving enzymes 
have arisen several times during the course of evolution, perhaps by recruitment of 
nucleases with other cellular roles. Nonetheless, they are all metal ion-dependent 
endonucleases and seem to have a conserved catalytic mechanism. Recent sequence 
alignment analyses suggest that peering into the more distant evolutionary past, there 
are intriguing similarities between the metal-ion-binding sites of the integrase and 
nuclease superfamilies. Most of the junction-resolving enzymes can be fitted into 
these two main superfamilies of proteins with two outliers (T4 endonuclease VII and 
lambdoid prophage RusA). RuvC, the A22 pox virus resolvase and the yeast 
mitochondrial enzymes are related and form a subfamily within the integrase 
superfamily, whereas T7 endonuclease I and Hjc are classed with nucleases (Aravind 
et al., 2000; Garcia et al., 2000; Lilley and White, 2000; Lilley and White, 2001; 
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Rafferty Ct al., 2003). Differences in the topology of the central n-sheet in RuvC 
compared with the restriction endonucleases have led to the suggestion that any 
similarities between them are due to convergent rather than divergent evolution 
(Venclovas and Siksnys, 1995). A family tree that is consistent with the relationships 
is shown in Figure 1.5. Junction-resolving enzymes bind four-way DNA junctions in 
dimeric form. Binding is highly structure selective, but all the enzymes significantly 
distort the structure of the DNA on binding. Some of the resolving enzymes also 
have pronounced sequence selectivity at the cleavage stage; this can effectively 
ensure cleavage of Holliday junctions and not other branched DNA structures. 
Ancestral metal-
binding domain 
RNaseH Integrases RuvC 	Hjc T7 	Mull I RE I RE II 
Ceel endo I ,,. exo 
A22 	 Vsr 
Nature Review, I Molecular C.0 Biology 
Figure 1.5 Family Tree of Junction-resolving Enzymes (Lilley and White, 
2001) 
These enzymes are found in two superfamilies. The integrase superfamily includes the 
sequence-dependent resolving enzymes RuvC and Ccel, which probably share a 
eubacterial lineage. By contrast, archaeal Hjc and the phage 17 endonuclease I enzymes 
are members of a large nuclease superfamily. Other family members include the type I and 
type II restriction enzymes (RE) and repair proteins such as Vsr, MutH and A-exonuclease. 
All share a common metal-ion-binding domain that is required for catalysis, but these 
domains are arranged differently to accommodate the wide variety of substrate specificities 
of these enzymes. Despite some differences in strand topology, the nuclease and integrase 
superfamilies might themselves be related through a shared ancestral metal-ion-binding 
domain. The positions of branch points in this figure are not intended to indicate the degree 
of relatedness between family members. 
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1.3 This thesis 
1.3.1 Gene Identification via PSI-BLAST Searches 
Despite the low levels of absolute sequence identity, which have obscured the 
relationships between these resolvases to date, we found that PSI-BLAST searches 
initiated with the sequence of the mitochondrial resolvase Ccelp from 
Saccharomyces cerevisiae (Figure 1.6A) or Ydc2p from Schizosaccharomyces 
pombe identified the Yo1093wp putative protein from the S. cerevisiae, despite of the 
limited homology. It suggested that Yo1093wp potentially might be a member of a 
resolvase family. The sequences alignment of Ccelp with Yo1093wp is shown in 
Figure 1.6B. The hypothetical protein YOL093W is 882 nucleotides in length, and 
encodes protein of 293 amino acids with a predicted molecular weight of 34.5 kDa. 
No functional data were available for this protein in database searches. Iterative 
BLAST searches showed that Yo1093wp is a member of a family of proteins found 
widely in all free-living eukaryotes (Figure 1.7). This family of proteins has been 
described in both the PFAM database and the COGs (Cluster of Orthologous Groups) 
database as being conserved, with no ascribed function. There are some conserved 
acidic residues in this family, which might contribute to the binding site catalytic 
metal ion(s). However, sequence comparisons have failed so far to link the 
YOL093W family conserved domains to the same domains that show homology to 
Ccelp, therefore, this will need further investigations from bioinformaticians allows 
new connections to be made. The protein family revealed that each sequence has 
diverged substantially from every other with relatively small sizes, which are similar 
to those observed among the known resolvases. These homologues have not been 
charactensed and therefore did not help in determining the function of Yo1093wp. 
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>gil63244791ref1NP 014548.11 	Yo1093wp Length = 293 
Score = 26.2 bits (56). Expect = 8.3 
Identities = 16/44 (36%), Positives = 23/44 (52%) 
Yo 1093wp: 	IQEQCEFLEKLRQQKIREGRINILSMDAGVSNFAFSKMQLLNND 90 
IQE + E++ Q+ IRE RIN+ 	D+G+ 	 L ND 
Ccelp: 	IQEYIDRGEEVPQELIREPRINVNQTDSGIEIILDCSFDELMND 109 
http:/twww.ncbl.nim.nih.gov/BLAST/  
 
Yo 1093wp 	(20)- PVPEGMSKKQWKKMCKRQRWEENKAKYNAERRVKKKRLRHERSAK!QEYIDRGEEVPQE 99 
Cccl p MSTAQKAKILQLIDSCCQNAKSTQLKSLSFVIGAVNGTTKEAKRTYIQEQCEFLEKLRQQ 60 
Yo1093wp 	LIREPRINVNQTDSGIEI ILDCSFDELMND------------------------------129 
Cce I p K IREGR INILSMDAGVSNFAFSKMQLLNNDPLPKVLDWQKINLEEKFFQNLKKLSLNPAE 120 
Yo1093wp 	------------------ KEIVSLSNQVTRAYSANRRANHFAEIKVAP- -FDKRLKQRFE 169 
Cccl p TSELVFNLTEYLFESMPIPDMFTIERQRTRTMSSRHILDPILKVNILEQILFSNLENKMK 180 
* 	**. 	* ......... 	* ..... 
Yo I 093wp 	TTLKNTNYENWNHFKFLPDDKIMFGDEH I SKD- - - -KIVYLTADTEEKLEKLEPGMRYIV 225 
Ccelp YTNKIPNTSKLRYMVCSSDPHRMTSY*CIPREETPTSSKKLKSNKHSKDSRIKLVKKILS 240 
Yo I 093wp 	GGIVDKN--------RYKELCLKKAQKMGIPTRRLPIDEYINLEGRR-VLTTTHVVQLML 276 
Cccl p TSILEGNSTSSTKLVEFIGVWNNRIRNALTKKKSFKLCDILEIQDNSGVRKDDDLADSFL 300 
Yo I 093wp 	KYFDDHNWKNAFESVLPPRKLDAEAKSAS-------SSPAPKDT---------293 
Ccc 1 p HCLSWMEWLKNYES I TELLNSKTLVKTQFGQVFEFCENKVQKLKFLQNTYNND 353 
Figure 1.6 Sequence Identification of Yo1093wp by BLAST Search 
Initialled with the S. cerevisiae Ccel p (A), and the Sequence Alignment 
of YoI093wp with Ccel p (B) 
Proposed homologoues were identified by NCBI nr peptide sequence database. Sequences 
were aligned using the Clustal W alignment program. Stars highlight identical residues, and 
dots indicate the conservation of the nature of the amino acids at that site. The number in 
parentheses before the alignment indicate the numbers of amino acids from individual 
sequences not included in the alignment for clarity of presentation. 
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S. cerevisiae 	KSA--------SPAPKDT ---------------------------- 
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Figure 1.7 Sequence Alignment of Yol093wp with Putative Homologues 
in other Eukaryotes 
Proposed homologoues were identified using BLAST searches. Sequences were aligned 
using the EMBL ClustaIW program. A representative alignment is shaded to a 50% 
consensus using BoxShade, and indicates residues that are similar (grey background) or 
identical across species (black background). The number in parentheses before the 
alignment indicate the numbers of amino acids from individual sequences not included in the 
alignment for clarity of presentation. Sequences are: S. cerevisiae YolO93wp; S. pombe 
hypothetical protein SPAC6B12.09 (pir no: T39016); H. sapiens unknown (gb no: 
AAD210.19); C. elegans hypothetical protein F25H8.1 (pir no: T21368); D. melanogaster 
CG14618 gene product (gb no: AAF5059.1). 
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1.3.2 Yeast Research 
The yeast Saccharomyces cerevisiae is recognized as an ideal eukaryotic 
microorganism for biological studies. Although yeasts have greater genetic 
complexity than bacteria, they share many of the technical advantages that permitted 
rapid progress in the molecular genetic of prokaryotes and their viruses. Some of 
these properties make yeast particularly suitable for biological studies. Strains of S. 
cerevisiae have both a stable haploid and diploid state, and they are viable with a 
great many auxotrophic markers. The development of DNA transformation has made 
yeast particularly accessible to gene cloning and genetic engineering techniques. In 
addition, homologous recombination coupled with the high levels of gene conversion 
in yeasts has led to the development of techniques for the direct replacement of 
genetically engineered DNA sequences into normal chromosome locations. This 
approach, which relies on the great efficiency and accuracy of mitotic recombination 
in S. cerevisiae, results in the precise deletion of the entire gene. The phenotypes 
arising after disruption of yeast genes have contributed significantly toward 
understanding the functions of certain proteins in vivo. 
Because of the redundancy (the existence of sets of two or more genes encoding 
proteins with identical or very similar sequences) problem in the S. cerevisiae 
genome, and to enable the study of gene interactions, it will also be necessary to 
construct multiply deleted strains; easy methods to achieve this are already in hand 
(Langle-Rouault and Jacobs, 1995; Guldener et al., 1996). All these approaches 
should make S. cerevisiae the eukaryote of choice for the study of functions common 
to all eukaryotic cells, by reversing the traditional path of genetic research to one in 
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which the study of the gene (or DNA sequence) leads to an understanding of 
biological function, rather than a change in function leading to the identification of a 
gene. 
1.3.3 Work Objectives 
In this work, a variety of approaches have been used to characterize YOL093W. To 
get first clues about the function of the protein, a gene deletion was performed to find 
out whether the protein is required for cell viability. The YOL093W-disrupted strains 
could be used for further studies in order to check if disruption of this gene led to a 
detectable phenotype. Additionally, the interactions between Yo1093wp and other 
factors were investigated using either a two-hybrid screen or Tandem Affinity 
Purification (TAP) tag purification. This would help us to further understand the 
biological functions of YOL093W. The subcellular localization of Yolo93w protein 
was assessed. Furthermore, the purified protein was also used to investigate the 
general biochemical properties of YOL093W. 
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CHAPTER TWO 
Materials and Methods 
2.1 Materials 
2.1.1 General Reagents 
2.1.1.1 Chemicals 
Chemicals were purchased from the following sources, except where stated 
otherwise: Amersham, Fisher, Melford Labs, Scotlab, Sigma. 
2.1.1.2 Enzymes 
Restriction enzymes, DNA and RNA polymerases and other enzymes were 
purchased from the following sources unless otherwise stated; Epicentre 
Technologies, Gibco BRL, New England Biolabs (NEB), Pharmacia, Promega, 
QIAGEN, and Roche. 
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2.1.1.3 Growth Reagents 
Reagents for all growth media were purchased from the following sources: Beta Lab, 
Difco Laboratories, Gibco BRL, Oxoid and Sigma. 
2.1.1.4 Antibiotics 
Ampicillin, Hygromycin (hph), Kanamycin (G418 sulphate, kan) were purchased 
from Beecham Research, Roche and Sigma respectively. 
2.1.2 Bacterial and Yeast Growth Media 
2.1.2.1 General Information 
All liquid growth media were autoclaved prior to use, and stored at room temperature. 
For solid media, 2% (w/v) agar was added prior to autoclaving. Solid media were 
stored at 4°C. 
2.1.2.2 Bacterial Media 
Table 2.1 Bacterial Media 
Medium 	 Components 
Luria-Broth (LB) 	 1% (w/v) Bacto-tryptone 
0.5% (w/v) Yeast extract 
0.5% (w/v) sodium chloride 
pH adjusted to 7.2 with sodium hydroxide 
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2.1.2.3 Yeast Media 
Table 2.2 Yeast Media 
Medium 	 Components 
YPDA 	 2% (w/v) Bacto-peptone 
1% (wlv) Yeast extract 
2% (w/v) Glucose 
0.004% (wlv) Adenine sulphate 
Drop-out 	 0.67% (w/v) Yeast nitrogen base without amino acids 
2% (w/v) Glucose 
0.2% (w/v) drop-out powder 
1 pellet of NaOH per 500m1 
Sporulation 	 0.1% (wlv) Bacto-yeast eatract 
(for BMA38 strains) 	1% (w/v) Potassium acetate 
0.05% (w/v) Glucose 
(supplemented with nutrients as required) 
Sporulation Liquid 	0.02% Raffinose 
(for W303 strains) 1% (w/v) Potassium acetate 
(supplemented with nutrients as required) 
YPA Media 	 2% Potassium Acetate 
2% Peptone 
1% Yeast Extract 
* For solid media, 2% (w/v) agar was added prior to antoclaving. 
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2.1.2.4 Antibiotics 
Antibiotics were added to liquid media immediately prior to use, whereas for solid 
media antibiotics were added after autoclaving. Ampicillin was stored at —20°C, 
hygromycin B was stored at 4°C, and G418 sulphate was stored at RT. 
Table 2.3 Antibiotics 
Medium 	Abbreviation 	Solvent 	Final concentration (j.tg/ml) 
Ampicillin Amp H20 100 
Hygromycin B hph PBS* 300 
G418 sulphate kan H20 250 
Tetracycline Tet Ethanol 15 
* Dissolved in PBS (405 mg/nil) when purchased. 
2.1.2.5 Drop-out powder 
Drop-out powder was prepared by added and mixing 2 g of each of the following 
nutrients: adenine, alanine, arginine, asparagine, aspartic acid, cysteine, glutamic 
acid, glutamine, glycine, histidine, isoleucine, lysine, methionine, phenylalanine, 
proline, serine, threonine, tyrosine, tryptophan, uracil and valine. In addition, 4 g of 
leucine were added to the drop-out powder when required. For a specific drop-out 
powder, the relevant nutrients were omitted. This mix was then ground with a mortar 
and pestle to ensure complete mixing and was added to yeast media to a final 
concentration of 0.2% (w/v). One pellet of NaOH was added to each 500 ml of media 
containing drop-out powder, in order to adjust the pH. 
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2.1.3 Commonly Used Buffers 
Table 2.4 Commonly Used Buffers 
Buffer 	 Components 
X10 TAB 0.4 M Tris-acetate, pH7.5 
20 mM EDTA 
X10 TB 0.1 M Tris-HC1, pH7.5 
10 mM EDTA 
X10 TBE 0.9 M Tns-borate, pH8.3 
20 mM EDTA 
X10 TBST 0.5 M Tris-HC1, pH7.5 
1.5 MNaCI 
1% (w/v) Tween-20 
X20 MOPS 	 1 M MOPS 
1 MTns base 
2% (w/v) SDS 
20 mM EDTA 
2.1.4 Escherichia coil Strains 
Bacterial strains utilized during this work are listed in table 2.5 below. DH5cLF' was 
used for all cloning procedures and propagation of plasmid DNA, and for the 
propagation of plasmid DNA rescued from yeast cells (section 2.3.2.4). BL21(DE3) 
cells were utilized for the expression of recombinant S. cerevisiae proteins in E. coli. 
Table 2.5 Escherichia co/i Strains 
Strain 	Genotype 	 Source 
DH5cLF 	F, 080dlacZAM15, A(IacZYA-argF) U169, deoR Gibco BRL 
recAl, endAl, hsdR17 (rk, mk),  supE44, X, thi-1, 
gyrA96, re/Al. 
BL21 (DE3) 	F, ompl, hsdSB (r8, mB), gal, dem (DE3) 	Novagen 
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2.1.5 Saccharomyces cerevisiae Strains 
The strains used during this work are listed in table 2.6. 
Table 2.6 Saccharomyces cerevisiae Strains 
Strain Genotype Source 
BMA38a MATcz his34200, leu2-3, -112, ura3-1, trp1z1, A.E. Mayes 
ade2-1,canl-100 (J. Beggs Lab) 
BMA38a MATa, his3%200, leu2-3, -112, ura3-1, trpl4l, M. Albers 
ade2-1,canl-100 (J. Beggs Lab) 
BMA38 (2n) MATa/c4 his3A200, leu2-3, -112, ura3-1, trp1zi1, B. Dujon 
ade2-1,canl-100 Institute 
Pasteur 
MYY1 MATaJc4 his3A200, leu2-3, -112, ura3-1, trpl/il, This work 
ade2-1, can] -100, YOL093W1yo1O93wL%kan 
MYY2 MATaIc4 his3A200, leu2-3, -112, ura3-1, trpl ill, This work 
ade2-1, can] -]00, YOL093W1yo1093wzihph 
MYY3 MATaJc4 his3A200, leu2-3, -112, ura3-1, trplAl, This work 
ade2-1, can] -100, yo1093wztkan /yol093wiikan 
BMA38a/ 	MATa, his34200, leu2-3, -]]2, ura3-1, trp1i4t], 	This work 
YOL093W-TAP ade2-1, can] -]OO, YOL093W: TAP 
MYY3/pRS316- MATa/c4 his3ii200, leu2-3, -112, ura3-1, trp]%], 	This work 
YOL093W 	ade2-1, can] -100, yo1093wNcan /yol093wNcan 
(CEN) [pRS3]61Y0L093W, URA31 
MYY3/ 	MATa/c4 his3ii200, leu2-3, -112, ura3-1, trplAl, 	This work 
pYEplac 195- 	ade2-1, can] -100, yolO93wAJcan /yo1093wiikan 
YOL093W(2t) [pYEplac]951YOL093W, URA31 
MYY3/pRS3 16- MATa/cx his3A200, leu2-3, -]]2, ura3-1, trp]A1, 	This work 
SP021 (CEN) 	ade2- ], can] -100, YOL093W1yo1093w4hph 
[pRS3] 6/SPO2], URA31 
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Table 2.6 Saccharomyces cerevisiae Strains continued 
Strain 	Genotype 	 Source 
MATa/a his34200, leu2-3, -112, ura3-1, 
MYY3/pRS426- 	 This work 
trpl4l, 
SP021 (2p) 	ade2-1, can] -100, yo1093wiikan /yol093wiAkan 
[pRS4261SP021, URA31 
MYY3/pBL419- 
MA Ta! c 	his3ii.200, 	leu2-3, 	-112, 	ura3-1, This work 
trplLtl, 
RFC4 (CEN) ade2-1, can] -100, yo1093wAJcan IyolO93wAkan 
[pBL419/RFC4, URA31 
E11F153- MATa, his3-11, leu2-3, -112, ura3-1, trp]-ii2 Philip Jordan 
RAD5 ade2-1, adel::ADE2, cani -100, lys2-nde3', (This lab) 
J?4D 5 
EUF180- MATa, his3-11, leu2-3, -112, URA3, trpl-42 Philip Jordan 
RAD5 ade2-1, ADE1, CAN, lys2-nde5', RAD 5 (This lab) 
L40LG MATa, his3Et200, trpl -901, leu2 -3112, ade2, Hollenberg et 
LYS2::(41exAop-HIS3), URA3::(81exAop-lacZ,) al., 1995 
GAL4L%: .Kan 
L4OzG/ MATa, his34200, trpl-901, leu2 -3,112, ade2, This work 
pBTM1 16- LYS2::(41exAop-HIS3), URA3::(81exAop-1acZ), 
YOL093W GAL4A::Kan, [pBTMJ161YOL093W, TRPJ] 
Y187 MATa, his3-200, trpl-901, leu2 -3,112, Clontech 
ade2-1 01,, ura3-52, gal4z, mef, gal8OA 
URA2::GAL1 uAs-GAL1TATA-lacZ 
BMA38a/ MATa, his3zi.200, leu2-3, -112, ura3-1, trplz.%1, This work 
YOL093W-GFP ade2-1, cani -100, YOL093W: GFP 
BMA38cd 	MATa, his3zS200, leu2-3, -112, ura3-1, trpl4], This work 
YOL093W-MYC ade2- 1, can] -100, YOL093W: J3MYC 
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2.1.6 Oligonucleotides 
Oligonucleotides that were used in this study are listed below. All oligonucleotides 
were synthesized and purchased from MWG Biotech 
Table 2.7 General and Cloning Oligonucleotides 
Name 	 Sequence (5'-3') 	 Description 
YOL093W-KO-1 CTTTCAAGGTAAATAATTAAGT Used for ORF deletion 
GTCAATCTGCAGGCAAAACAA of YOL093W with kan 
CCGGATCCCCGGGTTAATTAA or hph (forward) 
YOL093W-KO-2 ACTATTTTGCTATTCAGTTACT Used for ORF deletion 
AATAATACTACAGTGATGGCT of YOL093W with kan 
GCTCGATGAATTCGAGCTCGTT or hph (reversed) 
R-hygromycin B 	GAATTCCCCAATGTCAAGCAC Hygromycin B internal 
primer (reversed) 
R-Kan 	 CATATGTAACATCATTGGCA 	Kanamycin internal 
primer (reversed) 
5C093W-testl 	GTGGTTGGTTTTCCCACCTT 	Used for checking 
YOL093W deletion 
(forward) 
5C093W-test2 	CCCACGGCCCTACATTAGAT 	Used for checking 
YOL093W deletion or 
tagging (reverse) 
F-Kan 	 GCAGTTTCATTTGATGCTC 	Kanamycin internal 
GA 	 primer (forward) 
R-3HA 	 ATACGGATAGCCCGCATAGTC HA internal primer 
(reversed) 
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Yo1093w-13mycl GCGGAAGCAAAATCCGCAAGCT Used for ORF tagging 
CTTCGCCAGCTCCAAAGGACAC of YOL093W withl3myc 
ACGGATCCCCGGGTTAAT TAA or GFP (forward) 
Yo1093w-13myc2 ACTATTTTGCTATTCAGTTACT Used for ORF tagging 
AATAATACTACAGTGATGGCT of YOL093W withl3myc 
GCGAATTCGAGCTCGTTTAAAC or GFP (reversed) 
Yo1093w-tapl 	GCGGAAGCAAAATCCGCAAGC Used for ORF tagging 
TCTTCGCCAGCTCCAAAGGACA of YOL093W with TAP 
CATCCATGGAAAAGAGAAG 	(forward) 	- 
Yo1093w-tap2 	ACTATTTTGCTATTCAGTTACTA Used for ORF tagging 
ATAATACTACAGTGATGGCTGC of YOL093W with TAP 
TACGACTCACTATAGGG 	(reverse) 
YOL093W- 	CGCCAGCTCCA AAGGACACA YOL093W internal 
TAP-test primer; Used for 
checking the YOL093W 
tagging (forward) 







Used for ORF deletion 
of YOL093W with kan 
or hph (forward) 
Used for ORF deletion 
of YOL093W with kan 
or hph (forward) 
NdeI-XbaI- 	GACATATGTCTAGAGfl'TTGC 	YOL093WPCR forward 
Y0L093 promoter- CTGCAGATTG 	 primer (with Ned I and 
R 	 XbaT site) 
MEI 
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Table 2.7 General and Cloning Oligonucleotides continued 













Used for ORF deletion 
of YOL093W with kan 
or hph (forward; 45bp 
upstream than 
5C093W-F) 
Used for ORF deletion 
of YOL093W with kan 
or hph (forward; 45bp 
downstream than 
SCO93W -R) 
Hygromycin B internal 
primer (forward) 
YOL093WPCR forward 
primer (with XbaI site) 
EcoRI-YOL093W CGGAATTCTAATTGAGGTCGTC YOL093Wpo1yA signal 
polyA-R 	 GAGCGA 	 PCR primer (reverse) 
BamIll-YOL093W CGGGATCCGGGCATGTTACCAT YOL093W promoter 
-promoter-F 	CTTTAG 	 PCR primer (forward) 
KpnI-YOL093W GGGGTACCGAGCAAGGCAATG YOL093W promoter 
prompter-F 	TACCGAA 	 PCR primer (forward) 
Sfi-YOL093W-F 	CGGGGCCGGACGGGCCATGTC Two-hybrid primer 
CAATGATGAGATAAA 	 (forward) 
Sfi-YOLO93W-R AGGGGCCCCAGTGGCCCTATG Two-hybrid primer 
TGTCCTTTGGAGCTG 	 (reversed) 
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Table 2.7 General and Cloning Oligonucleotides continued 
Name 	 Sequence (5'-3') 	 Description 
J26-1 	 CCGCTACCAGTGATCACCAAT 	Oligonucleotides for HJ 
GGATTGCTAGGACATCTTTGC 
CCACCTGCAGGTTCACCC 
J26-2 	 TGGGTGAACCTGCAGGTGGGC 	Oligonucleotides for HJ 
AAAGATGTCCTAGCAATCCAT 
TGTCTATGACGTCAAGCT 
J26-3 	 GATCTTGACGTCATAGACAAT 	Oligonucleotides for HJ 
GGATTTCTATGACACTTTGCC 
GTCTTCTCAATATCGGC 
J26-4 	 TGCCGATATTGACAAGACGGC 	Oligonucleotides for HJ 
AAAGATGTCCTAGCAATCCAT 
TGGTGATCACTGGTAGCG 
J26-2-COMP 	AGCTTGACGTCATAGACAATG 	Oligonucleotides for HJ 
GATTGCTAGTACATCTTTGCC 
CACCTGCAGGTTCACCCA 
R-FA6a-MX6 	GCGCCACTTCTA AATAAGCG 	Reverse primer for 
checking myc or GFP 
cassette 
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2.1.7 Antisera 
The antisera used in this study are described in Table 2.8 below. 
Table 2.8 Antisera 
Antibody 	Description 	 Reference 
Anti-HA 	Rabbit polyclonal antibodies raised against the 	Santa Cruz 
Haemagglutinin HA-i protein epitope of the Biotechnology 
influenza virus. 
1:1000 dilution for Western blotting. 
PAP (Anti- Peroxidase Anti-Peroxidase (PAP) Soluble 	Sigma 
protein A) 	Complex antibody produced in rabbit. 	 Biotechnology 
1:1000 dilution for Western blotting. 
Anti-Rabbit Donkey Anti-rabbit IgG covalently linked to 	Amersham 
IgG-HRP 	horseradish peroxidase. 
1:5000 dilution for Western blotting. 
Anti-c-Myc Rabbit polyclonal antibodies raised against the 	Santa Cruz 
(A-14) 	carboxy-terminus of human c-Myc. 	 Biotechnology 
1:1000 dilution for Western blotting. 
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2.1.8 Plasm ids 
The plasmids used during this work are listed in tables 2.9 and 2.10. 
Table 2.9 Cloning Vectors 
Plasmid 	Features 	 Source 
pBTM1 16 	LexA DNA binding domain fusion shuttle and 	S. Fields, 
expression vector: multiple cloning site, AmpR, S.U.N.Y 
colEl on., PADHI,  LexA DNA binding domain 	Stony Brook 
sequence, ADE1 transcriptional terminator, 2t, TRPJ 
pET 19b 	E. coli expression vector; MCS, T7 promoter 	Novagen 
- sequence,6x His-tag coding sequence, Enterokinase 	- 
cleavage site, T7 transcription termination sequence, 
AmpR, lacI,coiEl on. 
pRS316 	Yeast-E. coli shuttle vector; URA3, Amps?  MCS, 	Sikorski and 
CEN6, ARS 	 Hieter, 1989 
YEplac 195 Yeast-E. coli shuttle vector; URA3, AmpR  MCS, 	Gietz and 
2u, lacZa 	 Sugino, 1998 
pRS 1539 	Contains a MCS, TAP tag and a URA3 cassette; 	G.Riggaut 
colElori.,AmpR 	 1999 
pB27 	Derived from the original pBTM116: LexA DNA 	Hybnigenics 
binding domain fusion shuttle and expression 
vector: multiple cloning site, Tet1 , colEl on., 
PADHI, LexA DNA binding domain sequence, 
ADE1 transcriptional terminator, 2.t, TRP1 
Chapier iwo: 1t4'ajerjalc and t'iet/iuds 




pBTM1 16/ 	Modified pBTM1 16; contains Y0L093 W cloned in This work 
YOL093W frame with the LexA binding site encoding 
sequence. The construction of this plasmid is 
detailed in Figure 5.3. 
pRS316/ 	Modified pRS316: contains YOL093W coding 	This work 
YOL093W sequence with its wild-type promoter and polyA 
signal, CEN6, URA3 
YEplacl95/ 	Modified YEplac 195: contains YOL093W coding 	This work 
YOL093W sequence with its wild-type promoter and polyA 
signal, 2jt. URA3 
pRS3 16/ 	Modified pRS3 16: contains SP021 coding sequence A. Neiman, 
Spo2l with 300 bp on either side, CEN6, URA3 	 S.U.N.Y 
Stony Brook 
PRS426/ 	Modified pRS3 16: contains SP021 coding sequence A. Neiman, 
SP021 with 300 bp on either side, 2.t, URA3 	 S.U.N.Y 
Stony Brook 
pBL619 	Modified pRS316: contains RFC4 coding sequence P. Burgers 
with its wild-type promoter and polyA signal,, 	Washington 
CEN6, URA3 	 University 
pET19b/ 	E. coli expression vector used to produce a 6x His- 	J. Connelly 
YOL093W tagged Yo1093wp. Expression of Yo1093wp is 	This Lab 
controlled by IPTG-inducible lac promoter. MCS; 
(His)6-YolO93wp; Amps? 
pFA6a-13myc Contains a MCS, 13x myc tag and a hygromycion 	Longtine, 
-hph 	B-resistance cassette; AmpR 	 1998 
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Table 2.10 Modified Plasmids Continued 
Plasmid 	Features 
pFA6a-GFP 	Contains a MCS, GFP tag and a hygromycion 
- kanMX6 B-resistance cassette; AmpR 
pFA6a-3HA- Contains a MCS and a kanamycin-resistance 
kanMX6 	cassette; AmpR 
pAG32 	Contains a MCS and a hygromycion B -resistance 









pB27/ 	Modified pB27; contains Y0L093 W cloned in frame This work 
YOL093W 	with the LexA binding site encoding sequence. 
The construction of this plasmid is detailed in 
Figure 5.5. 
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2.2 Microbiological Methods 
2.2.1 Growth of Strains 
2.2.1.1 Growth of Bacteria 
E. coli strains were routinely grown at 37°C in LB medium (Table 2.1). To select or 
maintain selection for plasmid DNA, the transformed bacteria were grown in 
medium containing the appropriate antibiotic (Table2.3). 
2.2.1.2 Growth of Yeast 
Unless otherwise stated, yeast strains were grown at 30°C in YPDA medium (table 
2.2). To maintain selection for plasmid DNA, and/or for auxotrophic markers 
inserted on the genome, cells were grown in the appropriate drop-out medium or in 
YMM medium (Table 2.2) supplemented with appropriate nutrients (section 2.1.2.4). 
2.2.2 Preservation of Strains 
2.2.2.1 Preservation of Bacteria 
E. coli strains were stored for short period of time on solid medium at 4°C. Strains 
were stored permanently at -70°C in 15% (v/v) glycerol. One milliliter of cell culture 
was spin-down and resuspended with one milliliter of 15% glycerol. And snap-
frozen on dry ice. 
2.2.2.2 Preservation of S. cerevisiae 
Yeast strains were stored for up to two months on solid medium at 4°C. Strains were 
stored permanently at -70°C in 15% (vlv) glycerol. Yeast cells were grown to mid-
logarithmic phase. One milliliter of cell culture was spun down, resuspended with 
one milliliter of 15% glycerol, and snap-frozen on dry ice. 
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2.2.3 Yeast Sporulation and Tetrad Dissection 
2.2.3.1 Sporulation on Solid Plates 
Diploid yeast cells of the strain to be sporulated were grown on YPDA or selective 
solid medium (Table 2.2). Cells were patched onto solid sporulation medium (Table 
2.2) supplemented with the nutrients (section 2.1.2.4) required for growth of the 
diploid strain. Plates were incubated at 30°C to induce sporulation. After 
approximately five days, cells were examined microscopically to determine if 
sporulation occurred and tetrads had formed. 
2.2.3.2 Sporulation in Liquid Medium 
W303 strains to be sporulated were grown on YPDA (Table 2.2). A colony of cells 
was transferred to 2 ml of YPA media in a 15-mi glass tube and grown for 18 hours 
at 30°C. Cells were spun down at 200 rpm for 4 minutes and the YPA media was 
aspirated and replaced with 2 ml of sporulation medium (Table 2.2) supplemented 
with the nutrients required for growth of the diploid strain. Cultures were incubated 
in a rotor for 5-7 days at 30°C to induce sporulation. After approximately five days, 
cells were examined microscopically to determine if sporulation had occurred and 
tetrads had formed. 
* YPA Medium 	 2% Potassium Acetate 
2% Peptone 
1% Yeast Extract 
* Sporulation Medium 	1% Potassium Acetate 
0.02% Raffinose 
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2.2.3.3 Tetrad Dissection 
Upon successful sporulation and tetrad formation, cells were scraped from the 
sporulation plate with a loop and resuspended in 100 pi of sterile, distilled water. 3 
p1 of 3-glucuronidase (10 units/pi stock solution, Sigma) was added into this 
suspension, mixed gently and incubated at RT for 25-40 minutes. Upon successful 
cell wall digestion, 20 j.tl of the cell suspension was streaked onto solid YPDA plate 
(Table 2.2) and tetrads were dissected using a Singer MSM series 100 
micromanipulator. After dissection, spores were incubated at 30°C for 3-5 days. 
2.2.4 Transformation of E. coil 
2.2.4.1 Preparation of Chemically-competent Cells 
E coli DH5a F' (Table 2.5) cells were grown overnight on solid medium. Then a 
single colony was inoculated in 5 ml LB medium and grown at 37°C for overnight. 
Following this, 0.5 ml of this start culture was inoculated into 50 ml LB medium, and 
1 ml of 1 M MgC1 2 was added. Then incubated at 37°C until the 0D 600 was 
approximately 0.6. The culture was held on ice for 15 minutes, and transferred into 
sterile McCautney bottles. Cells were spun down at 4000 rpm for lOminutes (4°C, 
and resuspended in 1 ml TSB (Table 2.4). The competent cells were transferred in 
200 p1 aliquots to pre-chilled Eppendorf tubes and stored until required for use at - 
70°C. 
2.2.4.2 Transformation of Chemically-competent Cells 
The competent cells aliquots were thawed on ice and up to 10 p1 DNA was added 
into 100 lal of competent cells, and then transferred to a 15 ml tube. The tube was left 
on ice for 30 minutes before being transferred to 42°C for 2 mm. 900 p1 of TSB 
(Table 2.4) and 20 p1 of 1 M glucose were then added and the cells were incubated at 
37°C for 1 hour. Cells were then pelleted (3000 rpm, RT, Eppendorf 
Clwprer 7\vo: Il'!ate rinix and Met/wds 
microcentrifuge), and resuspended in 200 pA of LB medium. The cells were then 
placed on solid LB medium containing a suitable antibiotic. This was placed at 37°C 
overnight to produce visible colonies. 
2.2.5 Transformation of Yeast 
Yeast cells were transformed using the method of Gietz et al. (Gietz et al., 1992). 
2.2.5.1 Standard Yeast Transformation 
A single colony of the yeast strain to be transformed was inoculated into 10 ml of 
YPDA medium and grown at 30°C overnight. The following day, the cells were 
diluted into 50 ml YPDA to an 0D 600 of 0.1 and incubated at 30°C. 
Upon reaching an 0D 600 of 1.0, cells were harvested by centrifugation at 3500 rpm 
for 5 minutes (MSE Mistral 1000 centrifuge, RT), and washed once in 10 ml of 
sterile water. Cells were resuspend in 1 ml of 100 mM LiAc and transferred into an 
Eppendorf tube. Cells were pelleted by centrifugation in a microcentrifuge. Cells 
were finally resuspend in 250 p.1 of 100 mM LiAc. 50 p.1 of cell suspension was 
mixed with approximately 1 p.g of transforming DNA and 50 j..tg of salmon sperm 
DNA (Gibco BRL, incubated at 95°C for 10 minutes prior to use). 240 p.1 of 50 % 
(wlv) PEG3350 and 36 pA of 1 M Lithium acetate, and 18 pA of sterile water were 
added, mixed well and incubated at 30°C for 30 minutes on a rotating wheel. 
Follwing this, cell were heat-shocked at 42°C for 20 minutes, then sedimented at 
14000 rpm for 5 seconds. The pellet was resuspend in 200 jil of sterile water and 
placed onto the appropriate solid medium to select for transformants. Plates were 
incubated at 30°C for 2-3 days. 
* X10 LiAc: 1M Lithium acetate 
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2.2.6 ORF Replacement and Construction of Epitope-tagged Genes in 
Yeast 
2.2.6.1 ORF Replacement in Yeast 
Replacement of open reading frames in yeast was performed using the method of 
Baudin et at (Baudin et al., 1993). A linear DNA fragment was generated by PCR 
(section 2.3.2.9). This PCR template was chosen to contain the relevant DNA 
sequence required following integration. The primers were designed so that the final 
PCR product would contain a selectable marker and would be flanked at both ends 
by approximately 45 bp of sequence identical to the DNA immediately 5' and 3' to 
the coding sequence to be replaced. The PCR product was purified (section 2.3.2.11) 
and the relevant strain was transformed (section 2.2.5.1). Colonies growing on the 
appropriate selective plates were re-streaked onto fresh solid medium and the 
integration was investigated using PCR and, where relevant, Western Blotting 
(section 2.3.3.8). 
2.2.6.2 Construction of Epitope-tagged Genes in Yeast 
Epitope-tagged genes were generated using the same principal method that was used 
for ORF replacement (section 2.2.6.1). To construct an epitope-tagged allele of gene, 
however, an integration cassette was PCR-generated (section 2.3.2.9) was inserted 
immediately downstream of the final codon of t the target ORF. The integration 
cassette was chosen to contain a selectable/auxotrophic marker to select for the 
integration. 
2.2.6.3 Growth Curves 
Growth curves analysis was performed on yeast cells. Cells were grown in liquid 
medium to mid-logarithmic phase at 30°C. Then aliquots of cultures were to 
inoculate medium to an 0D 600 of 0.1. Cultures were then incubated at 30°C with the 
growth rate monitored by measuring the 0D 600 at regular intervals. 
I 
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2.2.6.4 Hydrophobic Spore Isolation in Yeast 
Cultures were sporulated in liquid for 5-7 days. The cells were harvested by 
centnfugation in a microcentrifuge (10 seconds), resuspended at a concentration of 
approximately 5 x 108  cells/mi in aqueous solutions of 250 units -glucuronidase (10 
units/tl stock solution, Sigma), and incubated at 30°C for 60 minutes until the ascus 
walls were digested. Cells were centrifuged at 1400g for 30 seconds in 1.5-mi 
polypropylene microcentrifuge tubes. The supernatant was discarded, and the cells 
were resuspended in lml of water, centrifuged, and resuspended in 100 p1 of water. 
Each tube was then agitated for approximately 2 minutes in an upright position, 
using a Vetox mixer at maximum speed. During this treatment, the spores clumped 
together and stuck to the walls of the tubes, which were relatively hydrophobic. 
Vegetative cells did not accumulate on the walls of the tubes and were removed by 
discarding the aqueous cell suspension and rinsing the tube several times with water. 
The spores were then resuspended by adding 1 ml of 0.01% Nonidet P-40 (Roche) 
and sonicating on ice for 3 x 45 seconds, using a Soniprep 150 (MSE) equipped with 
a microtip. 
2.2.6.5 Meiotic Assays in Yeast 
The enriched spores were spread onto YTvIM-ADE-ARG+CAN, YMM-URA-
ARG+CAN, and YMM-LYS-ARG+CAN. Canavanine (CAN) was used in all of the 
meiotic assays to select for haploid products and against unsporulated diploids. The 
increased number of papillae on YMIIvI-LYS-ARG+CAN media is indicative of the 
induction of meiotic heteroallelic recombination. Meiosis I non-disjunction was 
measured by papillation on YMM-ADE-ARG+CAN. Only strains carrying both 
homologues of chromosome I was able to grow on YMIM-ADE. As the parental 
diploid could grow on YIMM-ADE, canavanine was used to ensure that one was only 
looking at the haploid products of meiosis. Growth on YMIM-URA+CAN was used 
to assess reciprocal recombination between URA3-CANJ and ura3-1 and canl -100. 
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2.2.7 Yeast Two-hybrid Screen 
2.2.7.1 FRYL Library 
The FRYL library utilised in the two-hybrid screens described was constructed by M. 
Froment-Racine in the laboratory of P. Legrain (Institut Pasteur, Paris, France) 
(Fromont-Racine et al., 1997). The Y187 yeast cells were transformed with the 
FRYL library DNA, and stored at -80°C. 
2.2.7.2 Mating and Collection of Diploids 
The bait plasmid was introduced into the appropriate yeast strain (L40AG for 
pBTM1 16 plasmids) (Table 2.6) and propagated on —W drop-out medium (Table 2.2). 
Baits cells were grown in —W drop-out liquid medium to an 0D 600 of approximately 
0.8. An aliquot of Y187 cells containing the FRYL library was thawed on ice, 
inoculated into 20 ml of YPDA + Tetracycline (Table 2.2 & 2.3) and incubated at 
30°C for 15 minutes, with gentle shaking (approximately 120 rpm). Baits cells 
equivalent to 80 0D600 units (approximately 8 x 108  cells) were mixed with the 
recovered library-containing Y187 cells, and 1/12 volume of the cells concentrated 
onto a Millipore filters (47-mm diameter, 0.22 p.m pore size). Each filter was washed 
with 3 ml of YPDA + Tet medium and incubated for 5 hours at 30°C. Cells were 
collected by washing from the filters with 2 ml of —LWH drop-out medium (Table 
2.2). Collected cells were mixed thoroughly and 50 p.1 was removed for control 
plates. This 50 p.1 aliquot was diluted to 1:1000 by three 10-fold serial dilutions in - 
LWH drop-out medium and 50 p.1 was plated onto each of —L, -W, and —LW drop-
out media (Table 2.2). These plates were incubated at 30°C for 2 days. The 
remainder of the mated cells were spread onto —LWH + Tet drop-out medium at 250 
p.1 per plate, and incubated 30°C for 3 days. 
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2.3 Nucleic Acid Methods 
2.3.1 General Methods 
2.3.1.1 Phenol/chloroform Extraction 
Nucleic acids were purified away from protein in an aqueous solution by adding an 
equal volume of phenol: chloroform: i soamyl alcohol (25:24:1), vortexing for 10 
seconds and centrifuging at 14000 rpm for 4 minutes. The upper, aqueous, phase 
containing the nucleic acid was removed to a fresh tube. 
2.3.1.2 Precipitation of Nucleic Acid 
Nucleic acids were precipitated from solution by adding 2 volumes of ethanol and 
0.1 volumes of 3 M sodium acetate (pH 5.2). This was incubated at -20°C for 30 
minutes. Nucleic acids were than pelleted by centrifugation at 14000 rpm for 30 
minutes at 4°C, and the pellet washed in 70% (v/v) ethanol. The pellet was then dried 
and resuspended in an appropriated volume of distilled water. 
2.3.2 DNA Methods 
2.3.2.1 Small Scale Preparation of Plasmid DNA by Spin Column 
Plasmid DNA was prepared using the QlAprep spin miniprep kit (Qiagen), following 
the manufacturer's instructions. DNA was extracted from 1.5 ml of E. coli culture 
grown to stationary phase, eluted in 30 .tl of distilled water and stored at -20°C. 
2.3.2.2 Large Scale Preparation of Plasmid DNA by Filtration Column 
Plasmid DNA was prepared using the QlAfilter midiprep kit (Qiagen), following the 
manufacturer's instructions. DNA was extracted from lOOmI of E. coli culture grown 
to stationary phase, eluted in 500 p1 of distilled water and stored at -20°C. 
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2.3.2.3 Yeast Genomic DNA preparation 
Yeast genomic DNA was prepared using the method of Hoffman and Winston 
(Hoffman and Winston, 1987). 
A single colony of yeast strain was inoculated in 10 ml of the appropriate medium 
(table 2.2), and incubated at 30°C overnight. Cells were harvest by centrifugation at 
3500 rpm for 5 minutes (MSE Mistral 100 centrifuge, RT), and washed with lOml of 
distilled, sterile water. Cells were then resuspend in 1 ml of water and transferred 
into a 1.5 ml tube, and pelleted at 4000 rpm for 10 seconds. 200 p1 of glass beads 
(0.5mm, Biospec Products Inc.), 200 p1 of lysis buffer, and 200 p1 of 
phenol: chroroform: i soamyl alcohol (25:24:1) were added. The mixture was vortexed 
for 4 minutes. After this, 200 p1 of distilled water was added. The tube was then 
centrifuged at 14000 rpm for 5 minutes (RT). The upper phase was removed into a 
new tube and the nucleic acid precipitated and dried (section 2.3.1.2). For a yeast 
genomic DNA preparation, the pellet was resuspended in 100 p1 of distilled water. 
Typically, a yield of approximately 0.2 pg /pl is obtained. 
* Lysis Buffer: 	10 mlvi Tris-HC1, pH 6.8 
1% (wlv) SDS 
1 mM EDTA 
100 mMNaCl 
2% (v/v) Triton X-100 
2.3.2.4 Yeast Plasmid Rescure 
Plasmid DNA was rescued from yeast cells using the Zymoprep Yeast Plasmid 
Ivlinipreparation Kit (ZYIvIO Research), following the manufacturer's instructions. 
DNA was extracted from 5 ml of yeast culture grown to stationary phase, eluted in 
30 p1 of distilled water and stored at -20°C. 5 p1 of the DNA solution was used for 
transformation of E. coli cells. 
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2.3.2.5 Restriction Digestion of DNA 
Restriction endonuclease digestion of DNA was typically performed in volumes of 
20-100 p1. These contained the required quantity of DNA and the appropriate buffer 
(supplied and recommended by the manufacturer) at Xl concentration. Between 2 to 
5 units of restriction enzyme in question were added, ensuring that the total enzyme 
volume did not exceed 10% of the total reaction volume. The digestion was 
incubated at the appropriate temperature recommended by the supplier; typically 1-4 
hours. The products of the digestion were either analysed by agarose gel 
electrophoresis (section 2.3.2.6) or extracted (section 2.3.2.7) for further 
manipulations. 
2.3.2.6 Agarose Gel Electrophoresis 
DNA fragments produced either by restriction endonuclease digestion (section 
2.3.2.5) or generated by PCR (section 2.3.2.9) were analysed typically in 0.8-1.2% 
(w/v) agarose gels. Gels were prepared by melting agrose in 100 ml of Xl TAE 
buffer (table 2.4) and adding ethidium bromide to a final concentration of 0.5 tg/ml. 
Samples to be analysed were added to Ficoll loading buffer and were loaded directly 
onto the gel. Two hundred volts were supplied across the gel so that the DNA 
fragments separated with respect to size. The DNA could subsequently be visualized 
using a UV transilluminator. DNA markers of known molecular size were also 
loaded on the gel so that DNA fragments could be easily identified. 
* X6 Ficoll Loading Buffer: 15% (w/v) Ficoll (Type 400) 
0.25% (wlv) Xylene xyanol FF 
0.25% (w/v) Bromophenol blue 
2.3.2.7 Purification of DNA from Agrose Gels 
DNA fragments produced either by restriction endonuclease digestion or generated 
by PCR were purified by freshly separating DNA fragments by agrose gel 
electrophoresis (section2.3.2.6) and subsequently isolating the desired DNA band 
from the agarose gel using the QlAquick gel extraction kit (Qiagen) according to the 
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manufacturer's instructions. DNA was eluted in 30 lal of distilled water and stored at 
-20°C. 
2.3.2.8 Ligation of DNA Molecules 
Ligations were performed in a final volume of 10 p1, containing approximately 25 ng 
of vector DNA, about 3 times this amount (with respect to the number of moles) of 
insert DNA, Xl ligation buffer and 200 units of T4 DNA ligase (NEB). Reactions 
were allowed to proceed at 16°C for 18 hours and stopped by heat-inactivation at 
70°C for 15 minutes. 
2.3.2.9 Amplification of DNA by the Polymerase Chain Reaction (PCR) 
Specific regions of DNA were amplified using the polymerase chain reaction (PCR). 
Template DNA was either approximately 1 pg of plasmid DNA or yeast genomic 
DNA using specifically designed primers manufactured commercially. A typical 
PCR reaction using plasmid as template was as follows: 
X10 Polymerase Buffer (MgC12 plus*) 5 	.tl 
10 mM dNTPs (dATP, dCTP, dTTP, dGTP) 5 pJ 
Oligonucleotide primer 1 (10 pmol/p1) 3 p1 
Oligonucleotide primer 2 (10 pmol/pl) 3 p1 
Template DNA (10 ng/j.tl) 1 p1 
DNA polymerase (2 U/pi) 0.5 jtl 
Sterile distilled water 	 32.5 j.tl 
*MgC12 concentrations were adjusted as required to optimise reaction conditions. 
PCRs were carried out in a PTC-100 Hot Lid reactor or a DNA Engine Gradient 
Cycler (Genetic Research Instrumentation Ltd) programmed according to the length 
of the desired product and the annealing temperature of the oligonucleotide primers 
being used. 
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A typical cycling program is show below: 
30 cycles of step 1-step3: 
Step 1 	Denaturation 
Step2 	Primer Annealing 
Step 3 	Extension 
Step 3 	Final Extension 
94°C for 20 seconds 
40-65°C for 1 minute 
72°C for 1 minute# 
72°C for 10 minutes 
# This time was extended by one minute for every kb over 1kb of the length of the 
desired product. 
2.3.2.10 PCR from Yeast Colonies 
A single colony of yeast was picked with a sterile toothpick and resuspended in 100 
Al of distilled water. The cell suspension was boiled for 10 minutes and then placed 
on ice. 5 tt l of this suspension was used in a 20 j.tl PCR reaction. 
2.3.2.11 Purification of PCR Products 
DNA fragments generated by PCR (section 2.3.2.9) were purified from 
oligonucleotide primers, unincorporated nucleotides, polymerases and salts using the 
QlAquick PCR purification kit (Qiagen), following the manufacturer's guidelines. 
Purified DNA was eluted in 30 gl of distilled water and stored at -20°C. 
2.3.2.12 DNA Sequencing 
Plasmid DNA to be sequenced was prepared using the QlAprep spin columns 
(section 2.3.2.1) and quantified by visualization on an agrose gel (section 2.3.2.6). 
Genomic DNA to be sequenced was firstly amplified using PCR (section 2.3.2.9) 
with suitable primers (Table 2.7) and the resulting DNA fragment was purified using 
the QlAquick PCR purification kit (section 2.3.2.11). Sequencing reactions were 
then performed using a dRhodamine terminator cycle sequencing kit (Perkin Elmer) 
in a UNO-Thermoblock reactor (Biometra). A reaction mix was as follows: 
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Template DNA 	 250 ng of double-stranded DNA or 
100 ng of PCR product 
Terminator mix 	 2 p1 
Primer 	 1.6 pmol 
Distilled water 	 make-up volume to 10 p1 
35 cycles as described below were performed: 
Step 1: 96°C for 30 seconds 
Step 2: 50°C for 15 seconds 
Step 3: 60°C for 4 minutes 
10 p1 of distilled was then added into the reaction mix. 
Samples were run on an ABI PRISM 377 DNA Sequencer and the resulting DNA 
sequence studied using the Gene Jockey II computer program. 
2.3.2.13 32P DNA labelling 
DNA oligonucleotides (J26-1, -2, -3, -4, and J26-2-COMP.) were synthesized by 
MWG-Biotech AG. Labelling reactions were performed at 37°C for 30 minutes. A 
reaction mix was as follows: 
DNA (J26-2) 	 20 pmol 
X10 PNK buffer 	 4 j.tl 
32P-y-ATP 	 3 jtl 
PNK-ase 	 4 p1 
Distilled water 	 make-up volume to 40 p1 
After incubation, 8 p1 of 0.5 M EDTA (pH7.5) was added to stop the reaction. 
Oligonucleotides were precipitated from solution by adding 2 volumes of ethanol and 
0.1 volumes of 3 M sodium acetate (pH 5.2). Nucleic acids were than pelleted by 
centrifugation at 14000 rpm for 60 minutes at 4°C, and the pellet washed in 70 % 
(v/v) ethanol. The pellet was then dried and resuspended in 60 p1 of TIE buffer. 
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2.3.2.14 Preparation of the 32P-labelled duplex and Holliday Junction 
In all constructs, one of the oligos was [y- 32P]-end labelled, and after annealing the 
products were gel purified. Annealing reactions were performed in a PCR reactor. A 
reaction mix was as follows: 
(1) Duplex 
32P-y-labelled ssDNA (J26-2) 
Oligonucleotides DNA (J26-2-COMP) 
NaCl 
Distilled water 
approximately 	15 pmol 
50 pmol 
250 mM 
make-up volume to 20 tl 
(2) Holiday junction (HJ) 
32P-y-labelled ssDNA (J26-2) 
Oligonucleotides DNA (J26-1) 
Oligonucleotides DNA (J26-3) 
Oligonucleotides DNA (J26-4) 
NaCl 
Distilled water 





make-up volume to 20 p1 
The program as described below was performed: 
99°C 	 4 minutes 
65°C 	 10 minutes 
37°C 	 10 minutes 
28°C 	 10 minutes 
Samples were purified by loading on a 10% native acryamide gel. The bands were 
excised and 500 p1 of TE buffer was added per tube. Samples were incubated at 30°C 
overnight then centrifuged at and 12000 rpm for 10 mm (4°C) The supernatant was 
removed into a fresh tube and oligonucleotides were precipitated with ethanol. The 
pellet was dried and resuspended in 30 p1 of TE buffer. 
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2.4 Protein Methods 
2.4.1 Crude Extraction of Total Cellular Protein from Yeast 
10 ml of appropriate medium was inoculated with a single colony of yeast strain, and 
incubated overnight. Cells were harvested centrifugation at 3500 rpm for 4 minutes 
(Mistral 100 centrifuge, RT). The pellet was resuspended in 100 tl of H20 and 100 
p1 of X2 SDS loading buffer, and mixed well. 50 j.tl of glass beads (0.5 mm) was 
added and vortexed for 60 seconds. The lysate was incubated at 96°C for 60 seconds 
and then on ice for 60 seconds. These incubations were repeated for a further two 
times, after which the tubes were centrifuged at 14000 rpm for 5 minutes. Samples 
could be stored at -20°C. Samples were heated again at 95°C for 5 minutes before 
loading 15-20 p1 of the sample on a gel. 
2.4.2 Large Scale Yeast Whole Cell Extraction Preparation 
10 ml of the appropriate medium was inoculated with a single colony of yeast strain, 
and incubated at 30°C overnight. This was then taken and used to inoculate more 
volume of medium to 0D600 of approximately 0.1, and incubated until the 0D 600 was 
approximately 2. Cells were then centrifuged at 5000 rpm for 5 mm (JLA 10.500 
rotor, RT) and resuspended in 50 ml of AGK buffer. Cells were sedimented at 3500 
rpm for 5 mm (Mistral 1000 centrifuge, RT). The supernatant was removed and the 
resulting cell pellet was weighed. Cells were resuspended in 0.4 cell pellet volume of 
AGK buffer. Dli was added to a final concentration of 2 mM. Protease inhibitors 
(Roche) were added just before freezing. The cell suspension was then frozen by 
adding drop wise into liquid nitrogen. This could be stored at -70°C for one year with 
no loss of activity. 
The frozen cell pellet was then added into a mortar containing liquid nitrogen and 
ground to a fine powder with occasional additions of liquid nitrogen to ensure the 
pellet did not thaw. The frozen powder was transferred to a polycarbonate centrifuge 
tube, and thawed on ice. It was then centrifuged at 17000 rpm for 30 minutes (in a 
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JA2.50 rotor, at 4°C). The supernatant was transferred to chilled polycarbonate tubes 
avoiding the lipid layer during transfer. This was then spun in a pre-cooled 70.1 Ti 
rotor at 40000 rpm for one hour (Beckman, at 4°C). The supernatant was transferred 
to dialysis membrane with a molecular weight cut-off of approximately 10 kDa. This 
was placed in 1.5 litre of dialysis buffer and dialysed for 3 hours 4°C, changing the 
dialysis buffer once. The supernatant was then placed in a falcon tube and stored at - 
70°C until use. 
*AGK buffer: 
*Dialysi s  buffer: 
10 mM HEPES, pH 7.9 
1.5 mM M902 
200 mM KCI 
10% (v/v) Glycerol 
20 mM HEPES, pH 7.9 
0.2 mM EDTA 
50 mM KC1 
20% (v/v) Glycerol 
0.5 mMDTT 
2.3.3 Polyacrylamide Gel Electrophoresis (PAGE) 
Novex Mini Gels (Protein SDS PAGE) 
Protein samples with SDS loading buffer were heated at 95°C for 5 minutes before 
loading. Samples were then loaded onto a pre-cast 4-12% polyacrylamide gel 
(Novagen), alongside pre-strained molecular weight markers of known size (NEB) 
for reference. The gel was subject to electrophoresis in a Novex Mini-cell (Novagen) 
with Xl MOPS (Table 2.4) as buffer. Electrophoresis was performed at 200V until 
the bromophenol blue dye front reached the bottom of the gel. 
*X2 SDS loading buffer: 100 mM Tris-HC1, pH 6.8 
4% (w/v) SDS 
20% (vlv) glycerol 
200 mM DTF 
0.2% (wlv) Bromophenol blue 
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Classic Gels (Protein SDS PAGE) 
Two glass plates were separated by spacers. Resolving gel solution was prepared, 
poured between the plates, and overlaid with water over the top to prevent oxidation 
and to help form an even interface between the resolving and stacking gels. The gel 
was then left to set at room temperature, the water was removed, stacking gel 
solution was poured and an appropriate comb inserted to create loading wells. After 
polymerisation, the gel was subject to electrophoresis in a Mini-cell (BlO-RAD), the 
comb was removed and the wells were washed with Xl running buffer (Table 2.4). 
Protein samples were boiled for 5 minutes and loaded into the wells. 1X running 
buffer was poured into the upper and lower buffer chambers. Gels were run at 150V 
at room temperature until the bromophenol blue dye front reached the bottom of the 
gel. 
* 10 % resolving gel 
* Stacking gel solution: 
* Xl running buffer: 
375 mM Tns-HC1, pH 8.8 
1% (w/v) SDS 
10% (w/v) Acrylamide/bis-acrylamide (ratio 37.5:1) 
1% (w/v) Ammonium persulfate 
TEMED 
125 mM Tris-HC1, pH 6.8 
1% (w/v) SDS 
10% (w/v) Acrylamidefbis-acrylamide 
1% (w/v) Ammonium persulfate 
TEMED 
25 mMTris base 
0.1% (w/v) SDS 
250 mM Glycine 
Native DNA-Protein Gels 
Two glass plates were separated by spacers. Non-denaturing gel solution was 
prepared, poured between the plates, and an appropriate comb inserted to create 
loading wells. The gel was then left to set at room temperature. After polymerisation, 
the gel was subject to electrophoresis in a Mini-cell (BlO-RAD), the comb was 
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removed and the wells were washed with Xl TBE buffer (Table 2.4). Protein 
samples were boiled for 5 minutes and loaded into the wells. Xl running buffer was 
poured into the upper and lower buffer chambers. Gels were run at 150V at room 
temperature until the bromophenol blue dye front reached the bottom of the gel. 
* 4-6% Non-denaturing gel: 375 mM Tris-HC1, pH 8.8 
4-6% (wlv) Acrylamide/bis-acrylamide (ratio 19:1) 
1% (w/v) Ammonium persulfate 
TEMED 
2.3.4 Coomassie Staining of SDS Polyacrylamide Protein Gels 
In order to visualise total protein in an SDS polyacrylamide gel, the gel was 
incubated in coomassie solution for 30 minutes and then destained by incubation for 
7-12 hours in destaining solution under constant gentle shaking at room temperature. 
The destaining solution was replaced frequently. After destaining, the gel was dried 
on Whatman 31V11v1 paper using a Bio-Rad's Model 583 Gel Dryer. 
* Coomassie solution: 	0.1% (w/v) Coomassie blue 
50% (v/v) Methanol 
10% (v/v) Acetic acid 
* Destaining solution: 	10% (v/v) Methanol 
10% (v/v) Acetic acid 
2.3.5 Silver Staining of SDS Polyacrylamide Protein Gels 
Silver staining of the total protein in an SDS polyacrylamide gel was using the silver 
staining kit (Pharmacia Biotech) following the manufacturer's guidelines. 
2.3.6 GelCode Blue Staining of SDS Polyacrylamide Protein Gels 
GelCode Blue staining of the total protein in an SDS polyacrylamide gel was using 
the GelCode Blue Stain reagent (Pierce) following the manufacturer's guidelines. 
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This reagent utilizes the colloidal properties of Coomassie for protein staining on 
polyacrylamide gels. This unique reagent stains only protein and allows bands to be 
viewed directly on the gel during the staining process. 
2.3.7 Mass Spectrometry 
Silver- or GelCode Blue-stained proteins were digested in-gel with trypsin. Trypic 
peptides were sequenced by nanoelectrospray tandem mass sectrometry. Proteins 
were identified by searching peptide sequence tags against a comprehensive 
nonredundant protein database using a peptide mass fingerprinting tool from the 
UCSF Mass Spectrometry Facility (http://prosl2ector.ucsf.edu/ucsflitml4.0/msfit.htm).  
2.3.8 Western Blot 
Electrophoretic Transfer of Protein to PVDF Member 
Proteins were transferred electrophoretically form the SDS-polyacryamide gel to 
PVDF membrane (Amersham) using the Novex Mini-cell (Novagen). 
Electrophoretic transfer was performed in lx Western Transfer Buffer at 30V 
constant for one hour. 
* X10 Western Transfer Buffer: 	200 mM Tris-HCI, pH 6.8 
1.5 M Glycine 
2.3.9 Antibody Binding 
Non-specific protein interactions were blocked by incubating the PVDF membrane 
following transfer at RT for one hour or at 4°C for overnight. Blocking was 
performed in 25 ml of Blocking Buffer with constant shaking. Primary antiserum 
(Table 2.8) was diluted to the appropriate concentration in lOml of Blocking Buffer, 
added to the blocked membrane and incubated at 4 °C for one hour with constant 
shaking. The membrane was then washed in lx TBST three times for 15 minutes 
each. Secondary antiserum (HRP-conjugated or not) was then diluted in 10 ml of 
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Blocking Buffer, applied to the membrane and incubated at RT for 60 minutes with 
constant shaking. The membrane was then washed as detailed above. 
* X 1 Blocking Buffer: 	1X TBST (Table 2.4) 
5% (w/v) dry milk powder (J. S. Sainsbury Ltd) 
2.3.10 Enhanced Chemiluminescence (ECL) 
3 .tl of developer solution (Amersham) was prepared according to manufacturer's 
instructions, added to the membrane and incubated at RT for 60 seconds. Following 
incubation, the membrane was placed in Saran wrap and exposed to photographic 
film. Exposure times varied depending on the strength of the signal, but were 
typically between 10-60 seconds. 
2.3.11 Expression and Purification of His-tagged Recombinant Protein 
from E. coil 
Protein Expression 
500 millilitres of LB medium (Table 2.1) containing the appropriate antibiotics 
(Table 2.3) were inoculated with 25 ml overnight culture of the expression plasmid-
bearing E. coli strain. The culture was grown at 37°C to an 0D 650 value of 0.6. For 
induction of the expression, IPTG was added to a final concentration of 1mM and the 
culture was incubated at 37°C for 4 hours. The cells were harvested by centrifugation 
at 5000 rpm for 10 minutes at 4°C (Beckman JLA 10.500 rotor) and stored at —80°C. 
Preparation of Protein Extract 
Cells were thawed on ice and resuspended in 3 ml ice-cold binding buffer (500 mM 
NaCl, 20 mM Tns-HC1, 5 mM imidazole, pH 7.9) per gram cell weight. The 
suspension was then sonicated in a beaker on ice until the sample was no longer 
viscous. The lysate was transferred into 1.5 ml Eppendorf tubes and centrifuged at 
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12,000 rpm for 30 minutes at 4°C. The supematant was transferred to a universal 
tube on ice. 
Ni—NTA Affinity Purification of the His-tagged Protein 
All manipulations were done in the cold room at 4°C. 10 tl of Ni-NTA agarose 
(Novagen) were loaded and equilibrated with 30 ml of binding buffer for one hour at 
4°C. 10 ml of the prepared cell extract was added. The column was then washed 
with 10 ml of binding buffer and lOml of wash buffer (500 mM NaCl, 20 mM Tns-
HC1, 60 mM imidazole, pH 7.9). The flow through was collected as a batch. 
Eventually, the His-tagged protein was eluted with 60 ml of elution buffer (1 M 
imidazole, 500 mM NaCl, 20 mM Tris-HCI, pH 7.9) over an hour and the eluate was 
collected in fractions of 1 ml and stored at -80°C. 
20 ml aliquots of the eluates and the washes were resolved by SDS-polyacrylamide 
gel electrophoresis (section 2.3.2.6). The total proteins were visualised by coomassie 
staining (section 2.3.3.4). 
2.3.12 DNA-protein Binding Assays 
(1) Reactions for Agarose Gels 
All binding reactions were carried out at 30°C for 30 minutes. A reaction mix was as 
follows: 
Circular or linear DNA (plasmid pBR322) 	 1 jig 
X10 nuclease buffer 	 2 j.tl 
NaCl 	 200 mM 
BSA 	 2j.tg 
Distilled water 	 make-up volume to 20 p.1 
After incubation, samples were visualized on a agarose gel. 
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(2) Reactions for Native Acrylamide Gels 
All binding reactions were carried out at 30°C for 30 minutes. A reaction mix was as 
follows: 
32P-y-labelled DNA 	 0.5-2 pi 
X10 nuclease buffer 	 4 xl 
NaCl 	 200mM 
BSA 	 2pg 
Distilled water 	 make-up volume to 20 pi 
After incubation, load samples on a 4-5% native acrylamide gel. 
*Nuclease buffer (X10): 	12.5 mM DiT 
20% glycerol 
- 	250 mM Tris (pH 7.5) 
2.3.13 DNA Methylation Assays 
All methylation reactions were carried out at 30°C for 60 minutes. A reaction mix 
was as follows: 
tRNA (Roche, E. coli tRNAs) 	 630 pg of tRNA 
or HJ substrates 	 or 6.3 tl of HJ DNA 







Tns-HC1 (pH 7.4) 
MgC12 






make-up volume to 20 jil 
After incubation, samples were spun down for 10 seconds. 15 jil of samples were 
spotted on a 2.5-cm circle of Whatman DE81 paper on a vacuum manifold 
(Millipore). The filter papers were washed with 5 x 1 ml of 0.2 M NH4HCO3 , 3 x 1 
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ml of ethanol, and imi of diethyl ether. Tntium was determined in 5 ml of a 
scintillation fluid. 
2.3.14 Immunofluorescence for Visualization of GFP and 13Myc-tagged 
Antibodies 
Yeast cells were grown to mid-logarithmic phase, and then Formaldehyde was added 
directly into the growing medium to final concentration of 3.7%. The mix was 
further incubated at 30°C for 30 minutes. After fixation, cells were harvested by 
centnfugation at 3500 rpm for 3 minutes, and washed with 1 ml of 100 mM Kpi 
(pH7.4, 1.2 M Sorbitol added) (Buffer B). For spheroplasts, cells were resuspended 
in lml of Lyticase (250 tgIml, dissolved in 100 mM Kpi, pH7.4), and then 
incubated at 30°C for 40 minutes. Cells were pelleted by centrifugation at 3500 rpm 
for 1.5 minutes, and washed twice with 1 ml of Buffer B, followed by PBS/Sorbitol. 
Cells were resuspended in 1 ml of Buffer B. 20 p.1 of cells were spotted onto a slide 
coated with polysine (BDH, Polysine coated slides), and incubated for 10 minutes in 
the humid chamber. The slides were then washed twice with 1 ml of Buffer B, and 
blocked with 5% milk/PBS at RT for 45 minutes. Milk/PBS was aspirated right 
before adding primary antibody, and the slide was incubated at 4°C overnight in the 
humid chamber. After the incubation, the slide was washed twice with 5% milk/PBS 
before applying secondary antibody and incubated in the dark for one hour in the 
humid chamber. It was then washed 5 times with 5% milk/PBS. A drop of a 
mounting medium containing DAPI (Vectashield mounting medium, VECTRA) was 
added on each well, and a cover slip was applied. The slide was sealed with nail 
polish, and stored at -20°C. The sections were photoconverted using a conventional 
fluorescence microscope (Axioskop; Zeiss, Oberkochen, Germany) with a 
Photometncs SenSys CCD camera (Coherent Life Science). 
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2.3.15 TAP Tag Purification 
lgG Beads Binding 
200 lal of IgG agarose bead suspension (SIGMA A2909) was added to column and 
washed with 5 ml of IPP-150. To every 1 ml of yeast protein extract, 10 .tI of 1 M 
Tns pH8, 20 j.tl of 5 M NaCl, and 10 j.tl of 10% NP-40 were added. The mix was 
then added to column and rotated at 4°C for 2 hours. 
TEV Protease Cleavage and Calmodulin Beads Binding 
The column was drained by gravity flow, and washed with 30 ml of IPP-150, 
followed by 10 ml of TEV cleavage buffer. 1 ml of TEV cleavage buffer and 
approximately 60 units of TEV enzyme (GIBCOBRL) were added into the column. 
The column was closed and rotated at 4°C overnight. During the incubation, a new 
calmodulin bead column was prepared for using: 200 p1 of calmodulin bead 
suspension (SIGMA P4385) was added to a column and washed with 5 ml of 
calmodulin binding buffer (CBB). Eluate was then recovered from the IgG-bead 
column by gravity flow and collected into the calmodulin column. CBB (3 volumes 
of eluate) and 1 M CaC1 2 (3 lLl /ml) were added. The column was closed and rotated 
at 4°C for 1 hour. The column was then drained by gravity flow and washed with 30 
ml of IPP-150 CBB. Proteins were eluted with 200 p1 of IPP150 calmodulin elution 
buffer. 5 fractions were collected. All the fractions were then combined. 
2.3.16 Protein Precipitation with Trichioroacetic Acid (TCA) 
The eluate was adjusted to 20% TCA with 60% TCA. The mix was then placed on 
ice for 30 minutes. After incubation, the mix was pelleted at 14000 rpm for 30 
minutes at 4°C. The supernatent was removed and kept. The pellet was washed two 
times with 200 p1 of ice-cold acetone, followed by centrifugation at 14000 rpm for 5 
minutes at 4°C. The supernatant was removed and the pellet was air-dried. The 
pellet was resuspended in 25 p1 of Xl SDS loading buffer and stored at -20°C. 
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150 mM NaCl 
0.1% NP-40 





0.5 mM EDTA 
* 10 mM EDTA was added immediately before use. 
Calmodulin Binding Buffer (CBB): 	10 mM Tns pH8 
150 mMNaC1 
0.1% NP-40 
1 mM Mg2 Ac 
1 mM Imidazol 
2 mM CaCl2 
*Mercaptoethanol (BM1E) was added to final concentration of 0.7% 
immediately before use. 
Calmodulin Elution Buffer (CEB): 	10 mM Tns pH8 
150 mMNaC1 
0.1% NP-40 
1 mM Mg2 Ac 
1 mM Imidazol 
10 mM EGTA 
*BME was added to final concentration of 0.7% immediately before use. 
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2.4 Computer Analysis 
Yeast database searches were performed on the Saccharomyces Genome Database 
(SGD) network (http://www.yeastgenome.org/).  
Protein database search were performed on the NCBI server using the PSI-BLAST 
program (http://www.ncbi.nlm.nih.gov/BLAST).  
Pairwise and multiple protein sequence alignments were perform using the EMBL 
ClustaiWu program (http://www.ebi.ac.uk/clustalw/index.htm])  
The nuclear localization signal (NLS) was predicted using the Columbia University 
Bioinformatics Center Web Server: 
(http://cubic.bioc.columbia.edu/cgi/var/nair/resonline.pl).  
3D predictions were performed using the 3D-PSSM Web Server V 2.6.0 program 
(http://www.sbg.bio.ic.ac.uk/servers/3dpssm).  
Sequence identities and similarities were identified using the BOXSHADE 3.21 
server (http://www.ch.embnet.org/software/BOX_form.html).  
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CHAPTER THREE 
YOL093W Gene Replacement 
3.1 Sequence Analysis of the Yo1093w Protein (YoIO93wp) 
The Yo1093w protein is a hypothetical protein comprised of 293 amino acids (Figure 
3.1.A). The protein has a predicted molecular weight of 34.5 kDa, and isoelectric 
point (p1) of 10.03. At the start of this thesis, no functional data was available for this 
protein. 
The protein sequence, as shown in Figure 3.2, contains a predicted nuclear 
localization signal (NLS) in the N-ternunal region, which suggests that Yo1093wp 
might be a nuclear protein. The three-dimensional structure predictions of the protein 
fragments showed it contained a putative DNA binding domain and a DNAIRNA-
binding 3-helical bundle in its C-terminal end (Figure 3.3), but the significance of the 
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predictions was quite low. The domains were delineated by sequence analysis and 
there was no experimental data to suggest the function of the Yo1093wp. No other 
recognised protein motifs were identified. Examination of the sequence of Yo1093wp 
therefore did not reveal any clues as to the role of the protein; although it did suggest 
that Yo1093wp might bind to DNA or RNA. 
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YOL093WChr15 
MSN DEINQN EEKVKRTPPLPPVPEGMSKKQWKKMCKRQRW 
EEN KAKYNAERRVKKKRLRH ERSAKIQEYI DRGEEVPQELIRE 
PRINVNQTDSGIEIILDCSFDELMNDKEIVSLSNQVTRAYSANR 
RANH FAEIKVAPFDKRLKQRFETTLKNTNYENWNH FKFLPDD 
KIMFGDEHISKDKIVYLTADTEEKLEKLEPGMRYIVGGIVDKN R 





Ala[A] 15 5.1% 
Cys[C] 3 1.0% 
Asp[D] 18 6.1% 
GIu[E] 29 9.9% 
Phe[F] 9 3.1% 
GIy[G] 9 3.1% 
His[H] 6 2.0% 
IIe[I] 18 6.1% 
Lys[K] 34 11.6% 
Leu[L] 21 7.2% 
Met[M] 8 2.7% 
Asn[N] 19 6.5% 
Pro[P] 16 5.5% 
GIn[Q] 10 3.4% 
Arg[R] 23 7.8% 
Ser[S] 14 4.8% 
Thr[T] 13 4.4% 
VaI[V] 15 5.1% 
Trp[W] 4 1.4% 
Tyr[Y] 9 3.1% 
Total Length 293 
Figure 3.1 Amino Acid Composition of Y6I093wp 
(A) Amino acid sequence of Yo093wp. (B) Amino acid composition of Yo1093wp: no.-
number of times a particular amino acid is present in the protein. 
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uVJ(KRJ(reqr2.4)IPLV!JR Pottiai • 5 100 0 ht3l_arath nuc 
c2f_human nuc 
prt3_onany nuc 
prt4. onony nuc 
prth_onony nuc 
a:The x*erdiai NLS IRKI(PLMIKRJRKI{2.4}{PLVI]R has been delved from the experWnental NLS RIRKKLR 
format for NLS motifs: 
(KR] 	 reed KorR 
G{3} read GGG 
x(3.5) 	read between 3 and 5 x 
where x stands for any amino acier  
Figure 3.2 Nuclear Localisation Signal (NLS) Prediction of Yo1093wp 
The NLS was predicted using the Columbia University Bioinforn,atics Center Web Server. 
The proposed NLS is highlighted in red. 
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Putative DNA-binding domain 
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(ramber)PSS 	PredrOed Secondary Strucrure for your Sequence 
(number)_Seq Your Sequence 
(nanb.r)_S.q 	Ubry Sequence 
(numbei-)_SS Knn Secondery Structure of the Ubray Sequence (Assigned by STRIDE) 
CORE 	 A measure of the burial and number of contacts made by a resictie. 
(9 very bI.nied/malcWIg many contacts, 0 not txinedlmaiang few contacts) 
Putative DNA-binding domain 
	
	 DNAIRNA-blndlng 3-helical bundle 
("Winged helix" DNA-binding domain superfamily) 
PSSM E-value: 186: template length 75 PSSM E-value 775; template length 75 
http:llwww.sbg.bio. ic.ac. uklsecvers/3dpssmloutput/a0901 141 b3bc33a7.job_sixnmary.htrnl 
p:l/w.sbg.bloic.ac.Lilservers/3dpssrn/output/2a39d5e56250e69a.job_swnmary.httnl 
Figure 3.3 3D-predictions of YoI093wp Sequence Fragments 
Sequences were aligned using the 3D-PSSM Web Server V 2.6.0 program. The models as 
displayed were coloured from blue —* and N --> C. This model was generated directly 
from the alignment, with no subsequent refinement. It was intended only as a guide. The 
thick lines represent a deletion in the known library structure, i.e. there are residues in the 
known structure that are not aligned to residues in the query. The thin lines represent the 
reverse situation, i.e. thin lines represent an insertion in the known library structure. The 
numbers appearing at the beginnings and ends of these insertions and deletions represent 
the number of residues inserted into or deleted from the known structure respectively. 
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3.2 Gene Replacement of YOL093W 
3.2.1 Introduction of PCR-based Gene Disruptions in Saccharomyces 
cerevisiae 
In Saccharomyces cerevisiae, gene deletion and the modification of chromosomal 
genes by homologous recombination are now standard techniques. A PCR-mediated 
technique has been developed that allows single-step deletion or epitope tagging of 
chromosomal genes (Lorenz et al., 1995; Baudin et al., 1993; Lorenz et al., 1995; 
Wach et al., 1994) (Figure 3.4). In this method, a linear DNA fragment is generated 
by PCR, that comprises the selectable marker gene, flanked at both ends by 
approximately 45 base pairs of sequence identical to the DNA immediately 5' and 3' 
to the coding sequence to be replaced. The amplified DNA is introduced into yeast, 
and by homologous recombination, the gene can be deleted or epitope tagged. Genes 
can be replaced directly at high efficiencies in S. cerevisiae, permitting the 
convenient production of numerous altered forms of proteins. These techniques have 
been exploited extensively in the analysis of general questions in cell biology. 
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Upstream primer 
JIJJ 	 ULi 
y€ast homology 
	
PCR 	Downstream primer 
yeast 
homology 
45 bp 1 20 bp ] Selectable Marker 	20 bp I :4:5 bp 
Yeast transformation 
I 	I ATO 	 Yeast ORF 	Stop codor, I 	I 
Integration by homologous recombination 
Figure 3.4 Schematic Representation of the Strategy of ORF Deletion 
from the Chromosome 
Oligonucleotide primers were used to amplify the 3HA-kan or hph cassette flanking with 
45bp upstream sequence of the stop codon of the ORF, and 45bp downstream sequence of 
the ORF. PCR product was then introduced into the yeast cells. The cassette was integrated 
though homologous recombination. 
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3.2.2 Deletion of YOL093WORF from the BMA38 Genome 
3.2.2.1 Deletion of YOL093W 
As a first step in characterization of YOL093W, a gene replacement was performed in 
yeast. The entire YOL093W coding sequence (from ATG to the stop codon) was 
removed precisely and replaced by the kanamycin (kan) or the hygromycin B (hph) 
resistance marker using a PCR-based method of direct gene deletion. Using the 
oligonucleotides YOL093W-KO-1 and YOL093W-KO-2, kan or hph marker gene 
was amplified by PCR from the plasmid pFA6a-3HA-KanMX6 or pAG32. The 
diploid yeast strain BMA38(2n) was transformed with the purified linear PCR 
product containing the kan or the hph resistance marker flanked by approximately 45 
base pairs of the Y0L093 W locus at either site, so that integration of the marker gene 
can occur by homologous recombination. Kan-resistant or hph-resistant clones were 
streaked out onto fresh YPDA + kan or YPDA+ hph medium for colony purification. 
Kan- or hph-resistant transformants were then tested for integration of the marker 
gene at the desired locus by PCR, as shown in Figures 3.5 & 3.6. The following 
heterozygous YOL093W deletion mutants were made: MYY1 
(YOL093W/yolO93wNcan) and MYY2 (YOL093W1yolO93wAhph). The heterozygous 
mutants were then used as the parental strains for the second knockout of another 
copy of the Y0L093 W allele, and the homozygous YOL093W-deleted mutant, MYY3 
(yo1O93wAkan1yo1O93wzihph), was made. PCR analysis (Figures 3.7 & 3.8) and 
DNA sequencing (Figures 3.9 & 3.10) were used to confirm the gene replacement. 
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Figure 3.5 PCR Analysis of Heterozygous YOL093W ORF Deletion by 
the Kanamycin Marker 
PCR analysis of yeast transformants to confirm integration of the kanamycin (kan) marker 
into the chromosome. After transformation of BMA38(2n) with a linear PCR product 
containing the kan marker flanked by approximately 45 base pairs of the YOL093W locus at 
either site, Kan-resistant clones were streaked out onto fresh YPDA+ kan medium for colony 
purification. Cells from the transformants, and the parental BMA38(2n) were suspended in 
water, boiled for 10 minutes and used in a PCR using oligonuceotides P1: SC093-TEST-1, 
P2: SC093-TEST-2, P3: R-Kan as primers. (A) The positions on the template at which the 
primers anneal are indicated in the upper schematic drawing of the YOL093W locus (either 
wild type, or after kan-integration). The product failed to be amplified by yeast colony PCR 
has been crossed. (B) The products of PCR reactions. The fragment expected following 
successful integration of kan cassette into the YOL093W locus is indicated. The 3' junction 
of the gene replacement was also confirmed by PCR with an internal forward primer of the 
drug-resistant cassette and a reverse primer P2 (data not shown). 
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Unsuccessful Deletion 	 Expected product size 
P1 
	





2>(5 & 823 bp 
Transformants 




831 - 823 
Figure 3.6 PCR Analysis of Heterozygous YOL093W ORF Deletion by 
the Hygromycin B Marker 
PCR analysis of yeast transformants to confirm integration of the hygromycin B (hph) marker 
into the chromosome. After transformation of BMA38 (2n) with a linear PCR product 
containing the kan marker flanked by approximately 45 base pairs of the YOL093W locus at 
either site, Kan-resistant clones were streaked out onto fresh YPDA+ kan medium for colony 
purification. Cells from the transformants, and the parental BMA38 (2n) were suspended in 
water, boiled for 10 minutes and used in a PCR using oligonuceotides P1: SC093-TEST-1, 
P2:SC093-TEST-2and P3: R-hph as primers. (A) The positions on the template at which the 
primers anneal are indicated in the upper schematic drawing of the YOL093W locus (either 
wild type, or after kan-integration). The product failed to be amplified by yeast colony PCR 
has been crossed. (B) The products of PCR reactions. The fragment expected following 
successful integration of kan cassette into the YQL093W locus is indicated. The 3' junction 
of the gene replacement was also confirmed by PCR with an internal forward primer of the 
drug-resistant cassette and a reverse primer P2 (data not shown). 
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Figure 3.7 Detection of YOL093W ORF Deletion from the MYY1 
(VOL093W/yoIO93wM(an) Genome 
PCR analysis of the yeast transformants to confirm integration of the hygromycin B (hph) 
marker into the chromosome. After transformation of MYY1 (YOL093W1yoIO93wi::kan) with 
a linear PCR product containing the hph marker flanked by approximately 45 base pairs of 
the YQL093W locus at either site, hph-resistant clones were streaked out onto fresh YPDA + 
hph + kan medium for colony purification. Yeast colony PCR was performed using P1: 
SC093-TEST-1, P2: R-kan and P3: R-hph primers. (A) The positions on the template at 
which the primers anneal are indicated in the upper schematic drawing of the YOL093W 
locus (either the parental strain or after hph-integration). (B) The products of the PCR 
reactions. The fragment expected following successful integration of hph cassette into the 
YOL093W locus is indicated. The 3' junction of the gene replacement was also confirmed by 
PCR with an internal forward primer of the drug-resistant cassette and a reverse primer 
outside the YOL093W locus (data not shown). 
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Figure 3.8 Detection of YOL093W ORF Deletion from the MYV2 
(YOL093W1yoIO93wzhph) Genome 
PCR analysis of the yeast transformants to confirm the integration of the kanamycin (kan) 
marker into the chromosome. After transformation of MYY2 (YQL093W1yoIO93w:hph) with 
a linear PCR product containing the kan marker flanked by approximately 45 base pairs of 
the YOL093W locus at either site, Kan-resistant clones were streaked out onto fresh YPDA + 
kan + hph medium for colony purification. Yeast colony PCR was performed using P1: 
SC093-TEST-1, P2: R-kan and P3: R-hph primers. (A) The positions on the template at 
which the primers anneal are indicated in the upper schematic drawing of the YOL093W 
locus (either the parental type or after kan-integration). (B) The products of the PCR 
reactions. The fragment, which would be expected following successful integration of kan 
cassette into the YOL093W locus is indicated. The 3' junction of the gene replacement was 
also confirmed by PCR with an internal forward primer of the drug-resistant cassette and a 
reverse primer outside the YOL093W locus (data not shown). 
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YPDA 	 +kan 	 +hph 
Spore No 1 & 2 Genomic DNA Extraction 
i PCR 
Spore No 1 	 Expected product sizes 
P1 
kanr 	 - 	2283 bp 
2  
Spore No 2 
P1 
hph 	 2090 bp 
hr 
Sequencing reactions of the PCR products 
Figure 3.9 Schematic Representation of the Strategy for Sequencing the 
5'- and 3-junctions of YOL093W Replacement to Confirm the Gene 
Deletion 
Oligonucleotide primers were used to amplify the cassettes from YQL093W deletion genome 
flanking with 45 bp upstream sequence of the stop codon of the ORF, The 5' and 3' junctions 
of the PCR products were then sequenced. 
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yolO93wAhph spore sequencing data 
The sequence of the hph cassette 
yolO93'wEhph 	CI\ •\C1'( ii[1( 	\LAC 	CAFIA(fl(iftAAA\('(iA((TIiLAVF 2700 
Sequencing data (rFATAcRXIUIU3ATItX3ATACI'AuIt1XX2AittM:T1tnU1AAA&CXiiMJCR3]AAT 249 
ownstream senuence of the stop codcn of YOLD93/v 
I- 
yo1O93wthph 	I CAT 	 2760 
Sequencing data it - -CICA(XXAitACIUrAGIA'ITAUAGFAACItiATA( MMTAGTAATAGC1tU3 307 
Upstream sequence of the start codon of YOL093W 
yoI093wAhpl7 	 trnr.AU&A 1020 
Sequencing dat a 170 
The sequence of the hph cassette 
yoIO93wAhph 	 AC.\ThG 1080 
Sequencing data 230 
yoIO93wLkan spore sequencing data 
- 	 The sequence of the kijcessOe 
)o1093w1 k317 	 iAA 1020 
Sequencing data 	G4AcUTAAATAAiTAAGItJItPltITXAOXAMACAAOJJJA'I1i -YLrJJJ1TAATFAA 184 
)OlO93Vt'1 	 (A'iUITIi\CUCATACUtVRi1TCUIT -\(TA'IGC' (XXITATCCU1'ARL\( 	1080 
Sequencing data 	CA1tT1TFActtATAfflk'RTVBT1XMTAiTJa91tFA1UtTA-000U1U003flACrA 243 
****************************************** ** * ************ 
The sequence of the kan cassette 
}093.f4 	 (F-\\CR (1U 	\r1i'(. VI \CT-\_-\( 	(u(xvIr.'( ITI.-VuV i\ T('t \-VFIVAT 2820 
Sequencing data 	CfATAcRJC1u1t3AT1U1ATAC1'AAcX3ct.XflA1ttAcJ1T1'MAQ3Ar1UJAAT1t. - 259 
- -0 
• 	 - 	 C 2880 
Sequencing data 	3CIAiteC1UrAcJrATrATrAcJfMCI]ATAcflGAAATAc3TAATAGIt'11JJJr%Jc 319 
******************************** 	************************* 
Figure 3.10 Sequencing Analysis of YOL093W Deletion from the MYY3 
(yoIO93w4kan /yolO93w4hph) Gen ome 
Sequencing analysis of the MYY3 spores to confirm integration of the kanamycin (kan) or 
hygromycin B (hph) marker into the chromosome. The 5' and 3' junctions of the replacement 
were amplified by PCR, and the PCR products were then assessed by sequence analysis. 
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3.2.2.2 Tetrad Dissection Analysis of YOL093W Deletion Strains 
The diploid transformants that had been shown positive for the gene replacement 
(designated strains MYY1, MYY2 and MYY3) were sporulated. Tetrads were 
dissected onto YPDA agar plates and separated spores were incubated at 30°C for 3-
4 days (Figure 3.11). 
Result of the tetrad dissection is shown in figure 3.12. For the heterozygous strain 
MYY1 (YOL093W/yolO93wAkan), out of 43 tetrads dissected, in 38 cases (54.35%) 
all four spores grew to colonies of comparable size, in 14 cases (30.35%) only 3 
spores germinated, in 5 cases (10.87%) two spores grew to colonies, and in 2 cases 
(4.35%) one spore was viable. For the other heterozygous strain MYY2 
(YOL093W1yo1O93w1hph), in 38 cases (76%) all four spores germinated, leading to 
two small and two larger colonies for each dissected tetrads. In other 9 cases (18%), 
three spores germinated. In other 2 cases (4%), two spores grew to colonies, and in 
the other 1 case (2%), no spore was viable. For the homozygous gene knockout strain 
MYY3 (yo1O93wzkan1yo1O93w4hph), out of 58 tetrads dissected, in 44 cases 
(75.86%) only 2 spores grew to colonies, in 10 cases (17.24%) only 1 spores 
germinated, and in 4 cases (6%) no spore was viable. 
These data suggested that YOL093W is not essential for cell viability. However, the 
YOL093W double-knockout strain showed lower spore viability, which suggested 
that Y0L093 W might play a role in meiosis process. 
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Figure 3.11 Tetrad Dissection Analysis of the Eftects of YOL093W 
Deletion 
Tetrad analysis of strains (A) BMA38 (wt, YOL093W/YOL093W), (B) MYY1 
(YOL093W/yoI093wzkan), (C) MYY2 (YOL093W1yo1O93wtthph), and (D) MYY3 
(yoIO93w.1kan/yoIO93wLihph). Strains were streaked out onto sporulation medium plates. 
After 5-7 days of inoculation at 30C, tetrads were dissected onto the YPDA agar plate. 
Spores were incubated for a few days at 30C. 
Chapter Three: YOL093W Gene Replacement 
() BM38 (2n, wt) 	 (C) MVY2 (VW/ y3vlthpi,) 






0 2 4.65 
1 0 0 
2 5 11.63 
3 11 25.58 
4 25 58.14 
Total 43 100 






0 1 2 
1 0 0 
2 2 4 
3 8 18 
4 38 76 
Total 50 100 
(B) MYV1 (yolc93iitJcan/ YOLt&3W) 	 (D) MVY3 (yolO93it€&kan / yO3i'Eihph) 






0 0 0 
1 2 4.35 
2 5 10.87 
3 14 10.35 
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0 4 6 
1 10 17.24 
2 44 75.86 
3 0 0 
4 0 0 
Total 58 100 
Figure 3.12 Spore Viability of Tetrads in YOL093W Deletion Strains 
Tetrad dissection analysis of strains (A) BMA38 (B) MYY1 (C) MYY2 and (D) MYY3. Strains 
were streaked out onto sporulation medium plates. After 5-7 days of inoculation at 30C, 
tetrads were dissected onto the YPDA agar plate. Spores were incubated for 3-4 days at 
30C. The spore viability is shown on tables. 
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3.2.2.3 Temperature-sensitivity Tests of YOL093W Deletion Strains 
Cells of the spores of MYY3 (yo1093wAkan1yolO93wAhph) as well as cells from 
wild-type spores were serially diluted into microtiter plates and spotted onto YPDA 
or YPDA + Nocodazole plates using a pronged metal inoculator. The plates were 
incubated at a range of temperatures for 2-5 days (Figure 3.13). This confirmed that 
the deletion of YOL093W from the genome does not have a visible effect on the cell 
growth in rich medium. 
3.2.2.4 Growth Curves of YOL093W Deletion Strains 
To study the effect of YOL093W deletion on cell growth, the growth rate analysis 
was performed on the following strains: BMA38 (YOL093W/YOL093W), MYY1 
(YOL093W/yo1093w4kan), MYY2 (Y0L093 W/yolO93wAhph), MYY3 
(yo1O93w4kan1yo1O93wiihph), haploid strain MYY2/1 (YOLO93W), and haploid 
MYY2/2 (yo1093wLhph). Cells were inoculated in YPDA medium and incubated at 
30°C. The optical density (0D 600) of cells was measured at different time points. By 
comparing the growth rate of these YOL093W deletion strains with the wild type 
strain in Figure 3.14, only the haploid MYY2/2 (hph-resistant spore) showed slightly 
slow growth, which was seen in the tetrad dissection analysis of MYY2 (section 
3.2.2.2). This slow growth might be caused by the hph cassette integration. There 
was no difference on the growth rate in the other YOL03 W deletion strains with the 
EEO 
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wild-type strain BMA38(2n). Thus it suggested that the deletion of YOL093W alleles 
does not affect cell growth. 
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Figure 3.13 Temperature Sensitivity Analysis of the Effects of YOL093W 
Deletion from the Genome 
A. Haploid cells deleted for the YQL093W locus (II: strain MYY3/1; Ill: strain MYY3/2) as well 
as cells from (I) the parental wild-type strain and (IV) the diploid YOL093W deletion strain 
MYY3 were suspended in dilutions in microtiter plates, spotted onto YPDA plates and 
inculbated at a range of temperatures for a few days. B. Haploid cells deleted for the 
YOL093W locus (strain MYY1) as well as cells from the wild-type spore were suspended in 
dilutions in microtiter plates, spotted onto YPDA + Nocodazole plates and incubated at 30'C 
for 3 days. (I: wild-type; II: strain MYY3/1; Ill: strain MYY3/2; IV: MYY3) 
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Figure 3.14 Growth Curves of YOL093W Deletion Strains 
Growth rate analysis of strains BMA38 (YOL093W/YOL093W), MYV1 
(YOL093W/yoIO93wzikan), MYY2 (YOL093W1yo1O93wzlhph), MYY3 
(yo1093wAkan1yo1O93wzihph), as well as the haploid strain MYY2/1 (YOL093W), and MYY2/2 
(yo1093wzlhph) were performed. Cells were inoculated in YPDA medium and incubated at 
30C. Aliquots were removed at regular intervals and the optical density of the cells (OD) 
was measured. 
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3.2.2.5 Drug-resistant Tests of YOL093W Deletion Strains 
Spores of the tetrad dissection assay were replicated onto YPDA, YPAD + kan, 
YPDA + hph, and YPDA + kan + hph plates (Figure 3.15). In the cases which all 
four spores geminated only two spores grew on the selective plates as expected. 
Interestingly, some spores from the MYY3 strain (yo1093wLIcan1yo1O93wL%hph) grew 
on the YPDA + kan + hph plates (Figure 3.15 Q. It showed that these spores 
possessed two drug-resistant genes, which might suggest non-disjunction events 
happened during the chromosomal segregation. 
3.2.2.6 DAPI Stain of YOL093W Deletion Strain 
To learn more about the DNA components of spores from Y0093W deletion strain, 
the DAPI (4'6-diamidino-2-phenylindole) stain was used to examine the DNA inside 
tetrads of wild type BMA38(2n) strain as well as MYY3 strain 
(yo1093wAkan1yo1O93wAhph) (Figure 3.16). The micrographs showed abnormal 
DNA components inside YOL093W deletion tetrads; various numbers (from 1-4) of 
DAPI-strained spots were observed form a single tetrad. This result was consistent to 
the spore viabilities of MYY3 strain (section 3.2.2.2). 
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Figure 3.15 Drug Resistance Analysis of the Effects of YOL093W 
Deletion 
Haploid cells form (A) MYY1 	strain (yol093wZtkan/YOL093W), 	(B) MYY2 strain 
(YOL093W1yo1O93wLthph), as well as cells from (C) MYY3 strain 
(yoIO93w.4kan/yo1O93w4hph) were suspended in dilutions in microtiter plates, spotted onto 
YPDA, YPDA + kan, YPDA + hph plates and incubated at 30C for a few days (A, B' and C'). 
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(A) 	 (B) 
BMA38 (wt) 	MYY3 (yo1093wAkanlyo1093wtthph) 
Figure 3.16 DAPI Straining of Tetrads from YOL093W Deletion Strain 
Tetrad form (A) wild-type BMA38 (YOL093W/YOL093W) and (B) MYY3 
(yoI093wz1kan1yoIO93w1hph) were strained with DAPI and examined by fluorescence 
microscopy (X630 magnification). DAPI staining for DNA; DIC represents Differential 
Interference Contrast image. 
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3.3 Complementation Tests 
3.3.1 Complementation Tests of YOL093W Deletion with the Wild-type 
YOLO93W 
In order to prove that the lower spore viability of MYY3 
(yo1093wAkan1yo1O93wiihph) is in fact due to the deletion of YOL093W, 
complementation of the defect by providing Yo1093wp was tested. In parallel, the 
cross-back experiment was performed. 
For the complementation experiments, both S. cerevisiae 2p vectors and centromeric 
(CEN) vectors were used. 2t vectors contain the origin of the 2g circle, a multicopy 
endogenous yeast episome. Centromeric vectors contain an ARS origin of replication 
and one of several centromere loci. Centromeric vectors exist at a low copy number 
(1 to 2 per cell) and are generally more stable then those based on 2-.tm circle origin. 
The YOL093W ORF along with its endogenous promoter region (500 bp upstream) 
and its polyA signals (500 bp downstream) were amplified by PCR from the genomic 
DNA of strain BMA38 using primers BamH1-93W promoter-F and EcoRI-93W 
polyA-R. The PCR product was digested with BamHI and EcoRI, and then ligated 
into the CEN plasmid pRS316 or the 2g plasmid pYEplac195. The construct 
pRS3161YOL093W and pYEplacl956/YOL093W were confirmed by enzyme 
digestion (Figures 3.17 & 3.18). 
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Figure 3.17 Construction of pRS31 61Y0L093W Plasmid 
The YOL093W ORF was amplified by PCR from genomic DNA of strain BMA38. The PCR 
product was digested with BamHl/EcoRl, and ligated into the vector pRS316. (A) A 
schematic representation of the cloning strategy used to construct pRS316/YOL093W. (B) 
The construct was confirmed by the Baml/EcoRl enzyme digestion. The arrow indicates the 
1894bp DNA fragment, which would be expected following successful construction of 
pRS316IYOL093Wis indicated. V: pRS316 vector. 
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Figure 3.18 Construction of pYEpIacl 95/ Y0L093 W Plasmid 
The YOL093W ORF was amplified by PCR from genomic DNA of strain BMA38. The PCR 
product was digested with BamHl/EcoRt, and ligated into the vector pRS316. (A) A 
schematic representation of the cloning strategy used to construct pYEplacl 951Y0L093W. 
(B) The construct was confirmed by the Baml/EcofRl enzyme digestion. The arrow indicates 
the 1894 bp DNA fragment, which would be expected following successful construction of 
pYEplacl95/YOLO93Wis indicated. V: pYEplacl95 vector. 
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The 	CEN and 2p 	constructs were introduced into MYY3 
(yo1093wL%kan1yo1O93w4hph). The resultant strains, MYY3/pRS3 16-p93W-
YOLO93W-polyA and MYY3/pYEplac 1 95-p93W-YOLO93W-polyA respectively, 
were than used for tetrad dissection analysis (Figures 3.19 & 3.20). 
Surprisingly, transformation of MYY3 with either the CEN plasmid 
pRS316/YOL093W or the 2.t plasmid pYEplacl956/YOL093W did not complement 
the low spore viability defect. This suggested that the defect might be not caused by 
the YOL093W deletion, but some other gene. To test this possibility further, the 
chromosome feature map around YOL093W was retrieved from Saccharomyces 
Genome Database (SDG) (Figure 3.21). By identifying the functions of the proteins 
nearby the YOL093W, the RFC4 and SP021 were decided as candidates for 
complementation experiments. 
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Figure 3.19 Complementation Test of YOL093W Deletion by the 
pRS31 61V0L093W Plasmid 
The 	pRS3161YOL093W 	plasmid 	was 	introduced 	into 	MYY3 	strain 
(yoI093wkan1yoIO93whph). Transformants were selected on YMM-U medium, restresked 
for colony purification. Tetrad dissection analysis of strains (A) BMA38 
(YQL093W/YOL093VV), and (B) MYY3/pRS316-p93W-YOL093W-ployA was performed. 
Strains were streaked out onto sporulation medium plates. After 5-7 days of incubation at 
30C, tetrads were dissected onto the YPDA agar plate. Spores were incubated for a few 
days at 30C. 
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Figure 3.20 Complementation Test of VOL093W Deletion by the 
pYEpIac195IVOL093W Plasmid 
The 	pYEplacl95/YOL093W plasmid 	was 	introduced 	into 	MYY3 	strain 
(yoIO93wzkan1yoIO93whph). Transformants were selected on YMM-U medium, restresked 
for colony purification. Tetrad dissection analysis of strains (A) BMA38 
(YOL093W/YOL093W), and (B) MYY3/ pYEplacl95-p93W-YOLO93W-ployA was performed. 
Strains were streaked out onto sporulation medium plates. After 5-7 days of incubation at 
30C, tetrads were dissected onto the YPDA agar plate. Spores were incubated for a few 
days at 30C. 
102 
Chapter Three: YOL093W Gene F?ep!acernen 
Chromosomal Features Map 
Features around YOL093W on chromosome XV 
Spanning a region 1 0kb left and 10kb right 
(coordinates 132814 to 153695) 
	
2f 	 4) 	- 	 1CZ'O 
IlL 
PSl DED1 	P02 	PPPI 
130 	 .• 	 140 





IIIU RFC4 	 l44.9 
Feb 
• Represents the chronosone you are viewing 
— z Matson strand 01W 
—z Crick strand 01W 
—5 tRNfl gene 
—. RIRI gene 
* Transposon 
Ribosonal RMR 
— Snail Nuclear RNR 
— z snoRtlA gene 
• LW of Transposon 
— = RRS 
• 1kious ORI' 
— a )C elenent Core sequence 
—5 X elenent Conbinatorial Repeats 
— 2 Teloneric Repeat 
• Y' elenent 
Notes: 
Click on light blur bar to 
retrieve features left & right 
Click on any gene or ORF near, 
any little colorful bee, or 
centronere to retrieve the 
corresponding LOCUS entry in 
SG8 
P white box in the niddle of a 
blue or red bar indicates that 
there is an intron in the 01W. 
The size of the white box 
represents the length of the 
intron. 
For a definition of the features 
listed in the key please see the 
glossary. 
Figure 3.21 Chromosome Feature Map around YOL093W 
(http://www.yeastgenome.org/)  
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3.3.2 Complementation Tests of YOL093W Deletion with the Wild-type 
SPO21 
The Spo2lp is a component of the meiotic outer plaque of the spindle pole body. It 
is involved in modifying the meiotic outer plaque that is required prior to prospore 
membrane formation. 
The CEN plasmid pRS316/SP021 and the 2jt plasmid pRS426/SP021 plasmid were 
gifts from Aaron Neiman, SUNY Stony brook, NY, USA. The constructs were 
introduced into MYY3 strain (yo1093wL%kan1yo1O93wL%hph). Transformants were 
selected on YMIM-U medium, restreaked for colony purification. The resultant 
strains, MYY3/pRS316-SP021 and MYY3IpRS426-SP021, were then used for 
tetrad dissection analysis (Figure 3.22). 
Transformation of MYY3 with either the CEN plasmid pRS316/SP021 or the 2j.t 
plasmid pYEplac1956/SP021 did not complement the low spore viability defect. 
























Chapter Three; YOL093W Gene Replacement 
(A) MYY3 (yoI093wL.kan1yo!O93wLthph) 


































Figure 3.22 Complementation Test of the Low Spore Viability by the 
pRS31 6/SPO21 or pRS426/SP021 Plasmid 
The pRS316/SP021 or pRS426/SP02I plasmid was introduced into MYY3 strain 
(yoIO93wkan1yoIO93w.?ihph). Transformants were selected on '(MM-U medium, restresked 
for colony purification. Tetrad dissection analysis of strains (A) BMA38 
(YOL093W/YOL093W, wI), (B) MYY3/pRS316-SP02I and (C) MYY3/pRS426-SP021 was 
performed. Strains were streaked out onto sporulation medium plates. After 5-7 days of 
incubation at 30C, tetrads were dissected onto the YPDA agar plate. Spores were incubated 
for a few days at 30C. 
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3.3.3 Complementation Tests of YOL093W Deletion with Wild-type RFC4 
The Rfc4p is a DNA binding protein and ATPase that acts as a processivity factor for 
DNA polymerases delta and epsilon and loads proliferating cell nuclear antigen 
(PCNA) on DNA. 
The pBL619 (RFC4, URA3, CEN) plasmid was a gift from Peter Burgers, 
Washington University, USA. The plasmid was then introduced into MYY3 strain 
(yo1093wL%kan1yo1O93wL%hph). Transformants were selected on YMM-U medium, 
restreaked for colony purification. The resultant strain, MYY3/pBL619, was then 
used for tetrad dissection analysis (Figure 3.23). 
Transformation of MYY3 with the CEN plasmid pBL619 (RRC4, URA3, CEN) did 
not complement the low spore viability defect. This showed that the defect was not 
caused by the deletion of RFC4. 
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Figure 3.23 Complementation Test of the Low Spore Viability by the 
pBL619 (RFC4) Plasmid 
The pBL619 (RFC4, URA3, CEN) plasmid was introduced into MYY3 strain 
(yoIO93w4kan1yo1O93wzi.hph). Transformants were selected on YMM-U medium, restresked 
for colony purification. Tetrad analysis of strains (A) BMA38 (YOL093W/YOL093W) (B) 
MYY3/pBL619 was performed. Strains were streaked out onto sporulation medium plates. 
After 5-7 days of incubation at 30C, tetrads were dissected onto the YPDA agar plate. 
Spores were incubated for a few days at 30C. 
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3.4 Back-cross Experiments 
To check if there was a linked mutation existing in the genome, the back-cross 
experiments were performed by using the reference strain Y1643 
(YOL093W/yo1093w4kan) form Euroscrf (Figure 3.24). The haploid MYY3/2 strain 
(yo1093wz.thph) was mated with the Y1643 (yolO93wAkan), and the resulting diploid 
strains were streaked onto sporulation medium plates. After incubation at 30°C, the 
tetrads were dissected onto the YPDA agar plate. Spores were tested for drug 
resistance, and mating types of hygromycin B-resistant spores were then determined. 
Hph-resistant spores were then mated with MYY3/1 (yolO93w4kan) with the 
opposite mating types. The final resultant diploid strains were then sporulated and 
tetrads dissected. 
The data from the back-cross experiments did not reveal the expected segregation 
patterns in the tetrads, which suggested that the low spore viability phenotype was 
not truly due to the YOL093W gene deletion. As when the diploid parent is 
heterozygous at a locus, a 2:2 segregation of genotypes in the tetrads is expected, the 
most consistent reasonable explanation for a 2:2 segregation of live to dead spores in 
the tetrad of YOL093W deletion MYY3 strain would be a haplo-lethal mutation 
either associated with the disruption or more likely a random mutation (not insertion 
of the marker) somewhere else in the genome. 
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Figure 3.24 Back-cross Experiments of YOL093W Deletion Strains 
(A) A schematic representation of the back-cross strategy by using the reference strain form 
Euroscrf (yo1093wzlkan). The grey circle represents another mutant in the chromosome. (B) 
Tetrad dissection analysis of the final resultant strains. Diploid strains were streaked out onto 
sporulation medium plates. After 5 days of incubation at 30C, tetrads were dissected onto 
the YPDA agar plate. Spores were incubated for a few days at 30'C. 
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3.5 Melotic Assays 
3.5.1 Introduction 
As Holliday junction resolvases might be involved in meiotic processes, in order to 
investigate the effects of YOL093W deletion on meiosis, meiotic recombination 
assays were carried out. All assays were performed in derivatives of the Eurofan 
W303 strain. Two W303 derivative strains EUF153 RAD5 (MATa, lys2 ndel-3', 
adel::ADE2, ade2, canR, ura3-52) and EUF180 RAD5 (MATh, lys2 ndel-5', 
ADE1, ade2, CANS, URA3) were used. Multiple assays can be performed in the 
EUF153 RAD5 IEUF180 RAD5 diploid. The frequency of mitotic and meiotic 
intragenic recombination can be determined with the lys2 heteroalleles (Figure 3.25 
A), the mitotic and meiotic reciprocal crossover frequencies can be determined with 
the linked canR URA3 markers on chromosome V (Figure 3.25 B), and the meiosis I 
chromosomal non-disjunctions can be followed with the allelic ADE1Iade1::ADE2 
markers measured (Figure 3.25 Q. 
3.5.2 Deletion of YOL093W from the Genome of EUF153 RAD5 and 
EUF180 RAD5 Strains 
3.5.2.1 Gene Deletion 
The entire YOL093W coding sequence was removed precisely and replaced by the 
kanamycin (kan) resistance marker using a PCR-based method of direct gene 
deletion. Using the oligonucleotides YOL093W-KO-1 and YOL093W-KO-2, the 
kan-resistance marker was amplified by PCR from plasmid pFA6a-3HA-KanMX6. 
Haploid yeast strain ETJF153 RAD5 or EUF180 RAD5 was transformed with the 
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purified linear PCR product containing the kan resistance marker flanked by 
approximately 45 base pairs of the YOL093W locus at either site, so that integration 
of the marker gene can occur by homologous recombination. Kan-resistant clones 
were streaked out onto fresh YPDA + kan medium for colony purification. Kan-
resistant transformants were then tested for integration of the marker gene at the 
desired locus by PCR, as shown in Figure 3.26. The following heterozygous 
YOL093W deletion mutants were made: EUF153 RAD51yo1093wzikan and EUF180 
RAD51yol093wL%kan. 
3.52.2 Meiotic Assays of YOL093W Deletion Strains 
The two strains that had been demonstrated positive for the gene replacement were 
then mated with each other, and YMM-A-U medium was used to select for diploid. 
The resultant diploid strain was sporulated. Spores were isolated (section 2.2.6.4) and 
meiotic assays (section 2.2.6.5) were performed. Spores were spread onto YlvilvI-
ADE-ARG+CAN, YMM-URA-ARG+CAN, and YMM-LYS-ARG+CAN plates. 
Canavanine (CAN) was used in all of the meiotic assays to select for haploid 
products and against unsporulated diploids. The increased number of papillae on 
YMM-LYS-ARG+CAN media is indicative of the induction of meiotic heteroallelic 
recombination. Meiosis I non-disjunction was measured by papillation on YvllvI-
ADE-ARG+CAN. Only strains carrying both homologs of chromosome I are able to 
grow on Ylvilvi-ADE. As the parental diploid could grow on YMIIvI-ADE, canavanine 
was used to ensure that one was only looking at the haploid products of meiosis. 
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Growth on YMIvI-URA+CAN was used to assess reciprocal recombination between 
URA3-CAN1 and ura3-1 and cani -100. 
Results of the meiotic assays are shown in Figure 3.27. 30,000to 250,000 of spores 
were analysed per experiment. There was no difference between the wild-type strain 
and YOL093W deletion strains on these assays. Both of the strains showed similar 
frequencies on the meiotic heteroallelic recombination assay, the meiosis I non-
disjunction assay, and the reciprocal recombination assay. Therefore, deletion of 
YOL093W does not affect the meiotic recombination process. 
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FIgure 3.25 EUROFAN W303 Meiotic Assays 
(A) Heteroatlelic recombination (gene conversion) assay. Note: LYS2 = lysine biothesis. (B) 
Reciprocal crossover assay. Note: CAN = canavinine resistance (R) /sensitivity (S); URA3 = 
pyrimidine biosynthesis. (C) Meiosis I nondisjunction assay. Note: ADE1 and ADE2 = punne 
base metabolic genes. 
Meiosis I NDJ 
Growth without Adenine 
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Figure 3.26 Detection of YOL093W Deletion from the EUF153 RAD5 and 
EUF18O RAD5 Genome 
PCR analysis of the yeast transformants to confirm the integration of the kanamycin (kan) 
marker into the chromosome. After transformation with a linear PCR product containing the 
Kan marker flanked by approximately 45 base pairs of the YOL093W locus at either site, 
kan-resistant clones were streaked out onto fresh YPDA + kan for colony purification. Yeast 
colony PCR was performed using P1: SC093-TEST-1, P2: R-kan and P3: SC093-TEST-2 
primers. (A) The positions on the template at which the primers anneal are indicated in the 
upper schematic drawing of the VOL 093W locus (either the parental type or after kan-
integration). (B & C) The products of the PCR reactions. The fragment, which would be 
expected following successful integration of kan cassette into the YOL093W locus is 
indicated. The 3' junction of the gene replacement was also confirmed by PCR with an 
internal forward primer of the drug-resistant cassette and a reverse primer outside the 
YOL093W locus (data not shown). 
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Figure 3.27 Meiotic Assays of YOL093W Deletion Strain 
Spores were collected and spread onto (A) YMM -ADE -ARG+CAN plates (melosis I non-
disjunction), (B) YMM-LYS-ARG+CAN plates (heteroaHelic recombination), and (C) YMM-
URA-ARG+CAN plates (reciprocal recombination). Spores were incubated at 30°C for 2-4 
days and the colony number was counted. 30,000 to 250,000 of spores were analysed per 
expenment. 
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3.6 Gene Replacement of YOL093W in W303 Background 
Strains 
In order to check if the low spore viability defect observed in section 3.2.2.2 was 
caused by deletion of YOL093W, gene replacement was also performed in two other 
yeast strains, MAS386 and BY4743, with a W303 background. 
3.6.1 MAS386 Strain 
3.6.1.1 YOL093W Deletion 
The entire YOL093W coding sequence was removed precisely and replaced by the 
kanamycin (kan) marker using a PCR-based method of direct gene deletion. Using 
the oligonucleotides YOL093W-KO-1 and YOL093W-KO-2, the kan marker was 
amplified by PCR from plasmid pFA6a-3HA-KanMX6. Diploid yeast strain 
MAS386(2n) was transformed with the purified linear PCR product containing the 
kan resistance marker flanked by approximately 45 base pairs of the Y0L093 W locus 
at either site, so that integration of the marker gene can occur by homologous 
recombination. Kan-resistant clones were streaked out onto fresh YPDA + kan 
medium for colony purification. Kan-resistant transformants were then tested for 
integration of the marker gene at the desired locus by PCR, as shown in Figure 3.28. 
The following heterozygous YOL093W deletion mutant was made: 
MAS386Iy01O93wL%kan (YOL093W/yo1093wiikan). The heterozygous mutant was 
then used as the parental strain for the second knockout of another copy of the 
YOL093W allele. The gene was replaced by hygromycin B (hph) resistance marker 
amplified from pAG32 plasmid using primers YOL093W-KO-1 and YOL093W- 
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KO-2. The homozygous YOL093W deletion mutant, MAS3861yolO93wztkan-
yolO93wAhph (yo1093wAkan1yolO93wAhph), was made. 
3.6.1.2 Tetrad Dissection of YOL093W Deletion Strains 
Diploid transformant that showed positive for the gene replacement was sporulated. 
Tetrads were dissected and separated spores were incubated at 30°C for 3-4 days 
(Figure 3.29). By comparing with wild-type strain, tetrad dissection assay of 
YOL093W-deleted MAS386 strain showed two large and two small spores phenotype; 
similar to that was observed in the MMY2 strain (YOL093W1yo1O93w4hph). As 
YOL093W-deleted MAS386 strain did not show lower spore viability, this suggested 
that the lower spore viability of MYY3 was not caused solely by the YOL093W 
deletion. 
3.6.1.3 Drug-resistant Tests of YOL093W Deletion Strains 
Spores of tetrad dissection from YOL093W-deleted MAS386 strain were replicated 
onto YPDA, YPAD + kan, YPDA + hph, and YPDA + kan + hph plates (Figure 
3.30). In the cases that all four spores germinated, only two spores grew on the 
selective plates as expected. No spore from the MAS3861yo1O93wzikan-yo1O93w4hph 
strain grew on the YPDA + kan + hph plates. 
117 
Chapter Three: YOL093W Gene Replacement 
(A) 








Expected product size 
P1+P4:1312bp 




Transformants 	 Transformants 
Mwtl 23 4M 	 Mwt 1234 
bp 	 bp 
3000 	I I 





P , ..P4 	
P1 +P3 
Transformants 
M wt 1 2 3 4 
bp 
1000 
1150 J]Iff 832 
P1+P2 
Figure 3.28 Detection of YOL093W OAF Deletion from the MAS386 
Genome 
PCR analysis of the yeast transformants to confirm the integration of the kan and the hph 
markers into the chromosome. After transformation with a linear PCR product containing the 
Kan and hph markers flanked by approximately 45 base pairs of the YOL093W locus at 
either site, clones were streaked out onto fresh YPDA + kan + hph medium for colony 
purification. Yeast colony PCR was performed using P1: SC093-TEST-1, P2: R-kan and P3: 
R-hph, P4: SC093-TEST-2 primers. (A) The positions on the template at which the primers 
anneal are indicated in the upper schematic drawing of the YOL093W locus (either the 
parental type or after kan- or hph-integration). (B) The products of the PCR reactions. The 
fragment, which would be expected following successful integration of kan or hph cassette 
into the YQL093W locus is indicated. The 3' junction of the gene replacement was also 
confirmed by PCR with an internal forward primer of the drug-resistant cassette and a 
reverse primer outside the YOL093W locus (data not shown). 
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Figure 3.29 Analysis of the Effects of VOL093W Deletion in 
MAS386IyoIO93wztkan-yoIO93wLthph (yo1093w4kan1yo!O93wLthph) 
Tetrad dissection analysis of the YOL093W deletion strain as well as cells from the parental 
wild-type strain MAS386(2n) were streaked onto sporulation plates. After 5 days of 
incubation at 30C, tetrads were dissected onto the YPDA agar plate. Spores were incubated 
at 30C for a few days. (A) wt, MAS386(2n); (B) MAS3861yoIO93wkan-yo1O93wLhph 
(yoIO93wtkan1yoIO93w/hph). 
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Figure 3.30 Drug Resistance Analysis of YOL093W Deletion Spores of 
MA5386 Strain 
Haploid cells MAS3861yo1O93wZtkan-yo1O93wLihph were suspended in dilutions in microtiter 
plates, spotted onto (A) YPDA; (A') YPDA + kan, YPDA + hph, and YPDA + kan + hph plates, 
and incubated at 30'C for a few days. (B&B') Results from MYY3 strain 
(yoIO93wzkan/yoIO93wLthph) as seen in Figure 3.15. 
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3.6.2 BY4347 Strain 
3.6.2.1 YOL093W Deletion 
YOL093W deletion mutant of parent strain BY4743 was obtained from the 
EUROFAN strain library. Both homologues of the Y0L093 W coding sequences were 
replaced with a KanMX4 gene using PCR-mediated gene disruption. 
3.6.2.2 Tetrad Dissection of YOL093W Deletion Strains 
Diploid strain was sporulated. Tetrads were dissected onto YPDA agar plates and the 
separated spores were incubated at 30°C for 3-4 days (Figure 3.31). By comparing 
with the wild-type strain, tetrad dissection assay of YOL093W deletion BY4743 
strain did not show lower spore viability. This also suggested that the lower spore 
viability observed in the Y0L093 W deletion BMA38(2n) strain was not caused solely 
by Y0L093 W deletion. 
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Figure 3.31 Analysis of the Effects of YOL093W Deletion in 
BY47431yoIO93wZ kan-yoIO93whph (yo1093w4 karilyolO93wtthph) 
Tetrad dissection analysis of YOL093W deletion strain as well as cells from parental wild-
type strain BY4743(2n) were streaked onto sporulation plates. After 5 days of incubation at 
30C, tetrads were dissected onto the YPDA agar plate. Spores were incubated at 30'C for a 
few days. (A) wt, BY4743(2n); (B) BY47431yoIO93wL1kan-yoIO93wzhph. 
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3.7 Discussion 
The deletion of YOL093W ORF in BMA38 strain demonstrated that YOL093W was 
not essential for cell viability. Despite YOL093W deletion in MYY3 
(yo1093w4kan1yol093w/ihph) showed lower spore viability and potential non-
disjunction phenotypes, transformation of MYY3 with either the CEN plasmid 
pRS3 16/YOLO93W or 2j.t plasmid pYEp1ac1956IYOL093W did not complement the 
defect. This suggested that the defect might be not caused by Y0L093 W deletion, but 
by the interference of another gene in the genome. 
Furthermore, the gene replacement of Y0L093 W was also performed in MAS386 and 
BY4347 strains. By comparing with the wild-type strain, tetrad dissection assays of 
YOL093W deletion strains did not show lower spore viability or non-disjunction 
phenotypes. This also suggested that the lower spore viability seen in the YOL093W-
deleted BMA38(2n) strain was not caused by the YOL093W deletion. Similar 
observations were also suggested in the back-cross experiment and the YOL093W 
gene replacement in the other two S. cerevisiae strains. This circumstance might be 
avoided by assessing the phenotype more at the very early stage of experiments. One 
should check more gene-knockout transformants in order to confirm the phenotype is 
reproducible and is really due to the gene deletion itself. As any meiotic I 
segregation defect will give a mixture of tetrads with 4, 2 and 0 viable spores as the 
major classes, and when the diploid parent is heterozygous at a locus, a 2:2 
segregation of genotypes in the tetrads is expected. The most consistent reasonable 
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explanation for a 2:2 segregation of live to dead spores in the tetrad of YOL093W 
deletion MYY3 would be a haplo-lethal mutation either associated with the 
disruption or more likely a random mutation (not insertion of the marker) somewhere 
else in the genome. 
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CHAPTER FOUR 
Tandem Affinity Purification of 
Y61093wp 
4.1 Introduction of Tandem Affinity Purification (TAP) Tag 
As part of the general approaches, a Tandem Affinity Purification (TAP) tag was 
used to study the function of Yolo93wp. The TAP method is a generic procedure to 
purify proteins expressed at their natural level under native conditions using a novel 
TAP tag (Rigaut et al., 1999). The TAP tag contains two IgG-binding units of 
Staphylococcus aureus protein A and a Calmodulin-binding peptide (CBP) separated 
by a cleavage site for tobacco etch virus (TEV) protease. The TAP purification 
method involves the fusion of the TAP tag to the target protein of interest, either at 
C- or N-terminus, and the introduction of the construct into the cognate host cell or 
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organism. TAP-tagged proteins to be expressed in yeast can be constructed using 
standard cloning strategies and introduced in yeast plasmids or by recombination 
with an endogenous chromosome. However, the best and fastest way to generate a 
TAP-tagged protein in yeast is to use PCR-based genomic tagging (Figure 4.1). In 
brief, a PCR fragment containing a selectable marker and the TAP tag is integrated in 
the genome such as to fuse the TAP tag and the protein of interest. C-terminal 
tagging is often preferred because it should maintain expression of the target protein 
at its natural basal level. However, N-terminal tagging is also possible. By design, it 
is also possible to truncate the target protein at its N- or C- terminus. 
To purify protein complexes it is preferable to maintain expression of the fusion 
protein at, or close to, its natural level. The fusion protein present in extracts 
prepared from these cells, as well as associated components, are then recovered by 
tandem affinity purification (TAP) (Figure 4.2). 
The TAP procedure has similar applications to the yeast two-hybrid method (Chapter 
5). However, an advantage of the TAP procedure is that, under given conditions, all 
directly or indirectly interacting components are identified in a single experiment. In 
addition, the TAP system provides an indication of the approximate stoichiometry of 
the proteins present in a given complex and allows for direct biochemical analysis of 
the purified protein(s). In particular, the activity of mutant complexes can easily be 
analysed. Combined with the highly sensitive mass-spectrometry methods available, 
the TAP method is useful for identification of proteins interacting with a given target 
protein (Rigaut et al., 1999). 
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Figure 4.1 Schematic Representation of the PCR-based TAP Genomic 
Tagging 
(A) Two oligonucleotides complementary to the TAP tag-marker cassette at their 3 end and 
containing the appropriate region of homology with the yeast genome to allow in frame 
fusion of the TAP tag downstream of the gene of interest are designed. (B) PCR DNA 
fragments were generated and introduced into yeast cells. (C) Integration of the fragments 
by homologous recombination in the yeast genome fuses the TAP tag downstream of the 
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Figure 4.2 Overview of the TAP Protein Purification Procedure (Adapted 
from Rigaut eta!, 1999) 
The fusion protein and associated components were recovered from cell extracts by affinity 
selection on an IgG matrix. After washing, the TEV protease was added to release the bound 
matrix. The eluate was incubated with calmodulin-coated beads in the presence of calcium. 
This second affinity step was required to remove the TEV protease as well as traces of 
contaminants remaining after the first affinity selection. After washing, the bound material 
was released with EGTA. Stars represent contaminant proteins; Scissors represent 1EV 
protease; First affinity column = lgG beads column; Second affinity column = calmoduiin 
beads column. 
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4.2 TAP Purification of Y01093wp-TAP in S. cerevisiae 
4.2.1 Generation of a TAP-tagged Y01093wp in S. cerevisiae 
In order to isolate Yo1093wp and its associated proteins from yeast cultures that can 
be used for protein sequencing, a TAP-tagged version of Yo1093w was generated. 
For this purpose the coding sequence of the TAP tag was inserted immediately 
downstream of the final codon of the YOL093W gene. The high efficiency of 
homologous recombination in yeast bypasses the need to construct a plasmid to fuse 
the TAP-tag to the protein of interest. A strategy was used to generate DNA - 
fragments to introduce the C-terminal TAP tag into the yeast genome. The pBS 1539 
plasmid contains the URA3 marker from Kluyveromyces lactis adjacent to the TAP 
cassette as the selectable marker. Two oligonucleotides complementary to the TAP 
tag-marker cassette at their 3' end and containing the appropriate region of homology 
with the yeast genome allow in frame fusion of the TAP tag downstream of the gene 
of interest (Figure 4.1). Integration of the PCR DNA fragment by homologous 
recombination in the yeast genome fuses the TAP tag downstream of the gene of 
interest. Transformants are selected using heterologous markers to avoid 
recombination at the endogenous marker locus. 
The haploid BMA38(a) strain was transformed with a linear PCR product containing 
the TAP tag, which should be inserted immediately downstream of the final codon of 
the YOL093W gene. Uracil prototrophs were then streaked out onto fresh YMM - 
uracil medium for colony purification. The resultant haploid yeast strain 
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Figure 4.3 PCR on Yeast Transformants to Test for Integration of the 
TAP Tag into the Chromosome 
After transformation of BMA38 (a) strain with a linear PCR product containing the TAP tag, 
which should be inserted immediately downstream of the final codon of the YOL093W gene, 
uracil prototrophs were streaked out onto fresh YMM - U medium for colony purification. 
Then cells of the transformants and of the wt parental BMA38(a) were suspended in water, 
boiled for 10 minutes and used in a PCR using oligonuceotide primers P1: yo1093w-TAP-test 
1 and P2: A-protein A. The positions on the template at which the primers anneal are 
indicated in the upper schematic drawing of the YQL093W locus (either wild type or after 
TAP-tagged). The products of PCR reactions are shown in (B). The fragments expected 
following successful integration of TAP tag cassette into the chromosome are indicated. P2 
primer is the reverse sequence of lgG-binding units of protein A, therefore, there are two 
PCR products. 
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Figure 4.4 Western Blot Analysis of TAP-tagged Yo1093wp from 
BMA38(a)/ YOLO93W-TAP Stain 
Crude cell extract was prepared from BMA38(a) (wild type, lane 1) or from MYY4 (lane 2). 
Proteins were fractionated on a 4-12% SDS-polyacrylamide gel, electroblotted and probed 
with antibodies against protein A. Immunodetection was with HRP-conjugated anti-rabbit 
antibodies (Sigma). And proteins were visualized by ECL (Amersham). The position of the 
TAP-tagged Yo1093w (YolO93wp-TAP) is indicated. 
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4.2.2 Extract Preparation and TAP Purification of a TAP-tagged 
Y01093wp 
Preparation of the extract is a critical step in the purification process, since this step 
influences the total quantity of the desired protein recovered and the biological 
activity of the protein. A number of variables determine the success of a protein 
extraction procedure: the cell lysis method, the presence of protease inhibitors, the 
choice of buffers, etc (Puig et al., 2001). In this work, a standard procedure (Puig et 
al., 2001) that has been extensively used in Seraphin's lab (Centre de Génetique 
Moléculaire, France) was chosen. The fusion protein and associated components 
were recovered from extracts by affinity selection on an IgG-matrix. After washing, 
the TEV protease was added to release the bound material. The eluate was then 
incubated with calmodulin-coated beads in the presence of calcium. This second 
affinity step is required to remove the TEV protease as well as traces of contaminants 
remaining after the first affinity selection. After washing, the bound material was 
released with EGTA (Figure 4.2). Because proteins are purified under native 
conditions with the TAP method, the purified material can also be used for 
biochemical analysis and functional assays. 
To identify proteins interacting with the Yo1093wp, it was desireable to concentrate 
eluted fractions before loading them on an analytical gel. To achieve this goal, TCA 
preciptation (Ozols, 1990) was performed. Proteins in the fractions were separated by 
gradient SDS-PAGE (section 2.3.3.3). Proteins were then stained using PlusOne 
Silver Staining Kit (Pharmacia Biotech) (Figures 4.5) or GelCode Blue Stain 
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Reagent (Pierce, Rockford, IL, USA) (Figures 4.6) according to the manufacturer's 
instructions. GelCode Blue Stain Reagent utilizes the colloidal properties of 
Coomassie for protein staining on polyacrylamide gels. A typical sensitivity of the 
GelCode Blue stain is 30-1000 ng protein/band depending on the protein sizes. Silver 
staining is the most sensitive method for permanent visible staining of proteins in 
polyacrylamide gels. This visualization technique detects most proteins in the 
nanogram range, which is 100-fold more sensitive than Coomassie Blue staining. 
Typical sensitivity of silver staining is 0.2-0.6 ng protein/band. After GelCode Blue 
or silver staining, bands were excized and analyzed by MALDI-TOF mass 
spectrometer (done by Edinburgh Protein Interaction Centre Proteomics Facility, 
University of Edinburgh). 
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Figure 4.5 Purification of Proteins Associated with Yo1093wp by Using a 
C-terminal TAP Tag (Silver Stained) 
Silver-stained gels presenting proteins recovered from purification of the C-terminal TAP-
tagged YolO93wp is depicted. The purification was done from 8-16 litres of yeast culture. 
Lane M represents molecular weight markers. The arrows indicate the samples, which were 
sent to be assayed by mass spectrometry. The components successfully identified by mass 
spectrometry are shown on the right. 
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Figure 4.6 Purification of Proteins Associated with YoI093wp by Using a 
C-terminal TAP Tag (GelCode Blue Stained) 
A GelCode Blue-stained gel presenting proteins recovered from purification of the C-terminal 
TAP-tagged Yo1093wp is depicted. The purification was done from 8 litres of yeast culture. 
Lane M represents molecular weight markers. The arrows indicate the samples, which were 
sent to be assayed by mass spectrometry. The components successfully identified by mass 
spectrometry are shown on the right. Additional bands present in the purified fraction may 
represent contaminants, protein degradation or new subunits of the yeast Yo1093wp complex. 
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4.2.3 Identification of Proteins Functionally Interacting with Y01093wp 
Several components of the Yol093wp-TAP complex have been analysed by mass 
spectrometry. As shown in Figure 4.5, for gel S3, Yo1093wp-CBP was identified; for 
gel S4, Yo1093wp-CBP, Sselp (heat shock protein), and nbosomal proteins, Pr55p 
and RpsOp were identified; none of the bands from gel Si and S2 was identified. For 
gel B 1 (Figure 4.6), Yo1093wp-CBP, Ssa2p (heat shock protein), and a 
glyceraldeh yde-3 -phosphate dehydrogenase (Tdh3p) were identified. In summary, 
mass spectrometry analysis verified the identity of the purified complex by 
confirming that 6 of the purified proteins correspond to two heat shock proteins, two 
ribosomal proteins, Tdh3p, and Yo1093wp-CBP itsself (shown in Figure 4.7). In 
addition, the mass spectrometry data suggested that some bands at the low molecular 
weight region might be fragments of HSP70. 
Sselp and Ssa2p are members of the 70kDa heat shock protein (HSP70) family. Heat 
shock proteins are a group of specific proteins that are synthesized by both 
prokaryotic and eukaryotic cells after they have been exposed to a temperature that is 
higher than normal. Other stresses, eg. free radical damage, have a similar effect. 
Many members of the HSP family are not induced but are present in all cells (Mukai 
et al., 1993). 
RpsOAp and RpsOBp (also known as: NABJAIB, Nuclear Acid Binding protein) are 
protein components of the small (40S) ribosomal subunit. They are nearly identical 
to each other (Demianova et al., 1996) and required for maturation of 18S rRNA. 
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Deletion of either RPSO gene reduces growth rate and deletion of both genes is lethal 
(Ford et al., 1999). 
Pr55bp is also a protein component of the small (40S) ribosomal subunit and nearly 
identical to Rps19Ap and has similarity to rat S19 ribosomal protein (Planta and 
Mager, 1998). 
Tdh3p is one of the glyceraldehyde-3-phosphate dehydrogenases (GAPDH). 
Glyceraldehyde-3-phosphate dehydrogenase is one of the most abundant proteins in 
yeast cells (Krebs, 1953). There are three glyceraldehyde-3-phosphate 
dehydrogenase structural genes per haploid yeast genomes and each structural gene 
encodes an mRNA (Holland and Holland, 1979); (Holland et al., 1983). All three 
genes encode catalytically active enzyme and that the genes are expressed at 
different levels during logarithmic cell growth. The contribution of the TDH1, TDH2, 
and TDH3 gene products to the total 91yceraldehyde-3-phosphate dehydrogenase 
activity in wild type cells is 10-15, 25-30, and 50-60%, respectively (McAlister and 
Holland, 1985). Glyceraldehyde-3-phosphate dehydrogenase is a classical glycolytic 
protein and has been used as a "housekeeping" gene in studies of genetic expression 
and regulation (Ishitani et al., 2003). 
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Identity Mass (kD) MOWSE Score % Coverage 
Sselp 77.4 2.31e+6 24 
Ssa2p 69.6 6.905e+07 26 
YolO93wp 34.5 2.249e+10 62 
Tdh3p 35.8 1.512e+07 48 
RpaOA/Bp 27.9 4.291e+04 50 
Rp55bp 15.8 8.75e+005 60 
Figure 4.7 A Summary of the Results for the TAP Purification of 
YolO93wp 
Proteins were recovered from purification of the C-terminal TAP-tagged YolO93wp. Lane M 
represents molecular weight markers. The components successfully identified by mass 
spectrometry are shown on the right of the gel and on the table. The MOWSE score reported 
by MS-Fit is based on the scoring system described in Pappin eta!, 1993. % Coverage = the 
percentage of the protein covered by matched peptides. 
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4.3 Discussion 
In this work, it has been demanstrated that the Yo1093w protein was expressed in the 
TAP-tagged strain, and could be purified followed the TAP purification precedure. 
However, despite several bands being recovered on SDS-PAGE gels by TAP 
purification of the Yo1093wp complex, only two heat shock proteins, two ribosomal 
proteins, one glyceraldehyde-3-phosphate dehydrogenase, and Yo1093wp-CBP have 
been identified by the mass spectrometry. Heat-shock and ribosomal proteins are 
often recognised as contaminant proteins (Gavin et al., 2002). They are highly 
expressed proteins (Garrels et al., 1997), and in a study of TAP-tagging experiment, 
they appeared in more than 20 of the TAP purifications (3.5%) (Gavin et al., 2002) 
Therefore, they were usually considered as the experimental background. However, a 
DNAIRNA binding domain was found in the YoI093wp sequence analysis (section 
3.1), one cannot exclude the possibility that these ribosomal proteins may really 
interact with Yo1093wp in vivo. This could be further investigated by other 
experiments, such as co-immunoprecipitation. Glyceraldehyde-3-phosphate 
dehydrogenases are constitutively expressed in yeast cells (McAlister and Holland, 
1985), and are some of the most abundant proteins in yeast cells (Krebs, 1953). 
Therefore, it is possible that Tdh3p is also not a natural interactor of Yo1093wp. 
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CHAPTER FIVE 
Yeast Two-hybrid Screen of 
Yo1093wp 
In conjunction with the TAP tag purification method, the yeast two-hybrid system 
was used to identify natural interactors of Yo1093wp. By comparing results from 
these two assays, the significance of identified interacting proteins could be revealed. 
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5. 1 Yeast Two-hybrid System 
The two-hybrid system is a genetic assay for detecting protein-protein interactions in 
vivo. The basic concept of the yeast two-hybrid system is to detect the interaction 
between two proteins via transcriptional activation of one or several reporter genes 
(Fields and Song, 1989). A classical transcription activator contains a domain that 
specifically binds to a DNA sequence (the binding domain, BD) and a domain that 
recruits the transcription machinery (the activation domain, AD). Brent and Ptashne 
showed that the activation domain of yeast GAL4, a yeast transcription factor, could 
be fused to the DNA binding domain of E. co/i LexA to create a functional 
transcription activator in yeast (Brent and Ptashne, 1985). In the yeast two-hybrid 
system, these two domains are distinct polypeptides, each fused to a polypeptide, X 
and Y respectively. The application of the assay requires the co-production of two 
chimeric fusion proteins within one cell: (a) the bait protein consisting of the BD 
fused to a protein of interest (X); (b) the prey protein consisting of the AD fused to a 
protein (Y). Transcription will occur only if X and Y interact with each other (Figure 
5.1). The two-hybrid system has been used to investigate the interactions of two 
proteins or alternatively, by constructing a library of prey fusion proteins, a large 
number of proteins can be screened to identify proteins which interact with protein X. 
The yeast two-hybrid assay has three main applications in the study of protein-
protein interactions: (1) It can be used to provide molecular evidence for an 
interaction suspected between two proteins as a result of genetic or biochemical data, 
physiological experiments, sequence similarity etc. (2) It can be used to screen a pool 
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of clones that encode proteins to identify factors which interact with a protein of 
interest. (3) To define domains or individual amino acid residues which are critical 
for a particular interaction. 
The main advantage of the two-hybrid system is that it is a highly sensitive technique 
and can detect interactions not revealed by other methods. It is also an in vivo assay 
and therefore the protein components are present in the natural environment of the 
cell and are not subjected to harsh conditions. A significant advantage of the assay is 
that, unlike classical genetic screening methods such as synthetic lethal screens, it is 
not a prerequisite to isolate a conditional lethal mutant of the gene of interest. A two-
hybrid screen utilise of the wildtype sequence of the gene and therefore non-essential 
ORFs and novel genes for which no conditional mutants are available can be 
analysed. Another beneficial characteristic of the system is that a library screen 
results in the immediate availability of the gene encoding the interacting protein(s), 
therefore there is no need for any protein purification steps. In addition, the 
completion of the yeast genome sequencing project in 1996 allows the rapid 
identification of interacting factors generated by a two-hybrid screen. 
Nevertheless, the yeast two-hybrid system is an indirect genetic assay. Intrinsic 
limitations of the yeast two-hybrid system include reliance on complex 
transcriptional activation of reporter genes. Incorrect folding, inappropriate 
subcellular localization (bait and prey proteins must interact in a nuclear 
environment), or degradation of chimeric proteins and absence of certain types of 
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posttranslational modifications in yeast could lead to false negatives. Other 
properties of the assay may lead to the selection of false positives. 
In this study, the two-hybrid system was used to detect proteins that interact with 
Yo1093wp in order to further understand the biological functions of Yo1093wp. 
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Figure 5.1 General Overview of the Two-hybrid System by Mating 
Two hybrid proteins are produced within one cell: the bait fusion, consisting of the DNA-
binding domain (BD) of a transcriptional activator fused to a protein of interest X and the prey 
fusion, consisting of the transcription activation domain (AD) of a transcription factor fused to 
a protein Y. The interaction between the protein X and Y brings the two previously separated 
functional domains of a transcription factor together and can thus be monitored through the 
successful transcription of a reporter gene. This binds to an upstream activation sequence 
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5. 2 Yeast two-hybrid Screen Analysis of YOL093W 
5.2.1 Introduction 
5.2.1.1 General Strategy 
An efficient mating strategy (as shown in the schematic representation below) was 
used in the study. 
In brief, the L40LG (Table 2.6) strain transformed with the bait plasmid and a Y187 
(Table2.6) strain transformed with a yeast genomic DNA library (FRYL library, 
section 5.2.1.3). The mating procedure allows use of selective plates for direct 
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selection because the two fusion proteins are already produced by the parental cells. 
No replica plating is required. Prey plasmids from all colonies are sequenced at the 
Ga14 domain junction and prey fragments are classified according to their heuristic 
value. The classification of interacting proteins found in a two-hybrid screen allows 
selecting prey proteins to be used as bait for second-round screens. 
5.2.1.2 Bait Plasmid 
Bait plasmid was the pBTM1 16 vector, which encodes a LexA fusion protein. The 
plasmids were transformed into the L40EG strain containing His3 and LacZ reporter 
genes under the transcriptional control of LexA binding sites (Fromont-Racine et al., 
2000). 
5.2.1.3 FRYL Library 
The FRYL library utilised in the two-hybrid screens described was constructed by M. 
Froment-Racine in the laboratory of P. Legrain (Institut Pasteur, Paris, France) 
(Fromont-Racine et al., 1997). The FRYL library is a genomic DNA library 
composed of random fragments, and all the genomic regions should be present with 
more or less the same frequency. The library comprises 5 x 106  clones, with 
randomly generated inserts of an average size of 700 base pairs. Given the size of the 
yeast genome (12 x 106  bp), a fusion event occurs statistically once every 4 base 
pairs. Any given ORF should be present in multiple fusion fragments in the library. 
The Y187 yeast strain was transformed with the FRYL library DNA, and stored at - 
80°C. 
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5.2.1.4 Mating Experiment 
L 
Two strains were used: Y187, which harbours a sensitive lazZ reporter gene for Ga14 
binding domain bait proteins, and MOLG, which contains the yeast HIS3 and the 
bacterial lacZ reporter genes under the transcriptional control of lexA operators. The 
HJS3 gene is required in the yeast histidine biosynthetic pathway and it expression 
facilites colony growth in the media lacking histidine. 3-aminotriazole (3AT) is an 
inhibitor of the dehydratase encoded by the HIS3 gene. The bait-mediated 
background trans-activation can by reduced by including 3AT in the medium. The 
HIS3 gene also enables the selection of positive diploids in the absence of 3AT. The 
Y187 strain was transformed with the genomic library and MOLG cells harboured 
LexA bait plasmid. The L4OtG was generated by replacing the entire Ga14 coding 
sequence in LAO strain with the kanamycin-resistant cassette. Thus Ga14 activation 
domain-derived libraries transformed into Y187 were used for two-hybrid screens 
with LexA bait proteins. Diploid cells generated from the L40AG strain with Y187 
cells contain two LazZ genes. The one from the L4OLtG strain was controlled by 
LexA binding sites and functioned as a reporter gene for LexA baits, and the one 
from Y187 cells is controlled by Ga14 binding sites and is inactive in these diploid 
cells. 
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5.2.1.5 Classification of Prey 
To facilitate post-screen analysis, all candidates generated from a two-hybrid screen 
are classified into one of five categories (Figure5.2, as defined by Fromont-Racine et 
al., 1997). The Al category contains the most statistically significant candidates 
produced by a screen. These ORFs are those for which at least two distinct 
overlapping fusions are found. The A2, A3, and A4 ORFs are found only a single 
fusion, even though the same is found several times. The A2 ORFs are fusions 
starting close to the initiation codon of a yeast ORF, within 150 bases of the in-frame 
stop codon located upstream of this ORF. The A3 ORFs are fusions containing 
coding inserts of more than 1000 bases (significantly longer than the mean size of 
fragments in the library). The A4 category simply corresponds to prey which are 
found as single fusions and do not qualify for A2 or A3 status. B fusions express 
nonbiological peptides, i.e., antisense or intergenic regions. Out-of-frame fusions 
might be selected in the process. They are not discarded as they may encode genuine 
yeast polypeptides resulting from a frameshifting event. 
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Figure 5.2 Classification of Prey Selected in Two-hybrid Screens 
A fragment of a yeast chromosome is depicted, containing an open reading frame (open 
box). The initiation and termination codons of the ORF are included. The domain is shown 
(black box). Arrows indicate the position, length and orientation of the isolated fragments. 
The categories of prey are defined on the right. 
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5.2.2 Construction of the pBTM1161YOL093WBait Plasmid 
The two-hybrid screens performed in this study utilize bait based upon the E.coli 
repressor LexA DNA-binding domain. In order to fuse Yo1093w protein to the LexA 
binding domain, the full-length Y0L093 W open reading frame flanking by restriction 
enzyme sites was amplified by PCR using yeast genomic DNA of strain BMA38(2n) 
as a template. The PCR product was cloned into the pBTM1 16 vector to create 
pBTM1 161Y0L093W. The construct was confirmed by enzyme digestion (Figure 
5.3). This high copy-number plasmid produces the bacterial LexA DNA binding 
domain-Yo1093wp fusion protein under the transcriptional regulation of the 
constitutive ADH1 promoter. The 5' vector-insert junction and the entire insert were 
verified by DNA sequencing (data not shown). 
5.2.3 Construction of Yeast Strain Containing pBTM1161VOL093W Bait 
Plasm id 
The pBTM1 161YOL093W plasmid was introduced into yeast strain L4OLG to make a 
yeast strain containing bait plasmid (Table 2.6). Transformants were propagated on - 
W (Tryptophan) drop-out medium. The clone growing on the selective plate were 
restreaked and investigated by Western blot analysis to confirm the fusion protein 
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Figure 5.3 Construction of the pBTM1161YOL093W Bait Plasmid 
The YOL093W ORF was amplified by PCR from genomic DNA of strain BMA38(2n). The 
900bp PCR product was then digested with EcoIRI/BamHI, and ligated into the vector 
pBTM116. (A) A schematic representation of the cloning strategy used to construct 
pBTM116/YOL093W. (B) The construct was confirmed by the EcoRl/BamHI enzyme 
digestion. The arrow indicates the 930 bp DNA fragment, which would be expected following 
successful construction of pBTM116/ YOL093Wis indicated. V: pBTM116 vector. 
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5.2.4 Yeast Two-hybrid Screens with the pBTM116/YOL093W Bait 
Plasmid 
The initial two-hybrid screens (section 2.2.7) with the pBTM1 161YOL093W in this 
study were performed. The L40LG cells harbouring the pBTM1 16/YOLO93W bait 
plasmid were mated with the Y187 cells containing the FRYL library (Jean Beggs 
laboratory, University of Edinburgh, UK). After four-hour incubation, cells were 
collected and distributed on —LWH and —LWH+3AT (ranging from 1-50 mM) plates. 
To determine the mating efficiency, the number of diploids was estimated. For this 
purpose, an aliquot of cell suspension was diluted by three 10-fold dilutions steps. 50 
t1 of the 1000-fold dilution were spread onto —L, —W and —LW plates. 
Unfortunately, the Y187 cells containing the FRYL library were contaminated. There 
were two kinds of colonies formed on —LWH+3AT plates with different colours (red 
and white). The colonies turned into abnormal shape with further incubation. This 
made the two-hybrid screens with the pBTM1 161Y0L093W bait plasmid impossible 
to carry out. Consequently, another yeast two-hybrid screen for the other bait 
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Figure 5.4 Western Analysis of LexA-Yo1093wp Fusion Protein from L40 
G IpBTM116-YOL093W 
Crude cell extracts were prepared from L40G (wild type, lane 1) and from L40 G 
/pBTM116-YOL093W (lanes 2 & 3). Proteins were fractionated on a 15% SDS-PAGE gel, 
electroblotted and probed with antibodies against LexA. Immunodetection was with HRP-
conjugated anti-rabbit antibodies. And proteins were visualized by ECL (Amersham). The 
position of the LexA-Yo1093wp fusion protein is indicated. 
154 
Chapter Five: Yeast Two-Hybrid Screen of YoIO93wp 
5.2.5 Construction of the pB27/YOL093W Bait Plasmid 
The two-hybrid screens performed in this part of study also utilized bait based upon 
the E.coli repressor LexA DNA-binding domain. The full-length YOL093W open 
reading frame flanking by restriction enzyme sites was amplified by PCR using yeast 
genomic DNA of strain BMA38(2n) as a template. The PCR product was cloned into 
the pB27 vector to create the pB27IYOL093W. The construct was confirmed by 
enzyme digestion (Figure 5.5). This high copy-number plasmid produces the 
bacterial LexA DNA binding domain-Yo1093wp fusion protein under the 
transcriptional regulation of the constitutive ADH1 promoter. The 5' vector-insert 
junction and the entire insert were verified by DNA sequencing (data not shown). 
5.2.6 Yeast Two-hybrid Screens with the pB271 Y0L093 W Bait Plasmid 
The two-hybrid screens with the pB27/YOL093W were performed by 
HYBRIGENICS (As a service; a kind gift from Jean Beggs). HYBRIGENICS was 
set up using the yeast two-hybrid expertise of Pierre Legrain and Jean-Rain for 
commercial purpose. In this study, fifty million diploid cells were screened. 
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Figure 5.5 Construction of YOL093W Bait Plasmid 
The YOL093WORF was amplified by PCR from genomic DNA of strain BMA38. The -900bp 
PCR product was then cut with Sfil , and ligated into the vector pB27. (A) A schematic 
representation of the cloning strategy used to construct pB27/YOL093W. (B) The construct 
was confirmed by the PstlIEcoAl enzyme digestion. The arrow indicates the -930 bp DNA 
fragment, which would be expected following successful construction of pB27I YOL093W is 
indicated. V: p1327 vector. 
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5.2.7 Results from the Two-hybrid Screen for the pB27IVOL093W Bait 
Plasmid 
The identity and characteristics of the ORF encoded by the prey plasmid resulting 
from the screen are summarised in Figure 5.6. Only one ORF, YGRO23W (MLTJ), 
was identified in the screens. The protein encoded by the YGR023W gene was 
isolated once as an A4 candidate from the screen (section 5.2.1.5). The Mltlp 
protein is comprised of 551 amino acids and has a molecular weight of 57.5 kDa. It 
is involved in cell wall biogenesis. The isolated clone was in the A4 class, so it is 
possibly the result of non-specific interaction with the bait protein. There was 
insufficient evidence to suggest that this candidate actually interacts with Yol093wp 
in the cell and therefore will not be studied further. 
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Result of the Two-hybrid Screen 
\ 
OAF GENE nt OF OAF FREQUENCY OThER 
GATEGORY 
NAME NAME FUSION SIZE IN SCREEN INFOAMA11ON 
Involved in Cell 
YGRO23W FvffLl 612 1656 1 A4 
Wall Blogeneals 
Figure 5.6 Result of Two-hybrid Screen with pBT27/VOL093W 
The OAF and gene names were given by the Saccharomyces Genome Database (SGD). Nt 
of fusion refers to the distance from the start of the coding sequence to the point at which the 
fusion begins. ORF size is the number of nucleotides from the ATG initiation codon to the 
termination codon. Frequency in screen refers to the number of identical fusions that were 
isolated in the screens. The category used is described in Section 5.2. 
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5. 3 Discussion 
In this work, only one protein, Mtllp, was retrieved in the two-hybrid screens of 
Yo1093wp. The significance of this interaction was relatively low, so that it did not 
suggest possible biological functions of YoI093wp. The possible reasons for lack of 
results were: (1) The clone could be under-represented in the library. (2) The library 
was predominantly small peptides; therefore, some large interactors would never be 
full length in this library 
Ito et al (Ito et al., 2001) carried out a comprehensive two-hybrid analysis of the 
budding yeast proteome. They detected 4,549 interactions. Among them, the 
YOL093W fusion preys were retrieved twice when the MEC3 was used as the bait in 
the screens. MEC3 is involved in checkpoint control and DNA repair. However, this 
interaction was not included in their core data, which contains 841 interactions with 
more than 3 Interaction Sequence Tags (1ST) hits. Besides, the network they 
obtained in their screens did include some artefacts. It should be noted that the 
proteins having numerous interaction partners, some of which are likely caused by 
noise in the two-hybrid screens. As expected, the proteins with dozens of binding 
partners should be omitted from the analysis. Therefore, since MEC3 bait also 
identified the other 74 prey ORFs in their screens, it indicated some of them were 
non-specific interactions, and should omitted. 
Hazbun et a! (Hazbun et al., 2003) assigned functions to yeast proteins by integration 
of technology. From their yeast two hybrid data, when using YOL093W as bait 
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plasmid, the SML1 and SMALl were isolated twice in the screens. Smllp is a 
suppressor of mec lethality (Zhao et al., 1998), and a nbonucleotide reductase 
inhibitor (Chabes et al., 1999). Smil null mutant is viable and showed the following 
phenotypes: it suppresses mecl or rad53 lethality; suppresses mipl-1 at 37°C; 
suppresses duni DNA damage sensitivity; increased resistance to DNA damage; 
increased dNTP pools (Zhao et al., 1998). The Smal null mutant undergoes meiotic 
nuclear divisions but does not form spores. Smaip is involved in spore membrane 
assembly (Rabitsch et al., 2001). In Hazbun and his colleagues' screens, Smaip also 
interacted with 11 other proteins. 
All these data may not be conclusive, but they were all indicative of the possibility of 
Yo1093wp involving in DNA metabolism. All of these data may provide clues about 
the function of Yo1093wp. 
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CHAPTER SIX 
Subcellular Localization of 
Yo1093wp 
6.1 Introduction 
Eukaryotic cells are organized into a complex network of membranes and 
compartments, which are specialized for various biological functions. 
Comprehensive knowledge of the location of proteins within these cellular 
microenvironments is critical for understanding their functions and interactions. 
The traditional approach to study protein localization in Saccharomyces cerevisiae 
includes techniques of immunofluorescence microscopy. Tagging a protein with an 
epitope allows the surveillance of the protein with a specific monoclonal antibody. 
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This approach can elucidate the cellular location of a tagged protein as well as its 
size, abundance, posttranslational modifications, and interactions with other proteins. 
In this study, a myc tag was used to study the cellular location of YOL093W. 
Although these methods have been effectively used to visualize the targeting of 
specific cellular components, their use can be limited by the requirement for 
antibodies directed against the target protein. Antibodies against proteins found in 
low abundance can be difficult to obtain, and the level of detection of this class of 
protein is relatively insensitive. To circumvent these potential problems, an 
Aequorea victoria green fluorescent protein (GEP) fusion would be used in parallel. 
Gene fusions using GFP, in general, heightens the sensitivity of molecular detection. 
Since the GEP chromophore is formed by autocatalytic cyclization of three amino 
acids, and fluorescence is triggered by excitation with specific wavelength light, 
neither invasive sample preparation nor substrate addition is required, making it 
possible to study protein localization in living cells. In addition, since GEP is 
relatively small (238 amino acids) and can remain functional even when fused to a 
target protein, it allows protein localization to be monitored in real time. 
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6.2 13myc-tagged YOL093W 
6.2.1 Construction of a 13myc-tagged YOL093WStrain 
In order to investigate the subcellular localization of Yo1093wp, a 13myc-tagged 
version of the protein was also generated. For constructing 13myc fusion, the PCR-
mediated strategy (as shown in Figure 6.1) was used to engineer homology between 
13myc tag and the target gene to create in-frame fusions on the chromosome. Yeast 
strains were generated expressing full-length Yo1093w protein, tagged at the C-
terminal end with the 13myc tag, from their endogenous promoter by inserting the 
coding sequence of 13myc in-frame immediately preceding the stop codon of the 
YOL093W ORF. With this strategy, wild-type levels and patterns of protein 
expression are minimally perturbed. 
A pair of oligonucleotides, Yo1093w-13mycl and Yo1093w-13myc2, was used to 
amplify the 13myc tag and a marker from a plasmid template, and the resulting PCR 
products were introduced into a haploid BMA38((x) yeast strain. Hygromycin B 
(hph)-resistant colonies were streaked out onto fresh YPDA + hph medium for 
colony purification. Transformants were assayed by genomic PCR with one primer 
specific for the GFP tag (primer R-FA6a-MX6) and a second specific for the 
YOL093W ORF (primer Yo1093w-TAP-testl) to determine whether the cassette had 
integrated at the appropriate locus (Figures 6.2). In addition, the 13myc tag 
integration was also confirmed by Western blot analysis with antibodies against myc 
to show that cells produce a myc-tagged Yo1093wp protein. The cells expressed the 
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fusion protein at the expected size of the Yol093wp-myc (Figure 6.3). The resultant 
haploid yeast strains (BMA38((x)IYOL093W-13MYC) (Table 2.6) therefore produces 
C-terminally 1 3myc-Yo1093w protein (Yo1093wp- 1 3myc) which is expressed under 
the control of the endogenous Y0L093 W promoter. 
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Target Yeast OAF 
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yeast horrology 	 yeast horrology 
P/131TTC 	 Marker H_5 bp 
Yeast transformation 
4l 	cP/i,c 	I rvarcer 
I 	Taraet Yeast OAF IIUVII 
Integration by homokgous recorrtnation 
Figure 6.1 Schematic Representation of the Strategy tol3myc or GFP 
Tagging of VOL093Won the Chromosome 
(A) Oligonucleotide primers Yo1093w-1 3mycl and Yo1093w-1 3myc2 were used to amplify the 
GFP or 13myc tag flanking with 45bp upstream sequence of the stop codon of the ORE, and 
45bp downstream sequence of the OAF. (B) The PCR product was then transformed into the 
yeast cells. (C) The tag was integrated though homologous recombination 
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Figure 6.2 PCR on Yeast Transformants to Test the Integration of myc 
Tag into the Chromosome 
After transformation of BMA38((x) strain with a linear PCR product containing the myc tag, 
which should be inserted immediately downstream of the final codon of the YOL093W gene, 
hph-resistant transformants were streaked out onto fresh YPDA + hph medium for colony 
purification. Then cells of the transformants and of the wt parental BMA38((X) strain were 
suspended in water, boiled for 10 minutes and used in a PCR using oligonucleotides primers 
P1: yo1093w-TAP-test 1 and P2: R-hph. (A) The positions on the template at which the 
primers anneal are indicated in the upper schematic drawing of the YOL093W locus (either 
wild type or after myc-tagged). The products of PCR reactions are shown in (B). The 
fragments expected following successful integration of myc tag cassette into the 
chromosome are indicated (lane 1-4 were positive but with weak signal). 
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Figure 6.3 Western Blot Analysis of myc-tagged Yo1093wp from the 
Transformants 
Crude cell extracts were prepared from BMA38(a) (wild type, lane 1) or from transformants. 
Proteins were fractionated on a 4-12% SDS-polyacrylamide gel, electroblotted and probed 
with antibodies against c-myc. Immunodetection was with HRP-conjugated anti-rabbit 
antibodies. And proteins were visualized by ECL (Amersham). The position of the 13myc-
tagged YolO93wp (YolO93wp-1 3myc) is indicated. 
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6.2.2 Immunofluorescence (IF) Analysis of the 13myc-tagged YOL093W 
Strain 
6.2.2.1 Immunofluorescence Analysis 
The strain with 13myc-tagged YOL093W was grown to mid-logarithmic phase in 
medium. The localisation of the fusion protein was visualised by 
immunofluorescence (IF) techniques. Briefly, cells were fixed with 3.7% 
formaldehyde and spheroplasted by Lyticase. After incubation with the first antibody 
against c-myc and the second antibody conjugated with Cy3. DAPI stain 
(Vectashield mounting medium, VECTRA) was also applied onto the cells. The cells 
were then visualized using fluorescence microscopy to characterize Yol093wp-
13myc fusion protein subcellular localization in S. cerevisiae cells. 
6.2.2.2 Localization of Yo1093wp-13myc Fusion Protein 
By using the antibodies against c-myc, and DAPI stain as a marker for the nucleus, 
the localization of Yo1093wp-13myc fusion could be visualized. From the 
micrographs (shown in Figure 6.4), the fusion protein was co-localized with the 
DAPI stain, which suggested that the Yo1093wp-13myc localized in the nucleus. 
Some negative anti-myc images might due to the efficency of myc antibody staining. 
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Figure 6.4 Immunofluorescence Staining of 13myc-tagged YoI093wp 
Strain 
The strain with chromosomally 1 3myc-tagged YOL093W was grown to mid-logarithmic 
phase in medium. Cells were fixed with 3.7% formaldehyde and the localisation of fusion 
protein was detected by anti-myc antibody and visualized by the microscopy. Cells were 
strained with DAPI as a marker for the nucleus. (A) DAPI staining for DNA; (B) anti-myc 
shows the myc protein; (C) merge image. 
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6.3 GFP-tagged YOL093W 
6.3.1 Construction of a GFP-tagged YOL093W Strain 
In order to further clarify the subcellular localization of Yo1093wp, a GFP-tagged 
version of Yo1093wp was generated. The GFP may be fused to either the 5' or 3' end 
of the target gene, to generate either amino- or carboxy-terminal fusions, respectively. 
This choice is often made by predicting which region of the protein will most likely 
tolerate the addition of extra amino acids and still remain functional. The strategy 
chosen in this work, as shown in Figure 6.1, for constructing GFP fusions is to use 
PCR to engineer homology between GPF and the target gene to create in-frame 
fusions on the chromosome. Yeast strains were generated expressing full-length 
Yo1093w protein, tagged at the C-terminal end with the GFP tag, from their 
endogenous promoter by inserting the coding sequence of GFP in-frame immediately 
preceding the stop codon of the YOL093W ORF. With this strategy, wild-type level 
and pattern of protein expression are minimally perturbed. 
We tagged the YOL093W ORF in its chromosomal location through oligonucleotide-
directed homologous recombination. A pair of oligonucleotides, Yo1093w-13mycl 
and Yo1093w-13myc2, was generated that had homology to the desired chromosomal 
insertion site at the 5' end of each primer and homology to a vector containing the 
GEP tag at the 3' end. These primers were used to amplify or GFP tag and a marker 
from a plasmid template, and the resulting PCR products were transformed into a 
haploid BMA38(a) yeast strain (Figure 6.1). The selectable marker kanamycin (kan, 
G418)-resistant colonies were streaked out onto fresh YPDA+ kan medium for 
colony purification. Transformants were assayed by genomic PCR with one primer 
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specific for the GFP tag (primer R-FA6a-MX6) and a second specific for the 
YOL093W ORF (primer Yo1093w-TAP-testl) to determine whether the cassette had 
integrated at the appropriate locus (Figure 6.5). The resultant haploid yeast strains 
(BMA3 8(a)/Y0L093 W-GFP) (Table 2.6) therefore produces C-terminal GFP-tagged 
Yo1093w protein (Yo1093wp-GFP) which is expressed under the control of the 
endogenous Y0L093 W promoter. 
171 













M 	wt 	1 	2 
bp 
g 	 4- 779 
Figure 6.5 PCR on Yeast Transformants to Test the Integration of GFP 
Tag into the Chromosome 
After transformation of BMA38(a) strain with a linear PCR product containing the GFP tag, 
which should be inserted immediately downstream of the final codon of the YOL093W gene, 
Kan-resistant transformants were streaked out onto fresh YPDA + kan medium for colony 
purification. Then cells of the transformants and of the wt parental BMA38(a) were 
suspended in water, boiled for 10 minutes and used in a PCR using oligonucleotides primers 
P1: yolO93w-TAP-test 1 and P2: R-FA6a-MX6. (A) The positions on the template at which 
the primers anneal are indicated in the upper schematic drawing of the YOL093W locus 
(either wild type or after GFP-tagged). The products of PCR reactions are shown in (B). The 
fragments expected following successful integration of GFP tag cassette into the 
chromosome are indicated. 
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6.3.2 Fluorescence Analysis of the GFP-tagged YOL093W Strain 
6.3.2.1 Fluorescence Analysis 
In this work, GFP signal was monitored in fixed cells. The strain with GFP-tagged 
YOL093W has been analysed using fluorescence microscopy to characterize protein 
subcellular localization of the protein inside a yeast cell. This strain was grown to 
mid-logarithmic phase in medium. Cells were fixed with 3.7% formaldehyde, 
spheroplasted by Lyticase, and visualized by the microscopy. DAPI stain 
(Vectashield mounting medium, VECTRA) was also applied onto the cells. 
6.3.2.2 Localization of YoIO93wp-GFP Fusion Protein 
By using DAPI as a marker for the nucleus, the localization of a Yo1093wp-GFP 
fusion could be visualized. From the micrographs (shown in Figure 6.6), the fusion 
protein was co-localized with the DAPI stain, which suggested that Yo1093wp-GFP 
localized in the nucleus. However, one should be aware that the background level 
expression was quite high, which might influence the interpretations. 
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(A) 
Figure 6.6 Immunofluorescence Staining of GFP-tagged YoI093wp 
Strain 
The strain with chromosomally GFP-tagged YOL093W was grown to mid-logarithmic phase 
in medium. Cells were fixed with 3.7% formaldehyde and the localisation of fusion protein 
was detected by fluorescence microscopy. Cells were strained with DAPI as a marker for the 
nucleus. (A) DAPI staining for DNA; (B) GFP image; (C) DIC represents Differential 
Interference Contrast image; (D) merge image. 
(C) 
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6.5 Discussion 
In this study, the immunofluorescence micrographs of Yo1093w-GFP and 
Yo1093wp-13myc in combination with DAPI straining suggested that the Yo1093wp 
fusion protein was located in the nucleus. The poorer GFP image may be improved 
by looking at unfixed living cells. The fixation process may affect the apparent 
location of the GEP protein. However, in conjunction with myc-tagging data, it 
revealed the localization of Yo1093p was in the nucleus. 
Huh et al. (Huh et al., 2003) described the construction and analysis of a collection 
of yeast strains expressing full-length, chromosomally tagged GFP fusion proteins. 
They classified the proteins into 22 distinct subcellular localization categories, and 
they defined the subcellular localization of Yo1093wp-GFP fusion protein was in the 
nucleus/cytoplasm. From the micrographs they showed on the website 
(http://yeastgfp.ucsf.edu/displayLoclmage.php?loc=15192),  one could find that the 
GFP signal was much stronger inside the nucleus than in the cytoplasm. 
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CHAPTER SEVEN 
Biochemical Assays o 
Yo-1-093wp 
7.1 Expression and Enrichment of His-Yo1093w Fusion 
Protein in E. coil 
7.1.1 Introduction 
To investigate the function of the Yo1093wp in vitro, the recombinant His-tagged 
Yo1093wp was expressed in E. coli. The expression vector used in this work was 
pET-16b (Navogen). pET vectors are ideal for protein expression in E. coli as they 
allow the gene of interest to be cloned under the control of the T7 promoter, which is 
not recognized by E. coli RNA polymerase (Dubendorff and Studier, 1991). 
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Therefore, no expression occurs until a source of T7 RNA polymerase is provided, 
allowing tight control of expression and avoiding plasmid instability due to the toxic 
effect that many expressed proteins may have on the host. The His.Tag®  sequence 
allows one-step protein enrichment as it binds to divalent cations (Ni 2 ) that can be 
immobilized on nitrilotriacetic acid (NTA) resin used for chromatography. The E. 
coli strain BL21 is ideal for protein expression using pET vectors as it carries the T7 
RNA polymerase gene under the control of the isopropyl-beta-D-
thiogalactopyranoside (IPTG)-inducible lacUV5 promoter. In addition, the strain is 
deficient for both ion and ompT proteases to reduce protein degradation. 
7.1.2 Expression of the His-YoI093wp in E. coil 
The ORF of YOL093W was acquired from the American Type Culture Collection 
(ATCC) as a lambda phage clone. The phage strain was used to amplify the 
YOL093W ORF that was inserted into a multiple cloning site of pET-16b vector 
(Novagen). The YOL093W sequence was fused to an N-terminal His.Tag®  (6 His 
residues) present in the pET-16b vector. The construct, pET-16b/YOL093W (Figure 
7.1), was prepared by John Connelly (University of Edinburgh). E. coii strain BL21 
(DE3) pLysS (Novagen, Table 2.5) was transformed with the pET-16b/YOL093W 
construct. Expression of the His-Yol093w fusion protein was induced by addition of 
IPTG. A high level of expression was obtained after four hours induction. His-
Yo1093wp was present in the cell supernatant, and therefore was soluble (Philip 
Jordan, this lab, University of Edinburgh). A mock induction of cells transformed 
with the pET-16b vector containing no insert was also performed as a negative 
control. 
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BL21 (DE3)pLysS 
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Figure 7.1 Production of Recombinant YoI093wp in E. coil 
Schematic diagram showing the product and purification of recombinant YolO93wp. Plasmid 
pET-16b/YOL093Wwas transformed into BL21(DE3)pLysS cells. IPTG was added to induce 
His-YolO93wp synthesis. The cells were then lysed, and the extract passed down a Ni-NTA 
column and eluted, resulting enriched YolO93wp. The double circles represent the Ni-NTA 
column enriched His-Yolo93wp. 
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7.1.3 Enrichment of His-YoI093wp by Ni-NTA His.Bind ® Affinity 
Chromatography 
Cell extracts of His-Yo1093wp and the mock control were enriched using Ni-NTA 
His.Bind® Resin column chromatography (Novagen) (section 2.3.3.11). His-
YoI093wp and the mock supematants were applied to a 10-mi Ni-NTA column that 
was used for one-step purification of proteins containing His tag sequence by metal 
chelation chromatography. The His tag sequence bound to Ni 21  cations, which were 
immobilized on the Ni-NTA resin. After this unbound proteins were washed away, 
His-Yo1093wp was recovered by elution with imidazole. An Imidazole ring ispart Of 
the structure of histidine. The imidazole rings in the histidine residues of the His tag 
sequence bind to the nickel ions immobilized by the NTA groups on the matrix. 
Imidazole itself also can bind to the nickel ions and disrupt the binding of the 
histidine residues in the His sequence. When imidazole is applied to the Ni-NTA 
column, it competes with the bound protein resulting in its elution. Non-specific 
binding can be reduced by including a low concentration of imidazole in the 
lysisfbinding and wash buffer (5-20 mM imidazole). His-YolO93w fusion protein 
was dissociated from the Ni-NTA resin with imidazole. During a 1000 mM 
imidazole elution, fractions were collected. 20 pi of each fraction were subjected to 
SDS-PAGE (section 2.3.3.3.2) and stained with Coomassie blue (section 2.3.3.4). 
The results are shown in Figure 7.2. Coomassie blue staining revealed that the 
Yo1093wp preparation contained a number of other polypeptides: these could be 
contaminating proteins or degradation products of Yo1093wp itself. Fractions (fr. 13-
22) that contained the highest levels of Ni-NTA enriched His-Yo1093wp were 
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combined, and stored at -80°C. Identical fractions of the mock elution were also 
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(A) His vector only 



















Figure 7.2 Enrichment of His-Yo1093wp by Ni-NTA His.Bind ® Affinity 
Chromatography 
40 .tl of each sample were boiled for 5 minutes, and then 20 lal of samples were assessed by 
SOS-PAGE. The proteins were visualized by Coomassie blue staining. The enriched 
His.Tag®-Yol093wp is indicated. M: broad range protein marker; L: cell lysate; RT: Ni-NTA 
His.Bind Resin cell lysate supernatant run through (5 mM imidazole); Wi: Ni-NTA His.Bind 
Resin binding buffer wash (5 mM imidazole); W2: Ni-NTA His.Bind Resin washing buffer 
wash (60 mM imidazole); 12-39: elute fractions (1000 mM imidazole). 
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7.1.4 Concentrating Ni-NTA Enriched His-YoI093wp Fractions by 
VIVASPIN6 Concentrators 
The combined Ni-NTA enriched His-YolO93wp fractions (fr. 13-22), as well as 
identical fractions of the mock control, were concentrated by VIVASPIN6 
concentrator according to the manufacturer's instructions. The VIVASPIN6 
concentrators (Vivasceience) are disposable ultrafiltration devices for the 
concentration and/or purification of biological samples. The concentrator features 
twin vertical membranes for unparalleled speed and it is with a molecular weight cut-
off of 30,000 Da (MWCO 30,000). 20 tl of each of the resulting samples were 
assessed by SDS-PAGE. Proteins were visualized by Coomassie blue staining 
(Figure 7.3). It should be noted that the solution volume was only reduced to half and 
was only reduced to 1/4 for the mock control. This might be because the 
concentration of Ni-NTA enriched Yol093wp fractions was too high, so that the 
solution could not run through the membrane totally. 
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Lane 1: Ni-NTA enriched mock control 
Lane 2: Ni-NTA enriched His-Yo1093wp 
Lane 3: VIVASPIN6 concentrated mock control 
Lane 4: VIVASPIN6 concentrated His-Yo1093wp 
M: Broad range protein marker (NEB) 
Figure 7.3 Concentrating Ni-NTA Enriched YoIO93wp 
40 tl of each sample were boiled for 5 minutes, and then 20 .tl of samples were subjected to 
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7.2 DNA Binding Activity of Ni-NTA Enriched YoI093wp 
7.2.1 Double Strand (ds) DNA-Binding Assays Using Agarose Gel 
Electrophoresis 
As the known Holliday junction (HJ) resolvases are metal-ion dependent 
endonucleases that recognize and cleave four-way DNA junctions (reviewed in 
(White et al., 1997)), and as mentioned previously in Chapter 3, Yo1093wp sequence 
prediction revealed a DNA binding domain, Ni-NTA enriched His-Yol093wp and 
VIVASPIN6 concentrated His-Yo1093wp Were assessed for possible DNA binding - - 
activity (section 2.3.3.12). 
Circular and linear DNA was used in the assays. As revealed in Figure 7.4, Ni-NTA 
Yo1093wp enrichment caused gel mobility shifts to both double-strand circular and 
linear DNA substrates run on agarose gels, whereas Ni-NTA mock enrichment did 
not. This suggested that Ni-NTA enriched Yo1093wp had DNA binding properties. 
It should be noted that Ni-NTA enriched Yo1093wp showed more obvious binding 
shift than VIVASP1N6 concentrated Yo1093wp. Additionally, the gel mobility shift 
was concentration-related. With increased the protein concentration, decreased gel 
mobility was observed on agarose gels (Figure 7.5). 
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(A) pBR322 (circular) 	 (B) pBR322JEcoRI (linear) 







(C) PCR product (linear, 500 bp) 
Figure 7.4 dsDNA-Binding Assays Using Agarose Gel Electrophoresis 
Binding assays were carried out on ice for 30 minutes with different DNA substrates. (A) 
pBR322 DNA (NEB, circular) (B) pBR322 DNA digested with EcoRl (4316 bp, linear) (C) 
PCR product (500 bp, linear). The entire reactions were loaded on 0.8% agarose gels. Ml: 
100 bp DNA ladder; M2: A DNNEco4RI+Hindlll marker; Lanel: negative control (DNA 
substrates + elution buffer); Lane 2: DNA substrates + VIVASPIN6 concentrated YolO93wp 
(2 jtl); Lane 3: DNA substrates + Ni-NTA enriched YolO93wp (2 p1); Lane 4: DNA substrates 
+ Ni-NTA enriched mock proteins (2 41). 
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Figure 7.5 DNA Binding Assays with Difterent Concentrations of Ni-NTA 
Enriched YoI093wp Using Agarose Gel Electrophoresis 
Binding assays were carried out on ice for 30 minutes with different DNA substrates. (A) 
pBR322 DNA (NEB, circular) (B) pBR322 DNA digested with EcoRl (4316 bp, linear) (C) 
PCR product (500 bp, linear). The entire reactions were loaded on 0.8% agarose gels. M: A 
DNAJEcoRI-i-Hincilll marker; Lanel: negative control (DNA substrates + elution buffer); Lane 
2-6: DNA substrates + different concentrations of Ni-NTA enriched Yol093wp (2 l.tl). 
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7.2.2 Single Strand (ss) and Double Strand (ds) DNA-binding Assays 
Using Polyacrylamide Gel Electrophoresis (PAGE) 
The gel mobility shift assays were also analysed using non-denaturing 
polyacrylamide gel electrophoresis (PAGE) (section 2.3.3.3). 
To assess the DNA binding ability of Ni-NTA enriched Yo1093wp and VIVASPIN6 
concentrated Yo1093wp, a 60 bp 32P-labelled dsDNA ([y-32P]-dsDNA) was incubated 
with various amounts of protein, and gel mobility shift assays performed. In the 
absence of M902, a Yo1093wp-ssDNA and Yo1093wp-dsDNA complex that did not 
enter the gel was observed (Figure 7.6A). It revealed that more binding complex was 
obtained from Ni-NTA enriched Yol093wp and VIVASPIN6 concentrated 
Yo1093wp, which was similar to the result from agarose assays (Figure 7.4). 
Therefore, Ni-NTA enriched Yo1093wp was used for following assessments. 
To know if the binding is specific to YoI093wp extracts, not to the vector itself, a 60 
bp [y-32P]-dsDNA or a mobile [y-32P]-HJ was incubated with 2 j.tl of Ni-NTA 
enriched Yo1093wp and Ni-NTA enriched mock control proteins on ice for 30 
minutes. It showed that Ni-NTA Yo1093wp enrichment caused gel mobility shifts to 
DNA substrates run on polyacryamide gels, whereas Ni-NTA enriched mock did not 
(Figure 7.613); similar to that observed for the assays on agarose gels (Figure 7.4). In 
addition, as revealed in Figure 7.6C, more binding complexes were formed by 
increasing amounts of Ni-NTA enriched YoI093wp. 
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To learn about the DNA-binding preferences of Yo1093wp extracts, a 60 nt [y- 32P]-
ssDNA or a 60 bp [y- 32P]-dsDNA or a mobile [y- 32P]-HJ was incubated with 2 pi of 
Ni-NTA enriched Yo1093wp on ice for 30 minutes and gel mobility assay was 
performed. It showed that Ni-NTA Yo1093wp extracts bound preferentially to the 
mobile four-way junction compared to a 60 nt-ssDNA or a 60 bp-d5DNA (Figure 
7.6D). The difference is also shown in Figure 7.7. 
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Figure 76 Polyacrylamide Gel Electrophoresis of DNA Binding Assays 
of Yo1093wp Extracts (1) 
Binding assays were carried out on ice for 30 minutes with various DNA substrates. (A) A 60 
bp [y-P]-dsDNA was incubated with various amounts of Ni-NTA enriched or VIVASPIN6 
concentrated Yol093wp on ice for 30 minutes. (B) A 60 bp [y- 32 P]-dsDNA or a [y- 32 P]-HJ was 
incubated with Ni-NTA enriched Yo1093wp (1 i.tl) on ice for 30 minutes. (C) A 60 bp [y-P].. 
dsDNA or a [y-32P]-HJ  was incubated with various amounts of Ni-NTA enriched Yol093wp on 
ice for 30 minutes. (D) A 60 nt [y-P]-ssDNA or a 60 bp [y-P]-dsDNA or a mobile [y- 32 P]-HJ 
was incubated with Ni-NTA enriched Yo1093wp (2 pi) on ice for 30 minutes. The entire 
reactions were subjected on 4-6% polyacrylamide gels. -ye: negative control (DNA 
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Binding Assays 
Figure 7.7 A Bar Graph of DNA Binding Assays of Ni-NTA Enriched 
YolO93wp Using Polyacrytamide Gel Electrophoresis 
A 60 nt [y-32P]-ssDNA or a 60 bp [y- 32P]-dsDNA or a mobile [y- 32 P]-HJ was incubated with Ni-
NTA enriched Yol093wp (2 il) on ice for 30 minutes, and gel mobility shift assay was 
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As mentioned previously, HJ resolving enzymes are ion-dependent, so the effect of 
M902 was tested. Furthermore, the effect of S-adenosylmethionine (SAM) on the 
Yo1093wp-DNA complexes was also tested (see section 7.3). A 60 nt [y- 32P]-ssDNA 
or a 60 bp [y-32P]-dsDNA or a mobile [y- 32P]-HJ was incubated with 2 pi of Ni-NTA 
enriched Yo1093wp in the presence or absence of Mg 2 and SAM, and gel mobility 
shift assay was carried out. In the presence of low (1 mM) and high (10 mM) M902 
concentrations, the amounts of the Yo1093wp-DNA complexes were similar (Figures 
7.7A & B), despite of the amount of Yo1093wp-HJ complex was slightly increased in 
the presence of 5 mM M902  in Figurà 77A. No difference in the amounts of - 
complexes was detected in the presence or absence of SAM (Figure 7.713). 
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Figure 7.8 DNA Binding Assays of Ni-NTA YoI093wp on Polyacrylamide 
Gel Electrophoresis (2) 
Binding assays were carried out on ice for 30 minutes with different DNA substrates. (A) A 
60nt [y-32 P]-5sDNA or a 60bp [y- 32P)-d5DNA or a mobile [y- 32 P]-HJ was incubated with Ni-
NTA enriched or VIVASPIN6 concentrated Yol093wp (2 il) with no or the indicated amounts 
of MgCl2 on ice for 30 minutes. (B) A mobile [y- 32 P]-HJ was incubated with Ni-NTA enriched 
YoI093wp (2 Ill) with the indicated amounts of MgCl 2 and SAM on ice for 30 minutes. The 
entire reactions were subjected on 4-6% polyacrylamide gels. -ye: negative control (DNA 
substrates + elution buffer). The star represents the binding complexes at wells. 
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7.3 DNA Methylation Activity Assay of Ni-NTA Enriched 
YoIO93wp 
Toward the end of this study, Jackman et al. revealed that methylation G9 of yeast 
tRNA' (m 1 G9) is associated with ORF YOL093W, named TRM1O (NA 
methyltransferase) (Jackman et al., 2003). Extracts lacking TnnlOp have 
undetectable levels of m 1 G9 methyltransferase activity but retain normal m 1 G37 
methyltransferase activity. Yeast Trm lOp purified from E. coli quantitatively 
modifies the G9 position of tRNAGIY  in the presence of the methyl donor S-
adenosylmethionine (SAM). TrmlOp is responsible in vivo for most if not all m 1 G9 
modification of tRNAs, based on two results: tRNA °' ' purified from a trmlO-
A/tr,nlO-A strain is lacking detectable m 1 G; and a primer extension block occurring 
at m 1 G9 is removed in tnnlO-&tnnlO-zX-derived tRNAs for all 9 m'G9-containing 
species that were testable by this method. 
tRNA molecules are extensively modified after transcription. In addition to 5'- and 3'-
end maturation, CCA addition, and splicing of introns, all tRNAs contain a number 
of nucleoside modifications (Bjork, 1995; Grosjean et al., 1997; Hopper and Phizicky, 
2003). In Saccharomyces cerevisiae, 25 different modifications of base or sugar 
moieties have been identified within the 34 tRNA species that have been 
characterized (Spnnzl et al., 1998), and every tRNA molecule has some subset of 
these modifications, altering nucleoside identity at an average of 11 positions. The 
identity and position of many of these modifications are highly conserved; however, 
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despite their widespread conservation, the role that these modifications play in the 
cell is not fully understood. 
One modification of interest is methylation of guanosine (G) at the N-i position of 
the base. This modification occurs at two locations in tRNAs. m 1 G is found at 
position 37 in several tRNAs from all three major kingdoms. It is also found at 
position 9 in several cytoplasmic tRNAs from all eukaryotes that have sequenced 
tRNAs, in mitochondrial tRNAs from several animal species, in two vertebrate viral 
tRNAs, and in tRNA from at least one archaeal species (Sprinzl et al., 1998). In the 
yeast S. cerevisiae, m'G is found at position 9 in 10 tRNAs and at position 37 in 8 
tRNAs, with one species, tRNA °, having m'G at both positions. 
As previously we have shown in this work that Yol093wp extracts had DNA binding 
activity, methylation assays (section 2.3.3.13) on a mobile HJ with Ni-NTA enriched 
Yo1093wp were performed. As shown in Figure 7.9, by using the purified tRNAs 
from E.coli as a positive control, the Yo1093wp (TrmlOp) did not reveal DNA (HJ) 
methylation activity in these assays. 
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Figure 7.9 Methylation Assays of Ni-NTA YoI093wp Extracts 
All methylation reactions were carried out at 30°C for 60 minutes. 2 j.tI of Ni-NTA Yo1093wp 
was incubated with tRNA or HJ in the presence of 3 IiM [methyl- 3H]-S-adenosylmethionine 
([3H]-AdoMet). Samples were then spotted on a 2.5-cm circle of Whatman DE81 paper on a 
vacuum manifold, and washed with 5 x 1 ml of 0.2 M NH 4HCO3 , 3 x 1 ml of ethanol, and 1 
ml of diethyl ether. Tritium was determined in 5 ml of a scintillation fluid. 
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7.4 Discussion 
The YOL093W sequence was fused to an N-terminal His tag present in the pET-16b 
vector, and the His-Yo1093w fusion protein was expressed in E. coli. Extracts of His-
Yo1093wp and the mock control were enriched using Ni-NTA His.Bind ® Resin 
column chromatography. The Ni-NTA enriched proteins were then used for 
biochemical assays. 
DNA-binding assays revealed that Ni-NTA enriched Yo1093wp caused gel mobility 
shifts to DNA substrates, whereas Ni-NTA enriched mock did n6t. This iggested 
that Ni-NTA enriched Yo1093wp might have DNA-binding properties, however, 
increasing amounts of Ni-NTA enriched Yo1093wp, a decreasing gel mobility shift 
was observed. It could indicate some protein aggregation might have occurred. It was 
shown that M902, and S-adenosylmethionine (SAM) had no effect on DNA 
complex formation. Furthermore, the results revealed that Yo1093wp extracts bound 
preferentially to a mobile four-way junction than to a 60 nt-ssDNA or a 60 bp-
dsDNA. One should be noted that these experiments were relatively preliminary. 
Neither the protein concentration nor the molarity of DNA substrates was determined. 
Therefore, the preferential binding to four-way junctions should be investigated 
further to elucidate the specificity of this DNA binding. In our methylation assay, 
Yo1093wp extracts did not reveal niethylation activity on the mobile four-way 
junctions using purified tRNAs from E. coli MRE 600 as a positive control substrate. 
As the mechanistic basis for the site specificity and catalysis of m'G modification by 
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Yo1093wp needs to be further clarified (Jackman et al., 2003), this assay was 
relatively preliminary. 
As the Holliday junction resolvases have junction resolving activity, the enriched 
Yo1093wp could be further investigated for nuclease activity. 
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CHAPTER EIGHT 
Overview 
During genetic recombination in meiosis and the repair of DNA strand breaks, DNA 
molecules become linked at points of strand exchange known as Holliday junctions 
(Holliday, 1964). Resolution of these DNA structures was postulated by Holliday to 
be a key event during recombination. Consequently, the search for a DNA 
endonuclease (resolvase) capable of resolving Holliday junctions has driven research 
in this field for the last 20 years. Early research was accelerated by new methods to 
prepare plasmid substrates bearing authentic Holliday junctions and to synthesize 
structures from oligonucleotides that resemble these junctions. Pioneering work in 
West's laboratory led to the discovery of a Holliday junction resolvase encoded by 
the ruvC gene in the bacterium Escherichia coli (West, 1996). The RuvABC 
complex has proved a valuable system for understanding movement and resolution of 
Holliday junctions, but efforts to identify similar activities in eukaryotes have not 
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been as fruitful. Early efforts to purify a cruciform cleaving activity from yeast 
resulted in the identification of Ccelp, an enzyme that works in mitochondria 
(Lockshon et al., 1995). Other studies reported Holliday junction cleavage in extracts 
of yeast and mammalian tissues, but purification was not sufficient to enable 
identification of the gene products involved. 
Following discovery of the Mus8lp-Mms4p (Emeip) complex in yeast and human 
cells (Heyer et al., 2003), biologists were optimistic that they had identified the genes 
encoding the Holliday junction resolvase. Mus8 ip-Mms4p is a structure-specific 
endonuclease, which cleaves a variety of branched DNA molecules including 
Holliday junctions. The discovery that mus8l homozygous diploid mutants of the 
fission yeast Schizosaccharomyces pombe do not exhibit meiotic crossing over and 
that this defect is suppressed by expression of the bacterial resolvase RusA provided 
compelling evidence that Mus8lp is the yeast resolvase (Heyer et al., 2003). 
However, there was concern about the universality of this conclusion given that 
mus8l mutants of the budding yeast Saccharomyces cerevisiae have no obvious 
defects in crossing over. Thus, it seemed likely that eukaryotic cells might have 
another resolvase. 
In 2003, two forms of resolvase activity were identified in extracts of cultured human 
HeLa cells. One was MUS81, and the other co-purified with a branch migration 
activity. This suggested that the RuvABC resolvasome that cleaves Holliday 
junctions in bacteria might have a counterpart in eukaryotic cells (Constantinou et al., 
2002). The coupled branch migration/resolvase activities (described previously by 
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West's group) cleave Holliday junctions symmetrically to produce duplex products 
that can be ligated. In contrast, MUS81-M1MS4 preferentially cleaves Y junctions, 
and the cleavage products from Holliday junctions are not substrates for ligation. 
Thus, identifying branch migration and resolvase activities in mammalian cells has 
preoccupied those working on genetic recombination. 
In the new work, Liu et al. (Liu et al., 2004) follow up on the observation that 
partially purified HeLa cell fractions catalyze ATP-dependent branch migration and 
resolution of Holliday junctions. Their most exciting finding is that this activity 
requires RAD51C, akey recombination/repair protein, but not other proteins knowin 
to be involved in resolution or branch migration (MUS81, WRN, or BLM). 
Depletion of RAD51C with a highly specific monoclonal antibody reduced resolution 
and branch migration to almost background levels; resolvase activity could be 
reconstituted by adding back recombinant protein complexes containing RAD51C to 
the depleted fraction. Furthermore, Liu and colleagues discovered that Chinese 
hamster ovary cell lines lacking RAD51C, or its binding partner XRCC3, had greatly 
reduced resolvase activity. Together, these in vitro results provide compelling 
evidence that, in eukaryotic cells, the Holliday junction resolvase is either RAD51C 
itself or another protein that is activated by RAD5 1C. 
RAD51C is a member of a group of proteins called the RAD51 paralog family 
because they show 20 to 30% sequence identity to RAD51 and to each other 
(Symington, 2002). The genes encoding the budding yeast Rad51 paralogs, Rad55 
and Rad57, were first identified in screens for x-ray-sensitive mutants. Rad55 and 
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Rad57 are required for spontaneous and double-strand break- induced homologous 
recombination. Two of the mammalian paralogs, XRCC2 and XRCC3, were 
identified through genetic studies in which their structural genes were found 
defective in x-ray-sensitive cell lines. RAD51B, RAD51C, and RAD51D were 
discovered using polymerase chain reaction and sequence database analysis. All five 
paralogs have been disrupted in chicken DT40 cell lines--the resulting mutants 
exhibit defects in genetic recombination and DNA repair (Takata et al., 2001). The 
paralogs form two complexes: one composed of RAD51C and XRCC3, and the other 
containing RAD51B, RAD51C, RAD51D, and XRCC2 (Masson et al., 2001). Until 
recently, the paralogs were thought to act during the early steps of DNA repair by 
facilitating loading of RAD5 1 onto single-stranded DNA. This hypothesis was driven 
by the observation that formation of damage-induced RAD51 subnuclear foci 
(thought to correspond to sites of DNA repair) is dependent on the paralogs, and that 
overexpression of RAD5 1 partially suppresses the DNA-repair defect in paralog 
mutant cells (Takata et al., 2001). Recent genetic and biochemical studies suggest 
that the paralogs could also act later during recombination (Brenneman et al., 2002; 
Yokoyama et al., 2003). 
The data that Liu et al. present in support of RAD51C being a resolvase or resolvase 
activator are exciting and persuasive, but certain caveats remain. First, the authors do 
not show directly that RAD51C cleaves Holliday junctions. In vitro studies indicate 
preferential binding of the RAD51C-XIRCC3 complex to single-stranded DNA, 
which is more suggestive of an early role for this complex in recombination. 
However, RAD5 lB does bind to Holliday junctions and could potentially target the 
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complex to DNA structures formed late during recombination (Yokoyama et al., 
2003). Although it remains to be seen whether it is actually RAD51C or an 
interacting factor that is the resolvase, these studies provide compelling evidence 
linking the Rad5 1 paralogs to Holliday junction processing. Without doubt, the 
exciting findings of Liu and colleagues will spur biochemical and genetic studies of 
the Rad5 1 paralog complexes to dissect their late role in recombination, as well as an 
intensive search for interacting proteins. 
In this work, we aimed to identify HJ resolvases through protein sequence 
alignments. Despite the fact that junction resolvases are structurally diverse with low 
sequence similarity among any of the known examples, we identified S. cerevisiae 
Yo1093wp, a potential HJ resolvase, by the PSI-BLAST search with the sequence of 
the yeast mitochondrial resolvase Ccelp or Ydc2p. Yo1093wp is a highly conserved 
protein that is widely found in eukaryotes (Figure 1.4). The homologs of the 
Yo1093wp family are poorly related to each other; an observation similar to the 
families of known resolvases. Besides, the Yo1093wp family of proteins is relatively 
small, which is another characteristic of the known resolvases. As S. cerevisiae is 
recognized as an ideal eukaryotic microorganism for biological studies, and a 
DNAJRNA binding domain was found at the C-terminal of Yo1093wp, Yo1093wp 
was chosen from the family to be investigated in this study. 
A variety of general and specific approaches were used to characterize the functions 
of YOL093W in this study. We have shown that His-tagged Yo1093wp was expressed 
and enriched from E. coli. Biochemical analysis revealed that Ni-NTA enriched His- 
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Yo1093wp might have DNA binding properties (Chapter 7). However, the gel 
mobility shift assays showed an indication of protein aggregation. Stoichiometry of 
binding will be worthy being assessed in the future. One can compete bound dsDNA 
with HJ DNA. This would help to understand if the protein is DNA binding rather 
than just aggregating with DNA. Interestingly, in vitro studies revealed preferential 
binding of Yo1093wp extracts to the mobile four-way junctions than to a 60 nt-
ssDNA or a 60 bp-dsDNA (Chapter 7). The basis of this binding activity is still not 
known. Further analysis will be required to elucidate the specificity of this DNA 
binding. 
Despite the fact that Jackman et al. (Jackman et al., 2003) revealed that cell extracts 
lacking Yo1093wp (named TrmlOp) have undetectable levels of m'G 9 
methyltransferase which catalyses the methylation of G residues to m'G in tRNA °'' 
at position 9, the role of TrmlO protein still needs to be further clarified. Further 
studies are required to address the mechanistic basis for the site specificity and 
catalysis of m'G modification by TrmlOp. A search for homologs of each of two S. 
cerevisiae m 1 G methyltransferase proteins (Trm5p and TrmlOp) by BLAST yields a 
distinct family of enzymes for each one. Independent alignments of these two 
predicted families of m'G methyltransferases yield core sequences of conserved 
amino acids within each group; however, none of these blocks of conserved sequence 
are shared between the two groups of enzymes and their phylogenetic analysis 
indicates that there might have been functional diversification in this family of 
proteins. The methyltransferase proteins responsible for m 1 G37 formation are critical 
in both bacteria and yeast; Salmonella typhimurium trmD mutants and S. cerevisiae 
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trm5 mutants are each severely compromised for growth (Bjork et al., 2001). In 
contrast, a tnn10L? strain does not exhibit any obvious growth defect. Additionally, it 
is noteworthy that the extended superfamily of Trm5p homologs includes proteins 
that modify substrates other than tRNA, including rRNA and DNA (Jackman et al., 
2003). We previously also revealed that a potential DNAIRNA binding domain was 
found at the C-terminal of Yo1093wp, and showed a preferential binding of the 
Yo1093wp extracts to the mobile DNA four-way junctions which contain G residues 
at the junctions. These indicate Yo1093wp might have various functions in cells in 
addition to its tRNA methyltransferanse activity. In our methylation assay, 
Yo1093wp extracts did not reveal methylation activity on the mobile four-way - 
junctions using purified tRNAs from E. coli MRE 600 as a positive control substrate. 
As the mechanistic basis for the site specificity and catalysis of m 1 G modification by 
Yo1093wp needs to be further clarified (Jackman et al., 2003), this assay was 
relatively preliminary. 
Effect of YOL093W deletion on yeast was assessed (Chapter 3). It has been shown 
that cells lacking Yo1093wp have no obvious growth defects under standard growth 
conditions in rich media. Despite the initial observation that my YOL093W deletion 
MYY3 strain (yo1093wzikan1yo1093wLhph) showed lower spore viability and 
potential non-disjunction phenotypes, unfortunately, transformation of MYY3 with 
plasmids producing the wild-type Yo1093wp did not complement the defect. This 
suggested that the defect might be not caused by YOL093W deletion, but by the 
interference of another gene in the genome. Similar observations were also suggested 
in the back-cross experiment and the Y0L093 W gene replacement in the other two S. 
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cerevisiae strains. This circumstance might be avoided by assessing the phenotype 
more at the very early stage of experiments. One should check more gene-knockout 
transforinants in order to confirm the phenotype is reproducible and is really due to 
the gene deletion itself. As any meiotic I segregation defect will give a mixture of 
tetrads with 4, 2 and 0 viable spores as the major classes, and when the diploid parent 
is heterozygous at a locus, a 2:2 segregation of genotypes in the tetrads is expected. 
The most consistent reasonable explanation for a 2:2 segregation of live to dead 
spores in the tetrad of YOL093W deletion MYY3 would be a haplo-lethal mutation 
either associated with the disruption or more likely a random mutation (not insertion 
of the marker) somewhere else in the genorne. Furthermore, rneiotic recombination 
assays were performed in the YOL093W deletion strain. No effect on meiotic 
recombination was revealed. 
In this work, the immunofluorescence micrographs of Yo1093wp-GFP and 
Yo1093wp-13myc in conjunction with DAPI straining suggested that the Yo1093w 
fusion proteins were located in the nucleus. It is believed that tRNA methylation 
occurs in the nucleolus, which is not consistent with the observations in this study. 
Several general approaches were utilised in this work in order to get more clues 
about the functions of YOL093W. To identify Yo1093wp-interacting proteins, a yeast 
two-hybrid screen and TAP tag purification were used. In the two-hybrid screen, 
only one protein, Mtllp, was retrieved with relatively low significance (Chapter 5). 
The TAP purification of Yo1093wp complex showed that the Yo1093w protein was 
expressed in the TAP-tagged strain, and could be purified followed the TAP 
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purification precedure. However, the proteins that were identified as potential 
interactors were either common contaminants of TAP-tagging experiments (heat-
shock proteins and nbosomal proteins), or a very highly expressed protein 
(glyceraldehyde-3-phosphate dehydrogenases) (Chapter 5). These data did not 
generate strong evidence for the in vivo interactors of Yo1093wp. However, in the 
other genome-wide two-hybrid analysis showed the interactions between Yo1093wp 
and Mec3p (Ito et al., 2001), Smaip, or Smllp (Hazbun et al., 2003). Mec3p is 
involved in checkpoint control and DNA repair (Foiani et al., 2000). Smllp is also 
part of the DNA damage response involved in controlling ribonucleotide reductase 
(Chabes et al., 1999) and therefore the concentrations of dNTPs (Zhao et al.,-1998). - - 
Furthermore, Tong et al. performed a large-scale study of the yeast genetic 
interaction network. They showed a synthetic lethal effect between CDC2 and 
YOL093W (Tong et al., 2004). The cdc2-1 allele was used in this screen. CDC2 is a 
catalytic subunit of DNA polymerase delta and is required for chromosomal DNA 
replication during mitosis and meiosis (Aguilera and Klein, 1988), intragenic 
recombination (Gordenin et al., 1992), repair of double strand DNA breaks, and 
DNA replication during nucleotide excision repair (NER) (Burgers, 1998). 
Interestingly, if the mutant polymerase causes frequent pausing of replication, then 
fork reversal may occur and require resolvases for recovery (Grompone et al., 
2002). Tong and colleagues also revealed cdc2-1 had synthetic lethality with genes 
that were mainly DNA repair, replication, replication checkpoint, and meiotic 
genes. Among them, there were the putative resolvases: Mms4p (the partner of 
Mus81p) and Rad57p (the yeast Xrcc3p); checkpoint proteins: Mrclp, Rad24p, 
Radl7p and Ddclp. In fact, Radl7p and Ddclp interact with Mec3p which is the one 
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of the interactors of Yo1093wp by two hybrid (Kondo et al., 1999); (Ito et al., 
2001). It was also shown on the Schizosaccharomyces pombe GeneDB that the 
expression of S. pombe Yo1093wp is dramatically induced on entry to meiosis. 
(http://www.genedb.org/genedb/Search?name=SPAC6B  1 2.09&organi sm=pombe). 
All these data may not be conclusive, but they were all indicative of the possibility of 
Yo1093wp involving in DNA metabolism. Therefore, in addition to its tRNA 
methyltransferanse activity, Yo1093wp might have various biological function 
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